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ABSTRACT

Author: Xing, Zheng. Ph.D
Institution: Purdue University
Degree Received: August 2018
Title: Characterization of the Human DEAD-box RNA Helicase DDX5
Major Professor: Elizabeth Tran
Gene expression in eukaryotes is highly complex. The central player in gene expression
is the messenger RNA (mRNA). After transcription, the mRNA is bound by numerous RNA
binding proteins to form a messenger ribonucleoprotein complex (mRNP) that dictates the
function and fate of the messengers. Proper mRNP formation is critical for gene expression.
DEAD-box proteins are the largest class of RNA helicases that play fundamental roles in RNA
and RNP structure remodeling. However, the precise biological roles of the vast majority of them
are not well described. To fill in this gap, my research focused on the characterization of the
DDX5/Dbp2 subfamily of DEAD-box proteins in gene expression, cellular metabolism, and
carcinogenesis.
My research revealed that DDX5 is an active helicase in vitro. DDX5 has higher RNA
unwinding activities as compared to Dbp2, consistent with longer RNAs and more complex
RNA structures in mammalian cells. Distinct from Dbp2, DDX5 lacks duplex annealing
activities in vitro, which may contribute to faster unwinding. Despite differences in enzymatic
activities, DDX5 complements the growth defects and cryptic transcription of the dbp2∆
Saccharomyces cerevisiae strain, indicating that DDX5 and Dbp2 are funcitonally conserved.
Interestingly, Dbp2 and DDX5 are both involved in glucose metabolism. dbp2∆ yeast
displays reduced glucose uptake and increased respiration. Consistent with this, depletion of
DDX5 in the hepatocyte cell line AML12 leads to downregulation of glycolysis and upregulation
of respiration, indicating that DDX5 is a positive regulator of glycolysis in mammalian cells.
Glycolysis is a key process to maintain cellular energy homeostasis and is elevated in cancer
cells (i.e. the Warburg effect). Furthermore, DDX5 is frequently overexpressed in cancers.
Therefore, DDX5 may function to fulfill the energy requirement of cancer cells. Future research
will examine this hypothesis.
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CHAPTER 1

1.1

INTRODUCTION

Introduction
DEAD-box proteins belong to the superfamily 2 (SF2) helicases (Linder and Jankowsky

2011). Helicases are functionally diverse group of enzymes that are encoded by 1% of human
genes, suggesting biological importance. The DEAD-box proteins are ATP-dependent RNA
helicases. There are 38 members in humans, 25 in yeast and 9 in bacteria (Linder and Jankowsky
2011). Similar to other SF2 RNA helicases, DEAD-box proteins contain twelve highly conserved
motifs that are responsible for the RNA-dependent ATPase and ATP-dependent helicase
activities of DEAD-box proteins (Linder and Jankowsky 2011). The name “DEAD-box”
originates from the single letter amino acid codes Asp (D)-Glu (E)-Ala (A)-Asp (D) that are
present in the highly conserved motif II (Walker B motif) (Linder et al. 1989; Umate et al. 2011).
DEAD-box proteins function throughout the lifetime of cellular RNAs from synthesis to
biological activity, and to inevitable decay (Linder and Jankowsky 2011).
Since the identification of the conserved DEAD sequence in the DEAD-box protein
family, several subfamilies have been shown to play a role in human diseases (Fuller-Pace, 2013;
Lasko, 2013; Sharma & Jankowsky, 2014). The DDX5/Dbp2 subfamily is one such example.
Human DDX5 and S. cerevisiae Dbp2 are both active helicases in vitro (Hirling, Scheffner,
Restle, & Stahl, 1989; Ma, Cloutier, & Tran, 2013; Xing, Wang, & Tran, 2017). They are highly
conserved in sequence and are functionally equivalent when ectopically expressed in a dbp2∆
yeast strain (Xing et al., 2017). Members of this subfamily function in almost all aspects of RNA
metabolism, including RNA biogenesis, maturation, transport, and stability. They are also
involved in differentiation, development, and cellular metabolism. However, connections
between their biochemical properties and cellular functions are lacking. Here, we focus on the
founding members of this subfamily including mammalian DDX5 and its paralog DDX17,
Drosophila Rm62, and S. cerevisiae Dbp2. We will discuss major themes of their biochemical
activities and biological functions and try to identify the relationship between biochemical
properties and functionality.
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1.2

General biochemical properties of the DEAD-box proteins
DEAD-box proteins are RNA-dependent ATPases (Linder and Fuller-Pace 2013; Tanner

et al. 2003). In addition to ATPase activity, numerous studies have demonstrated that DEAD-box
proteins can function as RNA chaperones, RNA helicases, and RNA-protein complex remodelers
(Ballut et al. 2005; Young et al. 2013; Putnam & Jankowsky 2013; Jarmoskaite & Russell 2014).
The vast majority of DEAD-box proteins exhibit a cooperative binding with RNA and
ATP (Banroques, Cordin, Doere, Linder, & Tanner, 2008; Lorsch & Herschlag, 1998; Polach &
Uhlenbeck, 2002; Samatanga & Klostermeier, 2014; Theissen, Karow, Köhler, Gubaev, &
Klostermeier, 2008). Similar to other RNA helicases, DEAD-box proteins can also unwind RNA
duplexes. However, DEAD-box proteins utilize a different unwinding mechanism from
canonical RNA helicases (Rudolph and Klostermeier 2015). Most other RNA helicases use a
translocation-based duplex unwinding mechanism, where the helicase first binds to a singlestranded region next to the duplex and then translocates in a unidirectional manner (Fiorini,
Bagchi, Le Hir, & Croquette, 2015; Jankowsky, Gross, Shuman, & Pyle, 2000). DEAD-box
proteins do not unwind in a translocation-based fashion, but rather load directly onto the duplex
region and separate the two strands in an ATP-dependent manner (Yang and Jankowsky 2006;
Yang et al. 2007). This is possible because DEAD-box proteins can disrupt RNA duplexes
locally by bending one of the RNA strands (Rudolph & Klostermeier, 2015). Moreover, a single
cycle of ATP binding and hydrolysis is sufficient to completely unwind a short RNA helix (~6
base pairs) (Chen et al., 2008). This suggests that ATP-binding is sufficient for DEAD-box
proteins to unwind RNA duplexes.
Multiple X-ray crystallographic studies of DEAD-box helicases have demonstrated that
DEAD-box proteins contain a structurally conserved helicase core that consists of two globular
RecA-like domains (RecA_N and RecA_C) (Sengoku et al. 2006; Andersen et al. 2006; Del
Campo and Lambowitz 2009; von Moeller et al. 2009; Rudolph and Klostermeier 2015). The
two domains are connected by a flexible linker to form a characteristic “dumbbell-like” core.
During RNA unwinding, the helicase core binds to the dsRNA. Closing of the two domains upon
binding of the dsRNA and ATP bends one strand of the RNA so that it is incompatible with the
geometry of an A-form RNA duplex (Sengoku et al. 2006; Andersen et al. 2006; Del Campo and
Lambowitz 2009; von Moeller et al. 2009). This allows DEAD-box proteins to destabilize RNA
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duplexes locally and release the unbent RNA strand (Rudolph and Klostermeier 2015). Upon
ATP hydrolysis, the helicase dissociates from single-stranded RNA, terminating a single round
of the unwinding cycle (Henn, Cao, Hackney, & De La Cruz, 2008). The DEAD-box helicase
then either recycles back on the same RNA substrate or finds a new target (Fig 1.2; Rudolph &
Klostermeier 2015). Since each ATP hydrolysis cycle only unwinds ~ 6 base pairs of the RNA
duplex (Chen et al., 2008), multiple cycles of unwinding are required to completely separate
longer duplexes.
One of the major functions of DEAD-box proteins is to act as RNP chaperones to
promote structural rearrangement and remodel RNPs (Patrick Linder & Jankowsky, 2011). This
includes displacing and assembling RNA-binding proteins on RNA. This may be accomplished
by remodeling RNA structure to expose binding sites for RNA-binding proteins, or by
functioning as scaffolds on RNA. RNP remodeling has been demonstrated by relevant DEADbox proteins in pre-mRNA splicing and nuclear mRNA export (Ballut et al., 2005; Tran, Zhou,
Corbett, & Wente, 2007). In addition, DEAD-box helicases also promote loading of RNAbinding proteins onto RNA (Ballut et al., 2005; Kar et al., 2011; Laurent et al., 2012; Ma et al.,
2013). It is well established that the DEAD-box protein eIF4AIII is a clamp that can act as a
protein assembly platform for assembly of the multicomponent exon junction complex (EJC)
upstream of exon-exon junctions on mRNA (Ballut et al., 2005). RNA chaperone activity
involves both unwinding and annealing. Several DEAD-box proteins display annealing activity
independent of ATP (Rossler et al. 2001; Yang & Jankowsky 2005; Halls et al. 2007; UhlmannSchiffler et al. 2006; Ma et al. 2013; Young et al. 2013), an activity that can promote proper
folding of complex tertiary structures. This chaperone activity has been demonstrated to be
biologically relevant for splicing of the Group II intron by Mss116 (Potratz, Del Campo, Wolf,
Lambowitz, & Russell, 2011).
DEAD-box proteins recognize the phosphate backbone of RNA instead of the nucleotide
bases (Sengoku et al. 2006; Andersen et al. 2006; Del Campo & Lambowitz 2009; von Moeller
et al. 2009), suggesting that DEAD-box proteins bind to RNA substrates in a sequence nonspecific manner. This could potentially be an advantage for DEAD-box proteins to act as general
RNA chaperones that target many different RNAs (Jarmoskaite & Russell 2014). Paradoxically,
70% of DEAD-box protein genes in S. cerevisiae exhibit non-redundant biological functions,
suggesting specificity inside cells (Rocak & Linder, 2004). Accessory domains of some DEAD-
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box proteins can confer substrate specificity (Jarmoskaite and Russell 2014). In other cases,
protein cofactors provide targeting to specific biological substrates (Young et al., 2013).

1.3

The history and sequence analysis of the DDX5/Dbp2 subfamily.
The human DDX5 (or p68) was initially identified due to its cross-reactivity with an

antibody (pAb204) generated against the simian virus 40 (SV40) large T antigen (Lane &
Hoeffler, 1980). Later, extensive homology was found between human DDX5 and murine
translation initiation factor eIF4A, leading to the authors to propose a new gene family defined
by these two proteins (Ford, Anton, & Lane, 1988). This gene family was then confirmed and
named as the DEAD-box proteins (Linder et al. 1989). A paralog of DDX5 exists in mammals
named DDX17 (or p72) (Lamm, Nicol, Fuller-Pace, & Lamond, 1996). Human DDX5 and
DDX17 protein sequences possess 69.7% sequence identity and 77.6% similarity (Lamm et al.,
1996). To permit genetic analysis of DDX5’s function, Iggo et al. cloned yeast genes related to
DDX5 and called them dbp2 in Schizosaccharomyces pombe and DBP2 in Saccharomyces
cerevisiae (S. cerevisiae), for DEAD-box protein 2 (Iggo et al., 1991). The Drosophila Rm62 is
the fly homolog of DDX5/DDX17, and was first described in a mutagenic screen designed to
search for modifiers of retrotransposon expression, where it was named as “Lighten up (Lip)”
(Csink, Linsk, & Birchler, 1994).
Human DDX5, DDX17, drosophila Rm62, and yeast Dbp2 protein sequences are highly
conserved (Fig. 1.1). All 12 DEAD-box motifs are found in the helicase core. Several DEADbox proteins possesses and arginine and glycine (RG)-rich region at the C-terminus (Yang &
Jankowsky 2005). RG-rich regions are found adjacent to the helicase core in all four
DDX5/Dbp2 subfamily members at both the N-terminus and C-terminus (Fig. 1.1). Interestingly,
the N-terminal RG-rich region of Rm62 is longer than other subfamily members. Generally, RGrich regions function in RNA binding, protein-protein interaction and/or protein localization
(Thandapani, O’Connor, Bailey, & Richard, 2013).
The N-terminal and C-terminal ends of the DDX5/Dbp2 subfamily are more diverse than
their helicase cores. DDX17 and Rm62 have N-terminal extensions that are missing in DDX5
and Dbp2 (Fig. 1.1). In fact, the N-terminal extension in DDX17 represents the major difference
between DDX5 and DDX17 in terms of sequence. Moreover, DDX5 and DDX17 possess
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mammalian specific C-terminal extensions (CTEs), whereas Rm62 and Dbp2 end with the Cterminal RG-rich region (Fig 1.1). These N-terminal and C-terminal extensions are largely
under-characterized.

1.4

DDX5 and Dbp2 are RNA-dependent ATPases and ATP-dependent RNA helicases
The RNA helicase activity of DDX5 was characterized shortly after its discovery

(Hirling et al., 1989). DDX5 purified from human 293 cells possesses RNA-stimulated ATPase
activity and ATP-independent RNA-binding activity, with a higher affinity towards doublestranded (ds) RNA (Hirling et al., 1989). Despite ATP-independent RNA binding, ATPdependent RNA unwinding activity has been observed (Hirling et al., 1989). Surprisingly, this
study showed that DDX5 unwound a 162 bp duplex (Hirling et al., 1989), a substrate
considerably longer than the ~ 12-20 bp unwound by other members of the DEAD-box protein
family (Cordin, Banroques, Tanner, & Linder, 2006). Later, Rossler and colleagues purified
recombinant DDX5 and DDX17 from Sf9 insect cells and showed that DDX5 and DDX17
require 3’ overhangs for duplex unwinding (Rossler et al., 2001). Consistent with the ability of
human DDX5 to unwind a 162 bp duplex, recombinant DDX5 and DDX17 are able to unwind a
25 bp duplex under single-turnover conditions, where the enzyme is titrated away from
remaining base-paired RNA if it is released during an enzymatic cycle (Rossler et al., 2001).
This indicates that DDX5 and DDX17 may perform multiple rounds of unwinding before
dissociation (Cordin et al., 2006).
In line with ATP-independent RNA binding, DDX5 and DDX17 promote strand
annealing of two ~130 nt RNAs with a 51 bp complementary region in an ATP-independent
manner (Rossler et al., 2001). However, caution must be taken when claiming ATP
independency due to the possibility of co-purified ATP during protein preparation. DDX5 and
DDX17 also promote RNA structure rearrangement that involves both unwinding and annealing,
such as strand exchange, whereby an RNA duplex is resolved and one strand re-associates with a
third strand of higher complementarity (Rossler et al., 2001).
In contrast to the 3’-5’ unwinding activity reported by Rossler et al., recombinant DDX5
purified from E. coli unwinds duplexes with either a 3’ or 5’ overhang (Huang & Liu 2002), and
even a blunt-ended RNA duplex (Xing et al., 2017), suggesting lack of directionality. In
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addition, bacterially expressed DDX5 does not unwind a 16 bp blunt-end duplex under singleturnover conditions (Xing et al., unpublished). Differences between DDX5 purified from
eukaryotic systems and prokaryotic systems are not surprising. Recombinant proteins expressed
in eukaryotic cells may harbor post-translational modifications or may copurify with factors that
modulate the enzymatic activities of DDX5.
Kinetic analysis was done to directly compare recombinant DDX5 and Dbp2 (Xing et al.,
2017). Using a 16 bp blunt-end RNA duplex, DDX5 displays faster unwinding as compared to
Dbp2 (Xing et al., 2017). Dbp2 anneals this RNA duplex in an ATP-independent manner,
whereas DDX5 did not display any annealing activity (Xing et al., 2017). Interestingly,
truncating the mammalian-specific CTE of DDX5 reduces the unwinding rates, but rescues the
annealing activity (Xing et al., 2017). Thus, the CTE may hold the helicase core of DDX5 in a
conformation that does not favor RNA annealing. Despite that CTE enhances the unwinding
activities of DDX5, DDX5∆CTE fully complements DBP2 in yeast (Xing et al., 2017). This
indicates that the CTE is not required in yeast, consistent with the fact that the CTE is missing in
Dbp2. These different biochemical properties may reflect differences in as of yet unidentified
physiological substrates for this family in mammals versus fungi.

1.5

Cellular functions of the DDX5/Dbp2 subfamily
Despite being expressed in distinct species that diverged over 1 billion years ago

(Douzery et al. 2004), DDX5, DDX17, Rm62, and Dbp2 share many similar biological
functions. This includes mRNA metabolism, processing of ribosomal RNA, functioning in
miRNA pathways, and regulating long noncoding RNA activities. The DDX5/Dbp2 subfamily
functions in concert with a large variety of RNA species, perhaps due to their lack of stringent
sequence specificity. Despite this, members from this subfamily appear to function as RNP
remodelers in most cases (See sections below, and Fig 1.3).
It is clear that mammalian DDX5 and DDX17 paralogs share some functional
redundancy in ribosome biogenesis (Jalal, Uhlmann-Schiffler, & Stahl, 2007), mediation of p53dependent microRNA processing (Suzuki et al., 2009), and activation of the Wnt signaling
effector protein b-catenin (Shin, Rossow, Grande, & Janknecht, 2007), whereas distinct
functions are also reported for DDX5 and DDX17. For example, DDX5, but not DDX17,
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coactivates the p53 tumor suppressor during DNA damage response (Bates et al., 2005).
Moreover, expression levels of DDX17 in breast cancers, but not DDX5, correlate with increased
overall survival (Wortham et al., 2009). However, many studies only characterize DDX5, while
others utilize simultaneous knockdown of both DDX5 and DDX17, leading to the fact that
individual functionalities are not fully known for each paralog.
1.5.1 Cellular localization of DDX5 and Dbp2
In eukaryotes, the nucleus and cytoplasm are separated by a double-membrane structure
termed the nuclear envelope (Cautain, Hill, de Pedro, & Link, 2015). The nuclear pore complex
(NPC) spans the nuclear envelope and functions as gate for trafficking of macromolecules
(Cautain et al., 2015). Transport of proteins through the NPC is mediated by the β-karyopherins
in an ATP-dependent manner. β-karyopherins are receptor proteins that recognize sequence
motifs in the protein cargoes termed the nuclear localization signals (NLS) or nuclear export
signals (NES) for nuclear import and export, respectively (Cautain et al., 2015)
DDX5, DDX17 and Dbp2 are predominantly nuclear proteins (Cloutier, Ma, Nguyen, &
Tran, 2012; Iggo et al., 1991; Kahlina, Goren, Pfeilschifter, & Frank, 2004; Lamm et al., 1996).
The localization of DDX5 is not static, but, rather, depends on cell cycle status, cell type, and
post-translational modifications. DDX5 displays a diffuse granular staining pattern during
interphase, but is localized to nascent nucleoli during telophase (Iggo et al., 1991; Nicol,
Causevic, Prescott, & Fuller-Pace, 2000). Consistent with both nuclear and cytoplasmic
localization, Wang and colleagues showed that DDX5 is a nucleocytoplasmic shuttling protein
using heterokaryon assays (H. Wang, Gao, Huang, Yang, & Liu, 2009). Cytoplasmic DDX5
increases during the G2/M phase (Choi & Lee, 2012). Furthermore, DDX5 localization is cell
type-specific and heterogeneous within a population of the same type of cells (Rossow &
Janknecht, 2003). The cellular localization of DDX5 varies from exclusively nuclear to
predominantly cytoplasmic (Rossow & Janknecht, 2003). Finally, phosphorylation of tyrosine
593 (Tyr593) in DDX5 promotes the nuclear export of the DDX5
Acid sequences 351-363 and 482-502 of DDX5 are nuclear localization signals (NLS),
while sequences 282-308 and 446-461 serve as nuclear export signals (NES) (Wang et al. 2009).
Tyr593 does not reside in either of the NLS or NES signals. However, phosphorylation of Tyr593
may induce conformational change that expose the NES signals.
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Interestingly, in S. cerevisiae, the nuclear localization of Dbp2 is responsive to nutrient
availability (Beck et al., 2014); Dbp2 is rapidly shuttled to the cytoplasm within 10 min of
glucose depletion with very low amounts of glucose (0.1%, versus 2% in normal growth media)
retaining Dbp2 in the nucleus. Interestingly, DDX5 localization is regulated similarly when
ectopically expressed in yeast (Xing et al., unpublished). Although the upstream events of Dbp2
glucose-dependent nucleocytoplasmic shuttling are not yet defined, several factors that are linked
to glucose deprivation are not required for Dbp2 relocalization following glucose deprivation
(Beck et al., 2014). These include the AMP-activated protein kinase SNF1, the mitogen-activated
protein kinase HOG1, and the TOR (target of rapamycin) signaling pathway (Beck et al., 2014).
Recent evidence shows that DDX5 functions upstream of mTOR (mammalian target of
rapamycin) in mammalian cells, suggesting that DDX5/Dbp2 may sense nutrient availability
directly through an as-of-yet unidentified mechanism ((Du et al., 2017; Taniguchi et al., 2016)
and see section 1.6).
1.5.2

The DDX5/Dbp2 subfamily functions in transcription regulation
RNA polymerase II transcription in eukaryotes is tightly regulated by numerous factors

(Lelli, Slattery, & Mann, 2012), including long noncoding RNAs (lncRNAs) (Rinn & Chang,
2012). LncRNAs are noncoding transcripts that are greater than 200 nt in length. They are
transcribed by RNA polymerase II, and regulate gene expression by binding and scaffolding
different protein factors, and/or directly interacting with the genomic DNA (Engreitz et al. 2016).
The DDX5/Dbp2 subfamily regulates chromatin environment and transcription by controlling
the activities of lncRNAs. In most cases, the DDX5/Dbp2 subfamily appear to serve as
remodelers for lncRNA-protein complexes (lncRNPs) (see below).
DDX5 and DDX17 regulate lncRNPs formed by lncRNAs and histone modifiers. DDX5
and DDX17 associate with the steroid receptor RNA activator (SRA) lncRNA, which then binds
to the trithorac group complex (TrxG) and the polycomb repressive complex 2 (PRC2)
(Wongtrakoongate, Riddick, Fucharoen, & Felsenfeld, 2015). These are enzyme complexes that
deposit histone H3 lysine 4 tri-methylation (H3K4me3) and lysine 27 tri-methylation
(H3K27me3), respectively. H3K4me3 is a mark for active transcription whereas H3K27me3 is a
repressive histone mark. Therefore, TrxG and PRC2 can create bivalent sites consisting two
functionally opposing histone modifications (Voigt, Tee, & Reinberg, 2013). DDX5 and DDX17
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enhance the interaction between SRA and TrxG, thereby increasing H3K4me3 at genomic
regions bound by both DDX5 and SRA. However, the interaction between SRA and PRC2 is
independent of DDX5 and DDX17 (Wongtrakoongate et al., 2015). Interestingly, PRC2 interacts
with DDX5 through another lncRNA, the Hox transcript antisense intergenic RNA HOTAIR
(Zhang et al., 2016). DDX5 stabilizes the SUZ12 subunit of PRC2, presumably by displacing the
RNA-binding E3 ligase Mex3b from the HOTAIR/PRC2 complex and. This promotes PRC2mediated gene repression (Zhang et al., 2016). ATP and RNA binding, but not ATP hydrolysis
are required for this activity (Zhang et al., 2016).
Moreover, DDX5 and DDX17 associate with the CCCTC-binding factor (CTCF), a DNA
binding protein involved in chromatin insulator activity, thorough the lncRNA SRA (Yao et al.,
2010). Chromatin insulators are DNA-protein complexes that bridge long distance interactions
and create insulated chromatin domains (Phillips-Cremins & Corces, 2013). SRA is necessary
for the recruitment of DDX5 to the genomic binding sites of CTCF (Yao et al., 2010).
Furthermore, DDX5, DDX17, and SRA are required for CTCF insulator activity (Yao et al.,
2010). Interestingly, the interaction between DDX5 and CTCF requires the N and C-terminal
domains but does not require the helicase core (Yao et al., 2010), suggesting that these accessory
domains are sufficient to mediate lncRNA-dependent complex formation in vivo. Rm62 is also
involved in insulator function in Drosophila (Lei & Corces, 2006).
Rm62 physically interacts with DNA-binding centrosomal protein 190 (CP190), the
gypsy insulator associated protein in Drosophila, in an RNA-dependent manner (Lei & Corces,
2006). Different from DDX5, Rm62 loss of function promotes the activity of the gypsy insulator
(Lei & Corces, 2006), suggesting negative regulation of the gypsy insulator and contextdependent roles of the DDX5/Dbp2 subfamily proteins.
DDX5 and DDX17 also coactivate transcription factors. These includes the nuclear
hormone receptors estrogen receptor alpha (ERα) and androgen receptor (AR), transcription
factors involved in differentiation MyoD and Runx2, and the tumor suppressor p53 (Fuller-Pace,
2013). DDX5 and DDX17 also repress transcription from specific promoters when associated
with histone deacetylase 1 (HDAC1) (Wilson et al., 2004). Although not demonstrated, it is
plausible that specific lncRNAs may be involved in formation of a protein complex with DDX5
and various transcription factors or cofactors, resembling the formation of the DDX5-HOTAIRPRC2 complex.
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Dbp2 also functions with the GAL lncRNAs in S. cerevisiae, but in a significantly
different manner from what has been established for mammalian DDX5. The GAL lncRNAs are
transcribed from the GAL gene cluster, which encodes the GAL genes required for galactose
metabolism (Houseley, Rubbi, Grunstein, Tollervey, & Vogelauer, 2008; Pinskaya, Gourvennec,
& Morillon, 2009; van Dijk et al., 2011). In the presence of glucose, the preferred carbon source
for yeast, the GAL genes are shut off transcriptionally. While the GAL genes are repressed, the
GAL lncRNAs are expressed and form RNA/DNA hybrids (R-loops) with the genomic DNA
(Cloutier et al., 2012, 2016). R-loops are generated by base paring of an RNA molecule to one
strand of the genomic DNA, leaving the other strand free. The GAL R-loops prepare the GAL
genes for faster induction during a nutritional switch to glucose-depleted, galactose-containing
media (Cloutier et al., 2016; Cloutier, Wang, Ma, Petell, & Tran, 2013). Dbp2 antagonizes the
function of the GAL lncRNAs: deletion of DBP2 increases the levels of the GAL lncRNAs,
promotes the GAL R-loop formation, speeds up transcription induction (Cloutier et al., 2016).
Interestingly, Dbp2 unwinds RNA-DNA hybrids in vitro (Ma et al., 2013). Therefore, it is
rational to propose that Dbp2 may resolve the GAL R-loop directly using its RNA helicase
activity since Dbp2 is capable of unwinding an R-loop in vitro (Ma et al., 2013). Furthermore,
deletion of DBP2 results in widespread misregulation of genes involved in sugar metabolism and
increases the rate of respiration in S. cerevisiae, suggesting a specific role for this helicase in
energy homeostasis (Beck et al. 2014; Wang et al. 2017). However, it is not known if DDX5 is
also involved in regulating R-loop formation in mammalian cells.
1.5.3 The DDX5/Dbp2 subfamily promotes mRNA processing
MRNA processing includes 5’ capping, 3’ polyadenylation, splicing of precursor mRNAs
(pre-mRNAs), and mRNA export, all of which are coupled with transcription to some extent
(Bentley, 2014). MRNA is bound by numerous RNA-binding proteins to form an mRNP (Bentley,
2014). RNA helicases, including the DDX5/Dbp2 subfamily of DEAD-box proteins, are involved
in many steps of mRNA processing and mRNP assembly.
1.5.3.1 The DDX5/Dbp2 subfamily functions in pre-mRNA splicing and alternative splicing
Many RNA helicases, including the DDX5/Dbp2 subfamily proteins have been linked to
splicing (Cordin & Beggs, 2013). Eukaryotic pre-mRNAs typically contain introns that are
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excised through two transesterification reactions catalyzed by a multi-megadalton RNP termed
the spliceosome (Shi, 2017). The spliceosome consists of U1, U2, U4, U5, and U6 small nuclear
ribonucleoproteins (snRNP). Assembly of spliceosome on pre-mRNA starts with recognition of
the 5’ splice site by the U1 snRNP, following by subsequent association of the other 4 snRNPs
(Shi, 2017).
Drosophila Rm62 was identified as a core component of spliceosome and a regulator of
alternative splicing in large-scale RNA interference (RNAi) screens (Park et al. 2004; Brooks et
al. 2015). Proteomic analysis also showed that DDX5 and DDX17 co-purified with the human
spliceosome (Rappsilber, Ryder, Lamond, & Mann, 2002; Zhou, Licklider, Gygi, & Reed, 2002).
Moreover, human DDX5 is crosslinked with the transient 5’ splice site (5’ ss) + U1 snRNP
complex (Liu et al. 1998), suggesting a direct role of DDX5 in spliceosome assembly. Indeed,
DDX5 promotes the dissociation of U1 from the 5’ ss, which allows the formation of a
catalytically active spliceosome (Liu 2002). The enzymatic activities of DDX5 are required for
the disruption of the U1-5’ ss complex (C. Lin, Yang, Yang, Huang, & Liu, 2005). Finally,
DDX5 depletion inhibits the in vitro splicing activities of Hela nuclear extract (Liu 2002).
DDX5 and DDX17 are also implicated in alternative splicing, a process that contributes
to protein diversity and is often aberrant in human diseases (Lee & Rio, 2015). Downregulation
of DDX5 leads to the inclusion of the proto-oncogene c-H-ras alternative exon IDX that harbors
an in-frame stop codon (Guil et al., 2003). Inclusion of exon IDX leads to production of a shorter
H-Ras protein, which induces a G1/S phase delay (Camats, Kokolo, Heesom, Ladomery, &
Bach-Elias, 2009). Furthermore, DDX5 and DDX17 depletion also affects the alternative
splicing of a histone variant macroH2A1 (mH2A1), leading to increased levels of the mH2A1.1
isoform, which alters the expression of genes involved in redox metabolism (Dardenne et al.,
2012).
Large-scale analysis also showed that DDX5 and DDX17 affect alternative splicing
(Dardenne et al., 2014). Alternative exons that are excluded upon DDX5 and DDX17 depletion
in human MCF7 breast cancer overlap with those that are excluded during epithelial–
mesenchymal transition (EMT) (Dardenne et al., 2014)(Dardenne et al., 2014)(Dardenne et al.,
2014)(Dardenne et al., 2014)(Dardenne et al., 2014)(Dardenne et al., 2014)(Dardenne et al.,
2014)(Dardenne et al., 2014)(Dardenne et al., 2014). Consistent with a role in alternative
splicing, DDX5 is found in a large multiprotein complex LASR (large assembly of splicing
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regulators) that recruits the alternative splicing factors Rbfox proteins in mammalian brain
(Damianov et al., 2016).
DDX5 and DDX17 seem to target specific sequence/structure elements in alternative
splicing. Overexpression of DDX17, but not DDX5, increases inclusion of the cell-surface
glycoprotein CD44 exons V4 and V5, by recognizing the AC-rich enhancer elements within the
alternative exons (Honig, Auboeuf, Parker, O’Malley, & Berget, 2002). DDX5 and DDX17 may
also regulate alternative spicing by resolving RNA structure (Dardenne et al. 2014; Kar et al.
2011). Simultaneous knockdown of DDX5 and DDX17 results in exclusion of exons that have
predicted downstream RNA G-quadruplexes, stable tertiary structures formed at G-rich regions
(Dardenne et al., 2014). Exon exclusion is likely manifested by reduced hnRNA H/F binding to
these G-rich regions that are otherwise exposed in the presence of DDX5 and/or DDX17
(Dardenne et al., 2014). DDX5 also regulates alternative splicing of the tau gene encoding a
neuronal microtubule-stabilizing protein (Kar et al. 2011). DDX5 triggers an open conformation
of the stem-loop structure at the 5’ splice site of tau exon 10, allowing binding of U1 snRNP and
promoting exon 10 inclusion (Kar et al. 2011). Predictably, the enzymatic activities of DDX5
and DDX17 are required in all three cases discussed above.
1.5.3.2 The DDX5/Dbp2 subfamily facilitates mRNA export
MRNA is bound by mRNA export factors in the nucleus, which enable transport through
the NPC (Bjork & Wieslander, 2014). Human DDX5 co-purifies with poly(A) RNAs (Choi &
Lee, 2012). Depletion of DDX5 results in the nuclear accumulation of the proto-oncogene c-fos,
presumably because of blocked mRNA export (Zonta et al. 2013). Moreover, DDX5 coimmunoprecipitates with the export factors ALY and TAP, with depletion leading to reduced
association of TAP with c-fos mRNA (Zonta et al., 2013). In S. cerevisiae, DBP2 genetically
interacts with mRNA export factors YRA1 (S. cerevisiae ALY) and MEX67 (S. cerevisiae TAP),
and is also required for efficient association of Yra1 and Mex67 with poly(A)+ RNA (Ma et al.,
2013). Interestingly, Yra1 inhibits the single-stranded (ss) RNA binding activity of Dbp2 in vitro
and prevents over-accumulation of Dbp2 on mRNA in vivo (Ma et al., 2016). This suggests that
Yra1 promotes release of Dbp2 from mRNA after mRNP assembly (Ma et al., 2016). Taken
together, DDX5/Dbp2 may promote mRNA export by assembling export factors on to the
mRNA.
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Drosophila Rm62 is found at polytene chromosome puffs, sites of active transcription
(Buszczak & Spradling, 2006). Loss of Rm62 results in accumulation of the heat shock hsp70
mRNA at its sites of synthesis (Buszczak & Spradling, 2006). Furthermore, the export factors
NXF1 (Drosophila TAP) and ALY are redistributed from the nuclear rim to the nucleoplasm in
Rm62 mutant cells (Buszczak & Spradling, 2006). This suggests that Rm62 also functions in
concert with the export factors to facilitate transcript clearance from the chromatin. Interestingly,
Rm62 is required for gene de-activation of the hsp70 after removal of the stimulus, indicating
that the nascent transcript hinders transcriptional repression (Buszczak & Spradling, 2006).
1.5.4 DDX5 and Dbp2 function differently in nonsense-mediated decay (NMD)
NMD is a surveillance pathway that targets a selection of mRNAs for degradation
(Lykke-Andersen & Jensen, 2015). Canonical targets for NMD are mRNAs containing
premature termination codons (PTC), however, normal transcripts can be affected by the NMD
pathway as well (Hug, Longman, & Caceres, 2016). DDX5/DDX17 and Dbp2 are involved in
NMD, but in different manners (see below).
DDX5 and DDX17 physically interact with hUPF3, an essential component of the NMD
machinery (Geißler, Altmeyer, Stein, Uhlmann-Schiffler, & Stahl, 2013). Depletion of DDX5
promotes the accumulation of transcripts harboring long 3’ UTRs, such as DDX17 and SMG5
transcripts, likely through NMD (Geißler et al., 2013). Consistently, DDX5 binds to these
endogenous transcripts and the EGFP reporter mRNA containing the 3’ UTR of SMG5 in vivo. It
is worth noting that SMG5 is also a component of the NMD machinery (Hug et al., 2016),
suggesting an intricate feedback loop controlling the expression levels of DDX5 and DDX17.
RNA helicase activity is not required for DDX5’s function in NMD per se, because
overexpression of a DDX5 Walker B motif mutant (DDX5-E249Q) inhibits the expression of
DDX17 similar to overexpression of wild type DDX5 (Geißler et al., 2013). However, another
Walker B motif mutant (DDX5-D248N) retains RNA binding activity (Zhang et al., 2016). Thus,
DDX5 may act as an RNA-binding protein that promotes or stabilizes the assembly of the NMD
machinery onto NMD-targeted RNA, consistent with the idea that RNA helicase may serve as
“place markers” to facilitate the recruitment of the degradation machinery (Hug et al., 2016).
This is reminiscent of the DEAD-box helicase eIF4AIII, which clamps NMD factors onto
mRNA, allowing EJC-dependent recognition of PTC (Ballut et al., 2005). Interestingly, DDX5
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and DDX17 do not affect PTC-containing transcripts in a reporter assay (Geißler et al., 2013).
Regardless, DEAD-box “RNA clamps” may be required for recruitment of the NMD machinery.
In S. cerevisiae, DBP2 genetically interacts with UPF1, the central component of the
yeast NMD pathway (Bond, Mangus, He, & Jacobson, 2001; He & Jacobson, 1995). Distinct
from the observations in humans, nonsense (PTC)-containing transcripts are accumulated in
dbp2∆ (Bond et al., 2001), suggesting a role of Dbp2 in canonical NMD. In addition, Walker B
mutation abolishes NMD activity, suggesting a requirement for ATP hydrolysis (Bond et al.,
2001). Consistent with the differences of DDX5 and Dbp2 in this specific pathway, ectopic
expression of DDX5 in dbp2∆ does not restore NMD (Bond et al., 2001). This also agrees with
the fact that pathways for NMD between yeast and humans are different (Hug et al., 2016).
Interestingly, it was recently found that Xrn1-sensitive antisense long non-coding RNAs
(XUTs) containing long 3’ extensions are degraded through the NMD pathway in a DBP2dependent manner (Wery et al., 2016). The 3’ extensions of XUTs are reminiscent of the long 3’
UTRs that renders NMD dependency on DDX5 (Geißler et al., 2013). Therefore, DDX5 and
Dbp2 possibly share a conserved role in the recruitment of the NMD machinery onto RNAs
harboring as of yet undefined 3’ elements.
1.5.5 The DDX5/Dbp2 subfamily promotes microRNA processing and ribosome biogenesis
Processing of RNA species other than the mRNA are also affected by members from the
DDX5/Dbp2 subfamily.
1.5.5.1 DDX5/DDX17 and Rm62 promote microRNA (miRNA) processing
MiRNAs are non-coding RNAs that target certain mRNAs for RNA silencing (Ha &
Kim, 2014). Primary-miRNAs (pri-miRNAs) are transcribed by RNA polymerase II or RNA
polymerase III and undergo two major steps for maturation that are catalyzed by enzymes in the
RNAse III family. Pri-miRNAs are processed by Drosha in the nucleus into precursor-miRNAs
(pre-miRNAs). Pre-miRNAs are then cleaved by Dicer in the cytoplasm and become the mature
miRNA (Ha & Kim, 2014). Drosophila Rm62 binds to pri-miRNA stem loops in vivo (Moy et
al., 2014). In human cells, DDX5/DDX17 associate with Drosha and are required for the
maturation of a subset of pri-miRNAs (Gregory et al. 2004; Salzman et al. 2007; Wang et al.
2012; Remenyi et al. 2016; Li et al. 2017).
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DDX5/DDX17 appear to interact with accessory proteins that regulate pri-miRNA
processing. First, the SMADs, signal transducer proteins that interact with Drosha through
DDX5, thereby promoting the processing of a subset of miRNAs in response to the transforming
growth factor β (TGF-β) and bone morphogenetic protein (BMP) family of growth factors
(Davis, Hilyard, Lagna, & Hata, 2008; Davis, Hilyard, Nguyen, Lagna, & Hata, 2010), as well as
p53 (Suzuki et al., 2009). The interaction between p53 and Drosha is sensitive to RNAse
treatment, suggesting a direct role for RNA molecules in the assembly of a p53-DroshaDDX5/DDX17 complex. Association with SMADs or p53 confer different pri-miRNA
specificities to the Drosha-DDX5/Drosha-DDX17 complex, but pri-mRNA processing was
enhanced by these factors in both cases (Davis et al., 2008, 2010; Suzuki et al., 2009). In
contrast, Cyclooxygenase 2 (COX-2), an enzyme involved in inflammation, represses miR-183
processing by interacting with the Drosha-DDX5 complex (Motiño et al., 2015). Taken together,
DDX5/DDX17 may be important for modulating miRNA maturation in a context-dependent
manner.
1.5.5.2 DDX5/DDX17 and Dbp2 promote ribosome biogenesis
The ribosome is a massive ribonucleoprotein complex (RNP), whose assembly requires
cooperative work of numerous (> 200) transiently associated factors (Jalal et al., 2007; Thomson,
Ferreira-Cerca, & Hurt, 2013). A subset of the DDX5/Dbp2 subfamily also functions in synthesis
and assembly of functional ribosome. DDX5 associates with the ribosomal RNA (rRNA)
promoter, and promotes transcription of primary rRNA transcripts (Saporita et al., 2011). DDX5
and DDX17 play redundant roles in the processing of 32S rRNA to mature 28S rRNA in
mammalian cells (Jalal et al., 2007; Saporita et al., 2011). Consistently, in S. cerevisiae,
processing of 35S pre-rRNA into mature 25S rRNA is reduced in the dbp2∆, along with the
levels of 60S subunits, monosomes, polysomes, and protein synthesis activity (Bond et al.,
2001). Interestingly, ectopic expression of DDX5 rescues the ribosome biogenesis defects in
dbp2∆ cells (Bond et al., 2001), suggesting conserved roles of DDX5 and Dbp2 in ribosome
biogenesis.
Ectopic expression of DDX5 or a DDX5 motif I (Walker A motif) mutant (DDX5K144N) that lacks ATP binding (Zhang et al., 2016), increases the polysome content of mouse
embryonic fibroblasts in sucrose gradients (Saporita et al., 2011). In S. cerevisiae, a Walker A
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motif mutant (Dbp2-K163R) exhibits defects in ribosome biogenesis, suggesting that helicase
activity of Dbp2 is required. However, the Dbp2-K163R mutant is not biochemically
characterized in vitro.

1.6

DDX5 and DDX17 are implicated in cancers
DDX5 and DDX17 promote cell proliferation (Jalal et al., 2007). In line with this, DDX5

and/or DDX17 are overexpressed in various types of cancers including colon cancers (Causevic
et al., 2001; Shin et al., 2007), prostate cancer (Clark et al., 2008), breast cancers (Wortham et
al., 2009), brain cancers (Wang et al. 2012), lung cancers (Z. Wang et al., 2015), gastric cancers
(Du et al., 2017), and leukemia (S. Lin et al., 2013). Depletion of DDX5 and/or DDX17 in many
of these cancers inhibit the growth of tumors cells, suggesting requirement of DDX5/DDX17 in
cancer development. Importantly, overexpression of DDX5 promotes growth of gastric cancers
and non small-cell lung cancer (NSCLC) cells both in vitro and in vivo, indicating that DDX5
may be a driver for cellular transformation (Du et al., 2017; Z. Wang et al., 2015). Oncogenic
roles of DDX5 and DDX17 have been mainly attributed to their functions in transcription
activation and signaling pathways (see below).
DDX5 and DDX17 coactivate oncogenic transcription factors including ER and AR,
which are important in the development of breast cancer and prostate cancer, respectively (Zhao
et al. 2008; Wortham et al. 2009; Clark et al. 2008; Clark et al. 2013). Furthermore, DDX5
associates with Mastermind-like 1 (MAML), a transcriptional coactivator essential for Notch
signaling (S. Lin et al., 2013). Inhibition of DDX5 decreased the expression of Notch target
genes and hinders the growth of T cell acute lymphoblastic leukemia (T-ALL) cells (S. Lin et al.,
2013), consistent with implication of the Notch signaling in proliferation and differentiation
(Andersson, Sandberg, & Lendahl, 2011). Interestingly, DDX5 and DDX17 also coactivate the
tumor suppressor p53 (Bates et al., 2005; Nicol et al., 2013). Depletion of DDX5, but not
DDX17, inhibits the expression of p53-responsive cell cycle arrest gene p21(Bates et al., 2005;
Nicol et al., 2013). However, DDX5 is dispensable for the expression of p53-responsive proapoptotic genes (Nicol et al., 2013). This suggests that DDX5 has selective coactivator activity
for p53 and may modulate the decision between cell cycle arrest and apoptosis, favoring cell
survival.
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DDX5 also activates pro-carcinogenic signaling pathways including Wnt and mTOR
pathways. First, in colon cancer cells and NSCLCs, Tyr593 phosphorylated DDX5 is
translocated to the cytoplasm to facilitate the nuclear translocation of b-catenin, which activates
Wnt target genes including Cyclin D1 and c-Myc (Yang et al. 2006; Yang et al. 2007; Shin et al.
2007; Wang et al. 2015). These Wnt targets then promote proliferation and tumorigenesis.
Moreover, DDX5 depletion inhibits the mTOR pathway in prostate cancer cells, as evidenced by
reduced phosphorylation of ribosomal protein S6 kinase 1 (S6K1) (Taniguchi et al., 2016). S6K1
phosphorylation represents the hallmark of mTOR activation (Saxton & Sabatini, 2017).
Consistently, DDX5 knockdown reduces the growth of prostate cancer cells (Taniguchi et al.,
2016). In addition, ectopic expression of DDX5 promotes mTOR and S6K1 phosphorylation, as
well as cell proliferation in gastric cancers (Du et al., 2017). Importantly, the pro-proliferative
roles of DDX5 are abolished through inhibition of mTOR, indicating that DDX5 functions
through mTOR to promote cancer cell growth (Du et al., 2017). It is worth to note that TOR and
mTOR regulate ribosome biogenesis in yeast and mammals, respectively (Iadevaia, Liu, &
Proud, 2014; Martin, Powers, & Hall, 2006). Thus, DDX5 and Dbp2’s roles in ribosome
biogenesis may be at least partially mediated though mTOR and TOR.
Interestingly, the DDX5/Dbp2 subfamily is recently implicated in glucose metabolism
(Guo et al., 2010; Mazurek et al., 2014; S. Wang et al., 2017; Xing et al., 2017), a process that is
altered in cancers. In normal cells, the end product of glycolysis, pyruvate, is usually oxidized
through oxidative phosphorylation, which results in efficient ATP production. When oxygen is
limited in some scenarios, pyruvate is converted to lactate. This way, the process of glycolysis
produces minimal amount of ATP. However, cancer cells often convert pyruvate to lactate
regardless of the oxygen availability, a phenomenon termed aerobic glycolysis, or the Warburg
effect (Liberti & Locasale, 2016). Although the roles of Warburg effect are still unclear, one of
the theories is that glycolysis supports biosynthesis, which is essential for rapid proliferation of
cancer cells (Liberti & Locasale, 2016). Depletion of DDX5 inhibits the expression of genes
involved in glucose metabolism and increases reactive oxygen species (ROS) levels in Acute
Myeloid Leukemia (AML) cells, which leads to apoptosis of the AML cells (Mazurek et al.,
2014). Moreover, a DDX5 S480A polymorphism has been connected to nonalcoholic
steatohepatitis, a liver disease found in patients with metabolic syndrome (Guo et al., 2010). The
most prominent risk factors for metabolic syndrome are metabolic abnormalities including
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alterations in glucose metabolic pathways (Kaur, 2014). Finally, downregulation of DDX5 in
human hepatocyte AML12 cells leads to reduction in glucose uptake and glycolysis, and
upregulation of respiration (Xing et al., 2017). This suggests that DDX5 promotes glucose usage
through glycolysis in AML12 cells, and that DDX5 facilitates the Warburg effect. We suspect,
however, that different human cells types may have diverse phenotypes upon DDX5 depletion,
owing to their heterogeneity.

1.7

“Helicase-dead” mutants harbor different biochemical properties
The biochemical properties of DEAD-box proteins include ATP binding and hydrolysis,

RNA binding, duplex unwinding, and strand annealing (Patrick Linder & Jankowsky, 2011).
These activities are not necessarily coupled. We observe that the literature sometimes uses
“helicase-dead” mutants to demonstrate that the RNA helicase activities are not required for
certain biological functions of the DDX5/Dbp2 subfamily. However, while such statements are
true, these mutants may still be partially active. ATP hydrolysis is required for recycling DEADbox proteins, allowing multiple rounds of duplex separation, but is not necessary for RNAbinding, or a single round of strand separation (Liu et al. 2008). Therefore, a mutant lacking ATP
hydrolysis may still possess RNA-binding activity. For example, point mutations in the motif II
in DDX5 (D248N) and DDX17 (D325N) do not affect the functions of DDX5 and DDX17 in
repressing the transcription of the herpes virus thymidine kinase (TK) promoter (Wilson et al.,
2004). Analogously, ectopic expression of the DDX5-D248N mutant coactivates transcription
factor p53 similar to ectopic expression of wild type DDX5 (Bates et al., 2005). The authors
concluded that DDX5 helicase activities are not required for these transcriptional roles.
However, it was later shown that DDX5-D248N possesses equal RNA binding activity and
reduced ATP hydrolysis activity as compared to wild type DDX5 (Table 1.1). This suggests that
the DDX5-D248N mutant can act as an “RNA clamp” that binds to RNA but does not readily
dissociate. Such activity may be required for transcriptional repression of the TK promoter
and/or coactivation of p53. In conclusion, taking the ensemble of biochemical properties into
account is necessary to decipher the roles of DEAD-box proteins in biological processes.
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1.8

Concluding remarks
A large body of evidence suggests that the DDX5/Dbp2 subfamily displays conserved

functions in different organisms. The major mechanism of action appears to be remodeling
various RNPs through the lifetime of cellular RNAs. Members of this subfamily thus function in
diverse biological processes via their RNA targets. Despite being intensively studied during the
38 years since human DDX5 was identified, the following aspects need to be further investigated
for the DDX5/Dbp2 subfamily.
(i) Substrate specificity of the DDX5/Dbp2 subfamily. DDX5 and Dbp2 bind and unwind
RNA duplexes with random sequences in vitro (Ma et al., 2013; Xing et al., 2017). It is
important to determine the substrate specificity of the DDX5/Dbp2 subfamily members in vivo.
In addition to nucleotide sequences, RNA structures may also confer specificity. Structure
mapping techniques will facilitate the identification of such structures. Furthermore, substrate
specificity of DEAD-box proteins may also be determined by protein co-factors (Young et al.,
2013). However, we do not know if this is true for the DDX5/Dbp2 subfamily.
(ii) Nutrient-dependent cellular trafficking and roles in metabolism. DDX5 and Dbp2 are
nucleocytoplasmic shuttling proteins with condition-dependent cellular localization
(section1.5.2). Particularly, Dbp2 displays glucose-dependent nuclear localization (Beck et al.,
2014). It will be interesting to examine if DDX5 and DDX17 shuttle in response to glucose in
humans, and to determine the upstream signals for DDX5/Dbp2 re-localization. Furthermore,
DDX5/Dbp2 was the first subfamily of RNA helicases that shown to be involved in glucose
metabolism (S. Wang et al., 2017; Xing et al., 2017). However, the underlying mechanism is
largely unknown. Defining factors required for DDX5/Dbp2-mediated metabolic regulation will
be required.
(iii) RNA metabolism and the roles of DDX5/DDX17 in cancers. DDX5 and DDX17 are
heavily implicated in cancers ((Fuller-Pace & Moore, 2011) and section 1.6). However, many
studies neglect the known biochemical roles of these RNA helicases. Therefore, it will be of
great interest to determine the relationships between DDX5 and DDX17’s functions in RNA
metabolism and in cancers. This may provide a novel entry point for future targeting of cancerspecific metabolism.
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Figure 1.1. Sequence alignment of the founding DDX5/Dbp2 subfamily members
Multiple sequence alignment of human DDX5 (NP_001307525.1), DDX17 (NP_006377.2),
Drosophila Rm62 (NP_524243.2), and S. cerevisiae Dbp2 (NP_014287.3) was conducted using
the Clustal Omega web service (McWilliam et al., 2013). 12 conserved domains in the helicase
core, the RG-rich regions, and the mammalian-specific CTE are highlighted with black boxes.
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Figure 1.2. DEAD-box proteins unwind duplexes non-processively via local strand
separation
Lines represent RNA strands and the two ovals represent the two RecA-like domains that are
connected by a flexible linker. In the absence of any nucleotide and RNA, the two RecA-like
domains are farther apart and exhibit a flexible “opened uproductive” conformation. During
unwinding, the two RecA-like domains come closer together to form a “closed productive”
conformation upon binding to the double-stranded RNA (dsRNA) and ATP (step 1). Closing of
the two domains bends one strand of the dsRNA and results in local duplex destabilization (~ 6
bp). Duplexes longer than 6 bp require multiple cycles of unwinding. ATP hydrolysis and
inorganic phosphate release convert the two RecA-like domains back to the “opened”
conformation (step 2). This causes dissociation of the helicase core from the partially opened
dsRNA. The partially opened dsRNA can potentially snap back to produce a non-productive
unwinding cycle (dotted arrow) or is subjected to another round of local duplex destabilization
(step 3). Another round of local duplex destabilization happens after the ADP is exchanged to
ATP in the DEAD-box protein or a new ATP-bound DEAD-box protein recognizes the partially
opened dsRNA. This allows the DEAD-box protein to fully disrupt the partially opened duplex.
Upon ATP hydrolysis, the ADP-Pi bound DEAD-box protein still associates with the bent strand
whereas the non-bent strand is released (step 4). The bent strand is eventually dissociated from
the DEAD-box protein once the inorganic phosphate is released (step 5) (Figure is modified from
Rudolph and Klostermeier 2015).
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Figure 1.3. The DDX5/Dbp2 subfamily functions in every aspect of gene expression by
association with different RNA species and by acting as RNP remodelers (see also section
1.5)
The DDX5/Dbp2 subfamily (orange circles, labeled as “DEAD”) regulates lncRNA activities
through remodeling lncRNP and possibly resolving R-loop, thereby affecting chromatin
environment. Members from this subfamily form complex with lncRNA and chromatin insulator
protein, which is important for chromatin insulation. They also associate with histone modifiers
including TrxG and PRC2 in a lncRNA-dependent manner. Moreover, the DDX5/Dbp2
subfamily remodels mRNPs to promote mRNA processing. This includes splicing, alternative
splicing, and mRNA export. Members from this subfamily display U1 snRNP, enabling the
formation of catalytically active spliceosome. They also resolve structures that are present at the
alternative 5’ ss, allowing initial loading of U1 snRNP. The DDX5/Dbp2 subfamily promotes
loading of export factors onto the mRNA and thus facilitates nuclear export of mRNA. mRNA
levels in the cytoplasm are controlled by miRNA and NMD pathways. The DDX5/Dbp2
subfamily associates with Drosha and generally promotes pri-miRNA processing. In addition,
they facilitate loading of the mature miRNA onto the RISC complex. Similarly, the DDX5/Dbp2
subfamily promotes assembly of the NMD machinery onto targeted mRNAs. These activities
promote degradation of a selection of mRNAs. Finally, mRNAs that survived the surveillance
pathways are translated by the ribosome. The DDX5/Dbp2 subfamily promotes ribosome
biogenesis by enhancing rRNA transcription and maturation of the pre-60S ribosome subunit.
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Table 1.1. Biochemically characterized DDX5/Dbp2 mutants
Mutants

Motif
I

ATP
binding
None

ATP
hydrolysis
None

RNA
binding
Reduced

RNA
unwinding
None

RNA
annealing
n.a.

DDX5-K144N

References

DDX5-D248N

II

n.a.

Partial

Wildtype

n.a.

n.a.

DDX5-E249Q

II

Wildtype

None

n.a.

None

n.a.

Jalal et al.,
2007

DDX5-R403L

V

Wildtype

None

n.a.

None

n.a.

Lin et al., 2005

DDX5-R428L

VI

Wildtype

None

n.a.

None

n.a.

Lin et al., 2005

Dbp2-K163N

I

n.a.

None

n.a.

n.a.

n.a.

Dbp2-D268Q

II

n.a.

None

n.a.

n.a.

n.a.

Cloutier et al.,
2012
Cloutier et al.,
2012

Zhang et al.,
2016, Jalal et
al., 2007
Zhang et al.,
2016
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CHAPTER 2
RECRUITMENT, DUPLEX UNWINDING AND
PROTEIN-MEDIATED INHIBITION OF THE DEAD-BOX RNA
HELICASE DBP2 AT ACTIVELY TRANSCRIBED CHROMATIN

2.1

Introduction
Gene expression is an extremely complex process that involves numerous, highly

choreographed steps (Zorio and Bentley 2004). During transcription in eukaryotes, the newly
synthesized messenger RNA (mRNA) undergoes a variety of intimately linked processing
events, including 5’ capping, splicing, and 3’ end formation, prior to nuclear export and
translation (Rouskin et al. 2014; Cramer et al. 2001; Zorio and Bentley 2004).
Throughout each of these steps, the mRNA is bound by RNA-binding proteins to form
messenger ribonucleoprotein complexes (mRNP), the composition of which is constantly
changing at each maturation stage (Chen and Shyu 2014). Proper mRNP formation is critical for
gene expression and requires correctly structured mRNA at the appropriate biological time point
(Rouskin et al. 2014; Laurent et al. 2012). Given the physical properties of RNA, this molecule
tends to form stable secondary structures that are long-lived and require large amounts of energy
to unfold and refold to alternative conformations (Herschlag 1995; Pan and Russell 2010). This
results in a need for proteins to accelerate RNA structural conversions inside the cell. MRNA in
the budding yeast S. cerevisiae appears to be largely unstructured in vivo, in contrast to
thermodynamic predictions (Rouskin et al. 2014), suggesting the involvement of active
mechanisms to prevent formation of aberrant structures. Consistently, ATP-depletion in budding
yeast results in increased formation of secondary structure in mRNA (Rouskin et al. 2014).
Moreover, recent genome wide analyses of mRNA secondary structure have found a striking
correlation between single nucleotide polymorphisms and altered RNA structure within
regulatory regions (i.e. miRNA-binding sites), indicating that structural abberations alters gene
regulation (Wan et al. 2014; Ramos and Laederach 2014).
Likely candidates for structural rearrangement of cellular mRNAs are ATP-dependent
RNA helicases, which act as RNA unwinding or RNA-protein (RNP) remodeling enzymes
(Jarmoskaite and Russell 2014; Putnam and Jankowsky 2013b). DEAD-box proteins make up
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the largest class of enzymes in the RNA helicase family with around 40 members in human cells
(25 in yeast). Members of this class are ubiquitously present in all domains of life from bacteria
to mammals and are involved in every aspect of RNA metabolism, including pre-mRNP
assembly (Linder and Fuller-Pace 2013). For example, alternative splicing of the pre-mRNA that
encodes the human Tau protein is regulated by a stem-loop structure downstream of the 5’ splice
site of exon 10 (Kar et al. 2011). In order for U1 snRNP to access the 5’ splice site of tau exon
10, this stem-loop needs to be resolved by the DEAD-protein DDX5 (Kar et al. 2011). Misregulation of splicing in the tau gene is highly associated with dementia, underscoring the
importance of remodeling for proper gene expression (Hutton et al. 1998; Hasegawa et al. 1999).
However, our understanding of the biochemical mechanism(s) of pre-mRNA/mRNA remodeling
has been hampered due to the complex and highly interdependent nature of co-transcriptional
processes. Moreover, individual DEAD-box protein family members exhibit a wide variety of
biochemically distinct activities including RNA annealing, nucleotide sensing, and RNP
remodeling, with further diversification of biological functions conferred by regulatory accessory
proteins (Yang and Jankowsky 2005; Ma et al. 2013; Putnam and Jankowsky 2013b; Tran et al.
2007)
The S. cerevisiae ortholog of DDX5 is Dbp2 (Barta and Iggo 1995). Our laboratory
previously established that Dbp2 is an active ATPase and RNA helicase that associates with
transcribing chromatin (Ma et al. 2013; Cloutier et al. 2012). Moreover, Dbp2 is required for
assembly of the mRNA binding proteins Yra1 and Nab2, as well as the mRNA export receptor
Mex67, onto mRNA (Ma et al. 2013). Interestingly, Yra1 interacts directly with Dbp2 and this
interaction inhibits Dbp2 unwinding in multiple cycle, bulk assays, demonstrating that Yra1
restricts unwinding by Dbp2 (Ma et al. 2013). Nevertheless, the mechanism and the biological
role of Yra1-dependent inhibition were not understood.
By utilizing a combination of biochemical, molecular biology and biophysical methods,
we now provide compelling evidence that Yra1 constrains the activity of Dbp2 to cotranscriptional mRNP assembly steps. This inhibition is important for maintenance of transcript
levels in vivo. Single molecule (sm) FRET and fluorescent anisotropy studies show that Yra1
inhibits Dbp2 unwinding by preventing association of Dbp2 with RNA without altering the
kinetics of duplex unwinding. Consistently, loss of the Yra1-Dbp2 interaction in yeast cells
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causes post-transcriptional accumulation of Dbp2 on mRNA. Taken together, this suggests that
Yra1 terminates a cycle of Dbp2-dependent mRNP assembly in vivo.

2.2

Materials and methods

Plasmids and Yeast Strains
Please see Table 2.1 and Table 2.2 for all the plasmids and yeast strains that were used in
this study.
Chromatin Immunoprecipitation Assays (ChIP)
ChIP analysis was performed as described previously (Cloutier et al. 2012), with the
following modifications. Sheared chromatin with or without RNase treatment was used in ChIP.
Isolated DNA was then subjected to qPCR using primers listed (Table 2.3). All ChIP
experiments were conducted with at least three biological replicates and three technical repeats.
Error bars indicate the SEM of the biological replicates.
Protein Immunoprecipitation Assays
Cells were harvested at mid-log phase and lysed with glass beads using a mini-bead
beater (BioSpec Products) in cold lysis buffer containing 20 mM Tris pH 6.5, 5 mM MgCl2,
0.5% Triton X-100, 70 mM NaCl, 1Xprotease inhibitor (Complete, EDTA-free protease inhibitor
cocktail tablet) (Roche), and 1 mM PMSF. Lysate was subjected to immunoprecipitation.
Proteins were resolved by SDS-PAGE and detected by western blotting.
RNA Immunoprecipitation (RIP) Assays
RNA-IP was performed as described (Gilbert and Svejstrup 2006) with the following
modifications and the isolated RNA was detected by RT-qPCR (for primers, see Table 2.4). All
RNA-IP experiments were performed with three biological and three technical repeats. Error
bars indicate the SEM of the biological replicates.
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Glycerol Gradient Centrifugation
Cells were harvested at mid log phase and lysed. Lysate in the presence or absence of 70
U of RNase A and 1000 U of RNase I was subjected to 10-30% glycerol gradients in 20 mM
HEPES pH 7.4, 110 mM KOAc, 0.5% Triton X-100 and 0.1% Tween. After centrifugation in an
SW41 rotor using Beckman Coulter Optima L-90K Ultracentifuge at 35, 000 rpm for 18 hours at
4°C, 600 µl fractions were collected from the top of the gradient and analyzed for the presence of
the proteins by SDS-PAGE followed by western blotting analysis. 0.6% of the lysate was used to
serve as an input (T). Molecular weights from each fraction in the glycerol gradients were
determined using a standard curve that was generated by resolving the molecular weight
standards comprising catalase (250 kDa), apoferritin (480 kDa), and thyroglobulin (670 kDa).
TAP tag Immunoprecipitation
Immunoprecipitation was conducted as described previously (Ma et al. 2013) in the
presence or absence of 70 U of RNase A and 1000 U of RNase I. Protein were resolved by SDSPAGE and detected by Western blotting analysis using indicated antibodies.
Recombinant Protein Expression and Purification
Expression and purification of pMAL MBP-TEV-DBP2, GST-TEV-YRA1, and
pET21GST-YRA1C in E. coli cells was conducted as previously described (Ma et al. 2013).
Single Molecule FRET
dsRNA hairpin was purchased from Integrated DNA technologies (IDT) and labeled as
described (Wood et al. 2012). Single molecule experiments were carried out as previously
described (Mundigala et al. 2014). Hexokinase treatment was conducted by incubating 10 nM
Dbp2 with 100 µM hexokinase and 1 mM glucose in the imaging buffer for 10 minutes before
imaging.
Gel Shift Assays
10 µL reactions containing 2 mM ADP-BeFX/MgCl2, 20 U of Superase-in (Ambion), 0.5
mM MgCl2, 0.01% NP-40, 2 mM DTT, 40 mM Tris-HCl, pH 8, 10 nM labeled ssRNA (16 nt,
5’-AGC ACC GUA AAG ACG C-3’), and 400 nM of recombinant, purified Dbp2 in the
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presence or absence of varying amounts of recombinant, purified yra1C. Varying amounts of
BSA with 400 nM of recombinant, purified Dbp2 was used to serve as specificity control.
Components were added in the order as indicated and incubated at 4°C for indicated time.
Reaction mixtures were resolved on a non-denaturing gel and signal was detected by
densitometry.
Fluorescence Anisotropy Assays
40 µL reactions containing 40 mM Tris-HCl (pH 8), 30 mM NaCl, 2.5 mM MgCl2, 2 mM
ADP-BeFx, 2 mM DTT, 40 U Superase-in (Ambion), and varying amounts of Dbp2 in the
presence or absence of 150 nM yra1C. Dbp2 and yra1C were first incubated in the reaction
buffer at 25°C for 15 min, then 10 nM fluorescently labeled ssRNA (5’-6-FAM-AGC ACC GUA
AAG ACG C-3’) was added and incubated at 25°C for another 100 min to reach equilibrium
binding. Fluorescence anisotropy signals of 6-FAM (λex = 495 nm and λem = 520 nm) was
measured using the BioTek Synergy 4 plate reader. The data were fitted to the following
equation: Y=Bmax*Xh/(Kdh+Xh) in Prism.
Transcriptional Shut Off Assays
Transcriptional shut off assays were conducted as described (Coller 2008). Cells were
grown at 25°C in glucose to log phase then shift to galactose for 10 hours to induce the GAL
genes expression followed by a shift to glucose to repress transcription. RNA was isolated at
indicated time points, subjected to Northern Blotting analysis, and detected by densitometry.
RNA half-lives were determined by measuring the amount of GAL10 or GAL7 transcript over
time with respect to the stable scR1 transcript. All experiments were performed with three
biological replicates.

2.3

Results

2.3.1 Dbp2 is recruited to chromatin via nascent RNA
The DEAD-box RNA helicase Dbp2 is predominately localized in the nucleus in
association with actively transcribed genes (Cloutier et al. 2012; Johnson et al. 2011; Zenklusen
et al. 2001; Beck et al. 2014). To determine if Dbp2 is recruited to chromatin via nascent RNA,
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we conducted chromatin immunoprecipitation (ChIP) assays with or without RNase treatment
(Abruzzi et al. 2004). Briefly, yeast cells harboring a 3XFLAG epitope tag fused to the 3’ end of
the endogenous DBP2 coding region were grown in the presence of galactose to induce
transcription of the GAL genes, known gene targets for Dbp2 association (Ma et al. 2013). DBP2
untagged strains were used to serve as a background control. Chromatin was then isolated and
incubated with a mixture of RNase A and RNase I or buffer alone prior to ChIP with the antiFLAG antibody. The eluted fractions were then subjected to quantitative (q)PCR with probes
across the GAL10 and GAL7 genes (Fig. 5.1A). Consistent with previous studies, this revealed
that Dbp2 is evenly distributed across the coding regions of both GAL10 and GAL7 with little to
no association with promoters (Fig. 5.1B). Interestingly, RNase treatment drastically reduced
Dbp2 occupancy across the entire locus for both the GAL10 and GAL7 genes to levels that were
not statistically different (p-value >0.05) from background (Fig. 5.1B). This suggests that Dbp2
is recruited to chromatin by interacting with newly transcribed RNA. The low level of RNaseresistant Dbp2 could be due to trace amounts of RNA still present after enzymatic digestion or an
alternative recruitment mechanism, such as interaction with RNA Polymerase II (RNA Pol II).
Dbp2 is required for efficient assembly of mRNA-binding proteins and export factors,
including Nab2, Mex67 and Yra1, and interacts directly with the C-terminal half of Yra1 (Ma et
al. 2013). Yra1 is co-transcriptionally recruited to chromatin through interaction with Pcf11, an
essential component of the cleavage and polyadenylation factor IA complex involved in 3’-end
formation (Johnson et al. 2009). To determine if the Dbp2-Yra1 interaction modulates
recruitment of Dbp2 to chromatin, we conducted ChIP as above in either wild type or yra1∆C
strains, the latter of which lacks the ability to associate with Dbp2 in vivo (Fig. 5.1C – 5.1D).
This revealed no difference in the recruitment pattern of level of Dbp2 to the GAL10 and GAL7
genes (Fig. 5.1E). Thus, Yra1 does not mediate recruitment of Dbp2 to chromatin.
2.3.2 Yra1 prevents accumulation of Dbp2 on RNA Pol II transcripts
To determine if the Dbp2-Yra1 interaction modulates the association of Dbp2 with RNA,
we conducted RNA immunoprecipitation (RIP) of a DBP2-3xFLAG strain. Since Dbp2
associates with the GAL10, GAL7, ACT1, and ADE3 genes shown by ChIP (Cloutier et al. 2012),
we selected these four gene transcripts as candidates whereas 18S rRNA serves as a negative
control. Analysis of the levels of immunoprecipitated transcripts by RT-qPCR revealed that
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Dbp2 associates with all four, candidate mRNAs at levels ~7-fold above an untagged
background control strain. Furthermore, loss of the Dbp2-Yra1 interaction in the yra1∆C strain
increased the association of Dbp2 with RNA Pol II transcripts by ~3 to 5 – fold (Fig. 5.2A),
suggesting that Yra1 prevents accumulation of Dbp2 on mRNA. Interestingly, the Dbp2-Yra1
interaction also affects the abundance of Dbp2 protein, with the yra1∆C strain exhibiting twofold more Dbp2 than wild type (Fig. 5.3A). To determine if the accumulation of Dbp2 on RNA
in the yra1∆C strain is due to overexpression of DBP2, we transformed wild type cells with a 2micron plasmid encoding DBP2 under the control of the highly active GAL1/10 promoter or with
empty vector and conducted RIP as above. Under this condition, Dbp2 protein level is at least
two-fold more abundant in pGAL-DBP2 than the wild type cells with empty vector (Fig. 5.3B).
Furthermore, this revealed co-precipitation of similar amounts of the GAL10, GAL7, ACT1 and
ADE3 transcripts regardless of the levels of Dbp2 protein (Fig. 5.3C). This suggests that the
accumulation of Dbp2 on mRNA is not simply due to overexpression but is specific to the
yra1∆C strain. Furthermore, the fact that Dbp2 accumulates on RNA not chromatin (Fig. 5.1E)
suggests this accumulation occurs after the transcript is released from the site of synthesis in
yra1∆C strains.
Prior studies have shown that loss of the C-terminal half of Yra1 in yra1∆C results in a
mild but detectible mRNA export defect (Zenklusen et al. 2001). To determine if the
accumulation of Dbp2 on RNA is caused by a block to mRNA export, we conducted RIP in rat71 strains, which harbor a mutation in the NUP159 gene required for mRNA export and has been
shown to induce export defects at the non-permissive temperature (37°C) (Krebber et al. 1999;
Gorsch et al. 1995; Del Priore et al. 1996). Interestingly, this revealed slightly lower levels of
Dbp2 on mRNA at the non-permissive temperature (37°C) in rat7-1 strain as compared to wild
type (Fig. 5.2B), indicating that the accumulation of Dbp2 on mRNA is not due to a block in
mRNA export.
2.3.3 Dbp2 is found in a large RNA-dependent complex in vivo
To determine if Dbp2 is found in a large complex in vivo, we subjected wild type whole
cell lysate to gradient fractionation followed by western blotting for detection of Dbp2, mRNA
binding protein Yra1, Mex67, and Nab2, and the DEAD-box helicase Dbp5. Approximate
molecular weights were then determined from the fractionation pattern relative to a molecular
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weight standard for each protein. Interestingly, Dbp2, Yra1 and Mex67 co-migrated in a large
~1.2 MDa complex, with no detectible free Dbp2 (Fig. 5.4A, fractions 14 – 17). This
corresponds to approximately 70% of the Dbp2 and Yra1 across all fractions and 40% of Mex67.
The presence of Dbp2 in a large complex is not an inherent property of DEAD-box proteins in
general as the mRNA export factor and DEAD-box RNA helicase Dbp5 migrated at a
significantly smaller size (Fig. 5.4A, fraction 2 – 4). The remaining fraction of Mex67 migrated
at a smaller position corresponding to fractions 5-10, partially overlapping the migration pattern
of Nab2 (Fig. 5.4A fractions 4 – 6). Approximately 3% of the total Yra1 co-migrated with Nab2
and Mex67, suggesting that the vast majority of Yra1 is also found in a large complex. This
suggests that there is little to no free Dbp2 in the cell and that Dbp2 may be in a large complex in
association with Yra1 and Mex67 in vivo.
To determine if the migration pattern of Dbp2 is dependent on RNA, we subjected yeast
cell lysate to RNase treatment prior to gradient fractionation. Interestingly, RNase treatment
shifted the migration pattern of Dbp2, Yra1 and Mex67 to lower gradient fractions in the absence
of RNA (Fig. 5.4B, fractions 6 – 8). Whereas the migration pattern of Nab2 was not significantly
changed, Dbp2, Yra1 and Mex67 were detected across multiple smaller fractions with a larger
portion of Mex67 (75%) co-fractionating with Nab2 than above (Fig. 5.4B, Lanes 3-6). This
suggests that Dbp2, Yra1 and a fraction of Mex67 all form large RNA-dependent complexes in
vivo.
To determine if Dbp2, Yra1 and Mex67 form a complex, we performed
immunoprecipitation assays with DBP2-TAP strains with and without RNase treatment. DBP2
untagged strains were used to serve as a background control. Though a faint band was observed
at the size that equivalents to Dbp2 in the elution fraction of DBP2 untagged strains (Fig. 5.4C,
lane 2), the signal of Dbp2 from DBP2-TAP strains was much stronger in either the presence or
absence of RNase treatment (Fig. 5.4C, lanes 4 and 5). This suggests that Dbp2 was successfully
precipitated. Consistent with in vitro studies, Yra1 was efficiently co-purified with Dbp2
regardless of RNase treatment (Fig. 5.4C, lanes 4 and 5). In addition, Mex67 was also copurified with Dbp2 independent RNA (Fig. 5.4C, lanes 4 and 5). This suggests that the large 1.2
MDa complex contains all three proteins and that formation of the Dbp2-Yra1-Mex67 complex
is not dependent on RNA. Consistent with gradient fractionation, Nab2 did not co-purify with
Dbp2 regardless of RNase treatment (Fig. 5.4C, lanes 4 and 5). Together with the glycerol
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gradient assays, this suggests that Yra1 does not maintain a free pool of Dbp2 but rather may
restrict the location of Dbp2 association with mRNA in vivo. As loss of Yra1-Dbp2 interaction
accumulates Dbp2 on RNA, but not chromatin, and Nab2 does not associate with Dbp2 (Fig.
5.1E and 5.4C), suggesting that the Yra1-dependent restriction happens at a point after mRNA is
released from chromatin but before association of Nab2 and subsequent mRNA export.
2.3.4 Yra1 does not alter the kinetics of Dbp2-dependent unwinding by smFRET
Our prior studies used bulk, multiple cycle assays to show that Yra1 inhibits Dbp2dependent unwinding in vitro (Ma et al. 2013). A limitation of these assays was the inability to
distinguish between kinetic effects of Yra1 on duplex unwinding rates or thermodynamic effects
on association of Dbp2 with RNA targets. To determine if Yra1 inhibits Dbp2 by decreasing the
duplex unwinding rate, we first established single molecule fluorescence resonance energy
transfer (smFRET) assays for Dbp2-dependent unwinding using a fluorescently labeled dsRNA
stem-loop molecule. Although the precise substrates for Dbp2-dependent unwinding are
unknown, a stem-loop is the most common secondary structure identified in cellular mRNAs to
date (Svoboda and Di Cara 2006; Rouskin et al. 2014; Ding et al. 2014; Wan et al. 2014), and,
thus, represents a likely physiological target for Dbp2 in vivo.
Briefly, a 39 nt hairpin dsRNA labeled with FRET pair fluorophores Cy3 and Cy5 was
surface-immobilized onto a pegylated microscopic quartz slide through biotin-neutravidin
linkage (Fig. 5.5A). The FRET pair fluorophores are close together and exhibit a high FRET
state (0.9) when the dsRNA forms a closed hairpin whereas the FRET pair fluorophores are
farther apart when the dsRNA is unwound with a low FRET state (0.1) (Fig. 5.5A). A threshold
of 0.6 FRET was used to distinguish between the open (0.1 FRET) and closed (0.9 FRET) states
of the hairpin. To study Dbp2-dependent unwinding at the single molecule level, we initially
established smFRET assays in the presence of low salt (30 mM NaCl) to parallel previous bulk
in vitro assay experiments (Ma et al. 2013). Under these conditions, 98% of the hairpin RNA
molecules exhibit a high FRET state (0.9) in the absence of any protein or nucleotide (Fig. 5.6A
and Fig. 5.6B), indicative of a stable dsRNA hairpin. In the presence of 10 nM Dbp2, we found
that 27% showed a single transition from a closed to open state within the course of the
experiment (Fig. 5.6A and Fig. 5.6B). This indicates that Dbp2 can unwind a dsRNA substrate in
the absence of ATP, an unexpected observation not seen in our previous in vitro bulk unwinding
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assays (Ma et al. 2013). Addition of 100 µM ATP and equimolar magnesium increased the
percentage of these molecules molecules to 61%, suggesting that more molecules are acted upon
by Dbp2 in the presence of ATP. This is consistent with the thermodynamic coupling of ATP
and RNA-binding in DEAD-box family members (Samatanga and Klostermeier 2014;
Banroques et al. 2008; Theissen et al. 2008). However, we were unable to monitor the kinetics of
duplex unwinding in these conditions because only ~15% of the RNA molecules exhibited
dynamic cycles of opening and closing (Fig. 5.6B).
To remedy this and to make our analyses more physiologically relevant, we conducted
smFRET in the presence of 150mM NaCl. The representative FRET time trajectory of RNA
alone shows that the hairpin dsRNA is stable at 150 mM NaCl (Fig. 2.5B). This resulted in 45%
of the molecules exhibiting dynamic behavior in the presence of Dbp2 and ATP (Fig. 2.5B –
2.5C). This increased dynamics was not due to a less stable RNA substrate as the smFRET
molecule remained stable throughout the timecourse (Fig. 2.5B). Interestingly, and consistent
with our low salt studies, the addition of Dbp2 alone also resulted in dynamic cycles of opening
and closing, albeit with less RNA molecules showing dynamic behavior in the absence of ATP
(Fig. 2.5B-2.5C). ATP-independent unwinding was not due to contaminating ATP in the Dbp2
purification as dsRNA hairpins still exhibited dynamic opening and closing cycles in the
presence of hexokinase and glucose (Fig. 2.5C). Interestingly, smFRET studies of the
mitochondrial group II intron also demonstrated an ATP-independent role for the DEAD-box
protein Mss116 in RNA folding, a process that requires both folding and unwinding steps
((Karunatilaka et al. 2010) and see Discussion).
To determine if ATP alters the opening and closing rates of the RNA molecules,
numerous (~100) trajectories were used to build dwell time histograms. Measurement of the
dwell time distribution in the presence of Dbp2 alone (no ATP) revealed opening and closing
rate constants of 4.1 s-1 and 3.3 s-1, respectively (Table 2.5). Interestingly, addition of ATP and
equimolar magnesium did not appreciably increase either the opening (6.3 s-1) or closing (5.9 s-1)
rates of the RNA duplex (Table 2.5). Together, this indicates that ATP does not affect the
unwinding rate but rather increases the population of dsRNA molecules acted upon by Dbp2.
Having established the unwinding behavior of Dbp2 at the single molecule level, we then
asked if Yra1 affects the rate of duplex unwinding by incorporating a GST-tagged C-terminal
half of Yra1 (yra1C) into our smFRET assays. Yra1C is the minimal Dbp2-interacting region in

47
Yra1, which is sufficient for inhibition of helicase activity and also lacks intrinsic RNA-binding
activity that would complicate experimental interpretation (Ma et al. 2013). Interestingly,
addition of a two-fold molar excess of yra1C, consistent with the ratio of Dbp2 and Yra1
proteins in yeast cells (Chong et al. 2015), did not appreciably reduce the opening (4.8 s-1) and
closing (5.5 s-1) rate of the hairpin (Table 2.5). However, yra1C did decrease the percentage of
unwound molecules (both dynamic and closed to opened) across the population in a dosedependent manner, to levels similar to Dbp2 without ATP (Fig. 2.5C). This suggests that Yra1
does not alter the kinetics of Dbp2-dependent unwinding of the RNA duplex.
2.3.5 Yra1 prevents Dbp2 from associating with ssRNA in vitro
ATP promotes high affinity RNA-binding by DEAD-box proteins (Rudolph and
Klostermeier 2015). The population effects seen in our smFRET studies suggest that Yra1
decreases the affinity of Dbp2 for RNA, similar to the absence of ATP. To test this, we
performed fluorescence anisotropy assays with Dbp2, 6-FAM-labeled ssRNA and the prehydrolysis ATP analog ADP-BeFx (Fig. 5.7A). We also utilized low salt conditions (30 mM
NaCl) as the increased dynamics would be predicted to reduce RNA-binding and the ability to
form a stable complex. ADP-BeFx was utilized to promote stable binding of Dbp2 RNA (Liu et
al. 2014). To ensure that our assays were performed under equilibrium conditions, we first
conducted a time course and monitored the change in anisotropy over time. This revealed that
equilibrium is established within 100 min (Fig. 2.8). Next, we conducted fluorescence
anisotropy with Dbp2 in the presence or absence of ADP-BeFx. This revealed that ADP-BeFx
decreased the dissociation constant (Kd ) of Dbp2 for ssRNA from 237 to 38 nM (Fig. 2.7A),
similar to other DEAD-box proteins (Cao et al. 2011; Henn et al. 2008). Interestingly, inclusion
of 150nM yra1C increased the Kd by 7-fold to 271 nM (Fig. 2.7A). This suggests that Yra1
inhibits Dbp2 by reducing the affinity for RNA.
To determine if Yra1 prevents initial RNA-binding by Dbp2, we exploited the slow on
rate of the ADP-BeFx-bound Dbp2 to RNA (Fig. 8; (Liu et al. 2014)) and asked if Yra1 reduces
the RNA-binding affinity of Dbp2 by performing an order of addition experiment under preequilibrium conditions for the Dbp2-ADP-BeFx-RNA complex. Briefly, Dbp2 and yra1C or
BSA were pre-incubated for 15 min in the presence of ADP-BeFx followed by addition of a
radiolabeled, 16 nucleotide ssRNA for an additional 15 min prior to resolution of RNA-bound
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complexes on a native gel (Fig. 5.7B). Consistent with the reduced RNA-binding affinity above
(Fig. 5.7A), pre-incubation of Dbp2 with yra1C resulted in a concentration-dependent reduction
of Dbp2 binding to ssRNA, from 100% bound to 58% (Fig. 5.7B, lanes 6-10). The reduction is
specific to yra1C, as BSA had no effect on the RNA-binding by Dbp2 (Fig. 5.7B, lanes 12-16).
Moreover, this is not due to competition between Yra1 and Dbp2 for RNA as yra1C does not
exhibit appreciable RNA binding activity ((Ma et al. 2013) and Fig. 5.7B, lanes 2-5). Yra1 also
reduced ssRNA binding by Dbp2 at physiological (150 mM) salt concentrations (Fig. 5.9). This
indicates that Yra1 inhibits the unwinding activity of Dbp2 by reducing the affinity for RNA.
Because Yra1 and Dbp2 exist in a 2:1 ratio in yeast cells (Chong et al. 2015) and Yra1 prevents
overaccumulation of Dbp2 on cellular mRNAs (Fig. 5.2A), this suggests that Yra1 functions
similarly to regulate Dbp2 in vivo.
2.3.6 Loss of the Dbp2-Yra1 interaction increases the half-life of GAL7 mRNA
To determine if Yra1-dependent inhibition of Dbp2 is necessary for proper gene
expression, we analyzed Dbp2-bound targets for expression defects in wild type and yra1∆C
strains. We also analyzed the DBP2 transcript itself since the yra1∆C strain shows higher Dbp2
protein levels than wild type cells (Fig. 5.3A). Interestingly, this revealed that both the DBP2 and
GAL7 transcripts and resulting proteins are significantly upregulated in yra1∆C strains (Fig.
5.10A-B). In contrast, none of the other Dbp2-associated transcripts exhibited altered abundance
(Fig. 5.10A). We were also unable to detect a change in protein level for GAL10 (Fig. 5.10B).
This suggests that the accumulation of Dbp2 results in a transcript-specific effect on gene
expression.
To determine the mechanism for increased GAL7 mRNA abundance in yra1∆C strains,
we asked if the increase occurred at transcription or decay. To this end, we conducted ChIP of
RNA Pol II and transcriptional shut off assays to compare the transcription and mRNA decay
efficiencies, respectively. ChIP using anti-Rpb3 revealed similar levels and patterns of RNA Pol
II occupancy in both wild type and yra1∆C strains across both GAL7 and GAL10, suggesting that
Dbp2 accumulation does not alter transcription efficiency (Fig. 5.10C). In contrast, however,
transcriptional shut off assays using glucose addition to the media and subsequent northern
blotting revealed that the half-life of the GAL7 mRNA is approximately two times longer in
yra1∆C strains as compared to wild type (Fig. 5.10D). This was not the case for the GAL10
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mRNA, whose half-life was unchanged. This suggests that Dbp2 accumulation prevents
efficient degradation of a subset of transcripts. Although it is currently unclear what renders
GAL7 mRNAs sensitive to Dbp2 accumulation, it is likely that this specificity is dictated by the
mRNA sequence and/or structure itself. Regardless, this demonstrates that Yra1-dependent
inhibition of Dbp2 alters mRNA metabolism in vivo. Taken together, and in conjunction with our
prior work and the current state of the mRNP assembly field (Ma et al. 2013; Oeffinger and
Montpetit 2015; Babour et al. 2012) we propose a model whereby Dbp2 promotes efficient
assembly of mRNA binding proteins including Yra1 onto mRNA during transcription which, in
turn, prevent recycling of Dbp2 onto the properly formed mRNP (Fig. 5.11 and Discussion).

2.4

Discussion
The human genome encodes approximately 100 helicases, of which ~60% are RNA-

dependent (Umate et al. 2011). DEAD-box proteins are the largest class in the RNA helicase
family and have been implicated in all aspects of RNA biology. However, there is a large gap in
our knowledge regarding the precise biochemical role(s) of individual DEAD-box protein family
members in the cell. Our studies provide evidence that Dbp2 associates with transcribed
chromatin via RNA, facilitates loading of RNA binding proteins most likely by resolving RNA
secondary structure, and is then released by one of the assembled proteins, Yra1. Yra1 is
recruited to chromatin through direct interactions with the mRNA 3’ end processing factor
Pcf11, which associates with the CTD of RNA Pol II (Abruzzi et al. 2004; Johnson et al. 2009).
Since Dbp2 is required for efficient assembly of Yra1 onto mRNA (Ma et al. 2013), this suggests
that Yra1 is brought to the chromatin through interactions with the transcriptional apparatus and
is subsequently transferred to mRNA by Dbp2. A recent study on the distribution of RNAprotein interactions and secondary structure in Arabidopsis has revealed an anti-correlative
relationship (Gosai et al. 2015). Given that Dbp2 unwinds RNA duplexes efficiently in vitro (Ma
et al. 2013) and that Yra1 is presumably a single-stranded RNA-binding protein, we envision that
this transfer occurs because Dbp2 has remodeled secondary structures that are refractory to
mRNP assembly. With the new advances in mRNA structural analysis in living cells (Ding et al.
2014; Rouskin et al. 2014; Wan et al. 2014), it may be possible to determine specific RNA
sequences that depend on Dbp2 or other DEAD-box proteins in living cells.
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The enzymatic activities of many DEAD-box proteins are regulated by protein co-factors
(Hilbert et al. 2011; Ma et al. 2013; Schutz et al. 2008; Granneman et al. 2006; Alcazar-Roman
et al. 2006). For example, the human tumor suppressor Pdcd4 inhibits both the unwinding and
the ATPase activities of the human DEAD-box protein eIF4A (Chang et al. 2009; Loh et al.
2009). This allows Pdcd4 to inhibit translation resulting in suppression of neoplastic
transformation and tumorigenesis in a mouse model (Yang et al. 2003; Cmarik et al. 1999;
Jansen et al. 2005). In contrast, the translation initiation factor eIF4B stimulates both the
unwinding and ATPase activities of rabbit eIF4A to promote efficient translation (Rozen et al.
1990; Rogers Jr. et al. 2001, 1999). This suggests that individual DEAD-box proteins may have
both activators and inhibitors in vivo, resulting in fine tuned control of enzymatic activity. This
phenomenon has been seen in the Ski2-like RNA helicase Brr2 during spliceosome maturation
whereby the spliceosomal protein Prp8 both stimulates and inhibits the unwinding activity of
Brr2 (Pena et al. 2009; Maeder et al. 2009; Mozaffari-Jovin et al. 2012, 2013).
Prior studies from our laboratory showed that Yra1 interacts directly with Dbp2 and inhibits
duplex unwinding activity without affecting the efficiency of ATP hydrolysis (Ma et al. 2013).
Using smFRET, we now show that Yra1 reduces the number of dynamic molecules across a
population and decreases the rate of unwinding of single dsRNAs. Moreover, Yra1 decreases the
ssRNA-binding affinity of Dbp2, an activity that is essential for duplex unwinding (Rudolph and
Klostermeier 2015). DEAD-box RNA helicases exhibit structurally distinct conformations based
on association with ATP and RNA (Sengoku et al. 2006b; Andersen et al. 2006; Aregger and
Klostermeier 2009). In the absence of either, these enzymes exist in a largely open confirmation,
whereas binding of ATP and RNA induces formation of a closed state with the RecA domains
coming together and bending the RNA into a structure that is incompatible with an A-form helix
(Sengoku et al. 2006b; Andersen et al. 2006). The DEAD-box protein remains bound to the bent
ssRNA until ATP hydrolysis promotes release.
Our data suggests that Yra1 does not inhibit Dbp2 from hydrolyzing ATP but prevents
stable association of Dbp2 with ssRNA (Ma et al. 2013). This likely occurs through an Yra1dependent structural rearrangement of Dbp2 which causes reduced RNA-binding affinity. To the
best of our knowledge, eIF4A and Ded1 are the only two DEAD-box proteins whose inhibition
mechanisms have been determined (Chang et al. 2009; Loh et al. 2009; Putnam et al. 2015).
Pdcd4 inhibits both the ATPase and unwinding activity of eIF4A through blocking RNA

51
binding, whereas eIF4G inhibits the unwinding activity of Ded1 via interfering oligomerization
of Ded1, and increases the affinity towards RNA. Since Yra1 inhibits Dbp2 helicase activity by
reducing ssRNA-binding activity without abolishing ATP hydrolysis, this suggests that Yra1
utilizes a distinct inhibition mechanism from Pdcd4 and eIF4G. Although it is not known how
this occurs, the fact that Yra1 prevents accumulation of Dbp2 on mRNA transcripts suggests that
Yra1 functions similarly in vivo as in vitro.
By using gradient fractionation, we found that Yra1 and Dbp2 co-migrate at a position
that corresponds to a large, RNA-dependent macromolecular complex. We speculate that this
migration reflects association with assembled mRNPs in the cell, consistent with the biological
roles of these two proteins. Although we cannot conclude that Yra1 and Dbp2 are present on the
same mRNA molecule simultaneously, the fact that these two proteins interact directly
regardless of the presence of RNA indicates that this is the case ((Ma et al. 2013)and Fig. 5.3).
The question then is how Yra1 can both interact with Dbp2 and promote release from RNA
simultaneously. One possible scenario is that Yra1 and/or Dbp2 is post-translationally modified
to control protein-protein interactions between these two molecules. In line with this,
ubiquitination of Yra1, Nab2 and Mex67 has been shown to modulate the interactions between
these three RNA-binding proteins and mRNA export factors in a manner that controls the timing
of pre-mRNP assembly in the nucleus (Iglesias et al. 2010). The fact that yra1∆C does not
exhibit increased Dbp2 accumulation on chromatin suggests that inhibition occurs posttranscriptionally following release of the mRNA from the site of synthesis. Consistent with this,
accumulation of Dbp2 causes stabilization of a subset of transcripts, a process that is
predominantly post-transcriptional (Bevilacqua et al. 2003; Anderson and Kedersha 2009).
Furthermore, both over-expression of DBP2 and yra1∆C lead to mild mRNA export defects
(Zenklusen et al. 2001; Ma et al. 2013), suggesting that Yra1 acts immediately prior to mRNA
transport from the nucleus.
Our results show that Dbp2 loads Yra1 onto poly(A)+ RNA (Ma et al. 2013), a role
previously assigned to the DECD-box protein Sub2 (Taniguchi and Ohno 2008; Luo et al. 2001).
Although this may seem redundant at first glance, the precise sites for Dbp2 and Sub2-dependent
assembly are not yet known. Moreover, Dbp2 and Sub2 exhibit vastly different duplex
unwinding activities in vitro with Sub2 exhibiting very weak activity (Ma et al. 2013; Putnam
and Jankowsky 2013a). Thus, Dbp2 may be specifically recruited to RNA structures for mRNP
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assembly whereas Sub2 may function as an ATP-dependent binding protein more similar to
eIF4AIII within the exon junction complex (EJC) (Ballut et al. 2005; Barbosa et al. 2012). This
suggests that Dbp2 and Sub2 perform distinct biochemical activities in gene expression which
both influence co-transcriptional loading of Yra1. Consistent with this, Sub2 has been proposed
to disassemble Yra1-Pcf11 complexes by promoting assembly of a Sub2-Yra1 complex on RNA
(Johnson et al. 2011). Thus, is possible that Dbp2 functions at the interface of this process to
ensure that the structure of the nascent RNA is amenable to assembly.
The mammalian ortholog of Dbp2, termed DDX5, is a well known oncogene whose
product is involved in numerous processes requiring modulation of RNA structure including premRNA splicing (Kar et al. 2011; Liu 2002; Guil et al. 2003) and rRNA processing (Jalal et al.
2007). Interestingly, the mammalian counterpart of Yra1, Aly, also interacts with DDX5 (Zonta
et al. 2013). This suggests that the inhibition mechanism for Dbp2 may be conserved in
multicellular eukaryotes. Several drugs have been successfully developed to target the DEADbox RNA helicase eIF4A, which alter the enzymatic activity of this enzyme by manipulating
RNA-binding activity and/or ATP hydrolysis activity (Eberle et al. 1997; Shuda et al. 2000; Gao
et al. 2007; Wen et al. 2007; Bordeleau et al. 2006, 2008, 2005; Low et al. 2005). Thus far, the
eIF4A inhibitors Silvestrol and Paetamine A have proven useful therapeutic tools for
uncontrolled cell growth (Bordeleau et al. 2005, 2008), suggesting that inhibition of individual
DEAD-box enzymes is a successful strategy for cancer intervention. Thus, understanding the
mechanisms for enzymatic modulation of helicases in vivo is crucial for designing novel drug
therapies.
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Figure 2.1. Dbp2 is recruited via RNA
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Figure 2.1 continued
(A) Schematic diagram of the GAL10 and GAL7 genes and the positions of qPCR amplicons. (B)
Dbp2 is recruited to chromatin in an RNA-dependent manner. Transcription of the GAL genes
was induced by growing yeast cells in rich media plus glucose initially and subsequently shifting
to media with galactose for 5 hours. Chromatin was then isolated, sheared by sonication, and
incubated with 7.5 U RNase A and 300 U RNase I or buffer alone before being subjected to
ChIP using anti-FLAG antibodies. Results are presented as the percent of precipitated DNA over
input averaged across four biological replicates with SEM. Student t-test was performed between
RNase untreated and treated samples or RNase treated samples and DBP2 untagged strains in all
primer sets. * indicate the difference between samples is statistically significant with a p-value <
0.05. (C) Schematic diagram of the primary sequence and functional motifs of Yra1(Zenklusen et
al. 2001; Stutz et al. 2000; Strasser and Hurt 2000; Johnson et al. 2009). The C-terminal half of
Yra1 is sufficient to interact with Dbp2 in vitro (Ma et al. 2013). (D) Dbp2 interacts with the Cterminal half of Yra1 in vivo. Immunoprecipitation assays were conducted using anti-FLAG
antibodies to isolate Dbp2-3xFLAG and associated proteins from wild type or yra1∆C lysate.
10% of the lysate was used as input. Dbp2 and Yra1 were detected by Western blotting with
protein-specific antibodies. Dbp2, Yra1 and yra1∆C from elution were quantified by
densitometry with respect to input. (E) Loss of the C-terminal half of Yra1 does not affect the
association of Dbp2 with the actively transcribing GAL10 (left) or GAL7 (right) gene. WT and
yra1ΔC strains were used for ChIP with anti-FLAG antibody against Dbp2-3xFLAG. Student ttest was performed between full-length YRA1 and yra1∆C strains in all primer sets. All the pvalues > 0.05.
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Figure 2.2. Yra1 prevents over-accumulation of Dbp2 on RNA Pol II transcripts
(A) Dbp2 accumulates on the RNA Pol II transcripts in a yra1∆C strain. RNA
immunoprecipitation (RIP) assays were performed to determine the level of RNA associated
with Dbp2 in wild type and isogenic yra1∆C cells. Cells were grown with galactose to promote
expression of GAL10 and GAL7 genes as in Fig. 5.1 and subsequently cross-linked with
formaldehyde. RNPs were isolated with anti-FLAG antibodies and transcripts were detected by
RT-qPCR with primers specific to the 5’ end of each mRNA (see 2.4). Dbp2-3xFLAG
occupancy on specific transcripts is shown as the average percent of isolated RNA over input for
three biological replicates. Error bars indicate the SEM. (B) The association of Dbp2 with RNA
Pol II transcripts is not altered in the mRNA export mutant strain, rat7-1. RIP assays were
performed as above with wild type cells, isogenic rat7-1 cells (Brykailo et al. 2007), or isogenic,
wild type untagged cells at both the permissive temperature (25°C, left) and the non-permissive
temperature (37°C, right) for rat7-1 (Krebber et al. 1999; Gorsch et al. 1995; Del Priore et al.
1996).
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Figure 2.3. Overexpression of DBP2 does not cause over-accumulation of Dbp2 on RNA Pol
II transcripts
(A) Loss of the C-terminal half of Yra1 upregulates the protein level of DBP2-3xFLAG. Western
blotting was conducted with the indicated antibodies. Dbp2 was quantified by densitometry with
respect to Pgk1. (B) Western blotting shows that pGAL-DBP2 is expressed. Western blotting was
conducted with the indicated antibodies from strains expressing vector alone or pGAL-DBP2 as
indicated. Signals from Dbp2 and Protein A-Dbp2 were combined and quantified by
densitometry with respect to Pgk1. (C) Overexpression of DBP2 does not affect the association
of Dbp2 with transcripts. RIP was performed as Fig. 5.2 with wild type strain with empty vector
or with a plasmid encoding DBP2 under the control of the galactose-inducible pGAL promoter.
Strains were grown in selective media (-URA) + glucose followed by a 5-hour shift to galactose
to induce overexpression of Dbp2. (D) Anti-Dbp2 and anti-Pgk1 antibodies can semiquantitatively determine the levels of Dbp2 and Pgk1, respectively, using Western blotting
analysis. The amount of whole cell extract (2 mg) that was used in the assays is within the linear
range of detection for both Dbp2 and Pgk1 antibodies.
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Figure 2.4. Dbp2 forms a large RNA-dependent complex with Yra1 and Mex67 in vivo
(A) Dbp2, Yra1 and Mex67 co-migrate as a large complex by glycerol gradient fractionation.
Glycerol gradient (10 – 30%) were performed with yeast lysate and the isolated fractions were
resolved by SDS-PAGE and proteins were detected by western blotting. Molecular weights were
determined using a standard curve that was generated by resolving the molecular weight
standards comprising catalase (250 kDa), apoferritin (480 kDa), and thyroglobulin (670 kDa).
(B) RNase treatment of yeast lysate prior to gradient fractionation disrupts formation of the
large Dbp2-Yra1-Mex67 complex. Glycerol gradient (10 – 30%) were performed as above but
with 70 U of RNase A and 1000 U of RNase I. (C) RNase treatment does not alter the Dbp2Yra1-Mex67 interaction. TAP-tag immunoprecipitation assays of Dbp2 were conducted in the
presence or absence of 70 U of RNase A and 1000 U of RNase I. Input (1%) and elutions were
resolved by SDS-PAGE and proteins were detected by western blotting. * indicative of heavy
chains from antibody. ** indicative of light chains from antibody. *** indicative of a nonspecific band.
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Figure 2.5. Yra1 decreases the unwinding rate and specific activity of Dbp2 in smFRET
studies
(A) Schematic representation of smFRET with a dual labeled hairpin RNA. Dual labeled RNA
(Cy3 and Cy5) was purchased from IDT and subsequently surface-immobilized on a pegylated
microscope quartz slide via biotin-neutravidin bridge (Lamichhane et al. 2010). The oval
represents Dbp2. The red star represents Cy5 and the green star represents Cy3. (B)
Representative FRET trajectory in the smFRET experiments. Representative trajectories of a
closed RNA hairpin alone (top left), in the presence of 10 nM Dbp2 (top right),10 nM Dbp2 and
100 µM ATP (bottom left), or in the presence of 10 nM Dbp2, 20 nM yra1C, and 100 µM ATP
(bottom right) are shown. Numerous (~100) trajectories were used to build the dwell time
histograms to determine the opening and closing rate constant. (C) Yra1 decreases the number of
hairpin dsRNAs unwound by Dbp2. The distribution of closed, closed to opened (single opening
events), or dynamic (multiple cycles of opening and closing) hairpin dsRNAs with 10 nM Dbp2
with or without 100 µM hexokinase and 1 mM glucose in the absence of ATP or 10 nM Dbp2
with increasing concentrations of GST-yra1C in the presence of ATP are shown. Trajectories
exhibiting more than one excursion into 0.2 – 0.8 FRET are considered dynamic molecules.
Trajectories exhibiting constant 0.9 or 0.1 FRET throughout the experimental time window are
classified as statically closed or opened molecules, respectively.
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Figure 2.6. smFRET in 30 mM NaCl
(A) Representative FRET trajectory of the smFRET experiment in 30 mM NaCl. FRET trajectory
of a closed RNA hairpin in the absence of any protein and ATP (top), in the presence of 10 nM
Dbp2 (middle), or in the presence of 10 nM Dbp2 100 µM ATP (bottom). (B) The hairpin
dsRNAs show low dynamic in low salt (30 mM NaCl). The distribution of closed, closed to
opened (single opening events), or dynamic (multiple cycles of opening and closing) hairpin
dsRNAs populations obtained from smFRET studies in 30 mM NaCl are shown. The molecules
show very low dynamic behavior (multiple cycles).
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Figure 2.7. Yra1 reduces binding of Dbp2 onto ssRNA in vitro
(A) Yra1 decreases the ssRNA-binding affinity of Dbp2. Fluorescence anisotropy assays were
conducted with varying amounts of Dbp2 and 10 nM of fluorescently labeled ssRNA in the
presence or absence of 2 mM ADP-BeFx under equilibrium condition. In the presence of 2 mM
ADP-BeFx, increasing amounts of Dbp2 and 10 nM labeled ssRNA were incubated with or
without 150 nM of yra1C. Three technical replicated were conducted in this experiment. Error
bars indicate the SEM. (B) Yra1 decreases the association of Dbp2 with ssRNA. Gel shift assays
were conducted in the presence of 2 mM ADP-BeFX/MgCl2, 10 nM of 5’-radioactively labeled
ssRNA (16 nt), with or without the Dbp2 (400 nM) and varying amounts of GST-yra1C or BSA
(0 nM, 300 nM, 600 nM, 1200 nM, and 1800 nM). Complexes were assembled at 4°C as
indicated in the schematic diagram followed by resolution on a 4% native PAGE and subsequent
autoradiography. ND indicates the protein-bound signal was not detected.
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Figure 2.8. Dbp2 reaches equilibrium binding with ssRNA within 100 min
Fluorescence anisotropy assays were conducted by incubating 20 nM of Dbp2 with 10 nM of
fluorescently labeled ssRNA in the presence of 2 mM ADP-BeFx. A time course was performed
to determine the time that requires for Dbp2 to reach equilibrium binding with ssRNA.

Figure 2.9. Yra1 reduces the affinity of Dbp2 for ssRNA at 150 mM NaCl
RNA-protein complexes were assembled as in Fig. 5.7B but in the presence of 150 mM NaCl.
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Figure 2.10. Inhibition of Dbp2 by Yra1 prevents overexpression of specific of gene
products in vivo
(A) Loss of the Dbp2-Yra1 interaction results in upregulation of the GAL7 and DBP2 transcript.
RT-qPCR was performed with transcripts that were extracted from wild type cells and isogenic
yra1∆C cells. Transcription of the GAL genes was induced by growing cells with galactose.
Transcript levels were normalized to 18S rRNA and wild type cells. Error bars indicate the SEM
from three biological replicates and * indicates a p-value <0.05 from a two-tailed student t-test.
(B) Loss of the Dbp2-Yra1 interaction increases the protein levels of Gal7 and Dbp2. Cterminally 3X-FLAG-tagged GAL10 and GAL7 strains were constructed in the yra1∆C strain by
standard yeast methods to provide an epitope for western blotting. Protein detection by western
blotting was conducted using anti-Dbp2 (Beck et al. 2014) or anti-FLAG as indicated.
Quantification of the protein signal is done by ImageQuant. Error indicates the SEM from three
biological replicates. (C) RNA Pol II exhibits a similar pattern of gene occupancy in both wild
type and yra1∆C strains. ChIP was performed as above, but with anti-Rpb3 antibodies, a subunit
of RNA Pol II. (D) The GAL7 mRNA has a longer half-life in yra1∆C strains than wild type
cells. Transcriptional shut off assays were performed by shifting indicated strains to glucose to
repress transcription of GAL genes after a 10 hours induction with galactose. RNA was extracted
at the indicated time points and transcripts were detected by Northern blotting. Transcripts were
quantified by densitometry and normalized to scR1. Half-lives were calculated from three,
independent biological replicates by fitting the data to an exponential decay equation.
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Figure 2.11. Enzymatic inhibition of Dbp2 by Yra1 restricts cycles of Dbp2-dependent
mRNP remodeling in vivo
Dbp2 is co-transcriptionally recruited to chromatin through RNA to resolve RNA duplexes. This
resolution allows co-transcriptional loading of RNA-binding proteins Yra1 and Mex67 onto the
nascent RNA. Dbp2 then guides Yra1 and Mex67 to assemble onto the RNA at site where it is
structure-free . After nucleotide exchange, Yra1 prevents post-transcriptional re-association by
reducing the single-stranded RNA binding affinity of Dbp2. This activity likely prevents Dbp2
from accumulating on mRNA, which results in aberrant transcript stabilization and
overexpression of specific gene products.

71

Table 2.1. Yeast and bacterial plasmids
Name

Description

Source/Reference

BTP22

pMAL-TEV-Dbp2

(Ma et al. 2013)

BTP27

GST-TEV-Yra1

(Ma et al. 2013)

GST-Yra1C

pET21GST-Yra1C (124-226)

(Johnson et al. 2009)

BTP2

pET28a-Sub2 (HIS-Sub2)

This study

HA-Yra1

YCpLac22-HA-Yra1

(pTRP- (Zenklusen et al. 2001)

HA-Yra1)
HA-Yra1 1-167

YCpLac22-HA-Yra1

1-167 (Zenklusen et al. 2001)

(pTRP-HA-Yra1 1-167)
pTRP

pRS314

(Sikorski and Hieter 1989)

pURA3

pRS316

(Sikorski and Hieter 1989)

pGAL-DBP2

pGAL-DBP2/2µ/URA3

Open Biosystems
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Table 2.2. Yeast strains
Strain

Genotype

Source

Wild Type (BY4741)

MATa his3∆1 leu2∆0 met15∆0 ura3∆0

Open Biosystems

DBP2-GFP

MATa DBP2-GFP:HIS3 his3D1 leu2D0 Invitrogen
met15D0 ura3D0

xrn1∆

MATa

xrn1::KanMx

his3D1

leu2D0 Open Biosystems

ura3∆0

leu2∆0 This study

ura3∆0

leu2∆0 This study

met15D0 ura3D0
dbp2∆ (BTY115)

MATa

dbp2::KanMx

his3∆0 TRP1 met- lys?
dbp2-K136N (BTY166)

MATa

dbp2::KanMx

his3∆0

TRP1

met-

lys?

+

pdbp2-

K136N/CEN/LEU2
dbp2-E268Q (BTY180)

MATa
his3∆0

dbp2::KanMx
TRP1

ura3∆0

met-

lys?

leu2∆0 This study
pdbp2-

E268Q/CEN/LEU2
spt6-1004

prGAL- MATα

FLO8:HIS3 (BTY217)

spt6-1004-FLAG

prGAL-FLO8- Reconstructed from

HIS3::KanMx ura3-52 leu2∆1 lys2-128∂ (Cheung
his4-912∂ trp?

dbp2∆

prGAL- MATa

2008)
prGAL1-FLO8- This study

dbp2::KanR

FLO8:HIS3 (BTY124)

HIS3::KanMx ura3 leu2 his3 trp? lys? met?

rrp6∆

MATa

rrp6::KanMx

his3D1

leu2D0 Open Biosystems

met15D0 ura3D0
DBP2-3XFLAG

MATa

DBP2-3XFLAG:KanMx

(BTY200)

leu2∆0 met15∆0 ura3∆0

dbp2∆ FT4 (BTY219)

MATa

ura3-52

trp1-Δ63

his3∆1 This study

his3-Δ200 This study

leu2::PET56 dbp2::KanMx
dbp2∆ FT4+Reb1BS∆

MATa

ura3-52

(BTY220)

leu2::PET56

trp1-Δ63

his3-Δ200 This study

gal10::URA3::pMV12

(EcoRI/XhoI-Reb1 BS∆ with BS2 silent)
dbp2::KanMx

et

al.
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Table 2.3. Primetime primers for ChIP
Name

Forward

Reverse

Probe

GAL10 – 1

CTTTATTGTTCGGA

GCTCATTGCTATATT

CGGTGAAGACGAGG

GCAGTGC

GAAGTACGG

ACGCACG

GAL10 – 2
GAL10 – 3
GAL10 – 4
GAL10 – 5
GAL7 – 1
GAL7 – 2
GAL7 – 3
GAL7 – 4
GAL7 – 5

TGGTGCTGGATACA AGGGAATGTGATGCT TGACTGTGTTGTTGC
TTGGTTC

TGGTC

TGATAACCTGTCG

TGAAGGTTTGTGTC

TCTGCCCGTAACTTT

CTTGGGTTCCGGTAA

GTGAGTG

GTATGG

AGGTTCTACAGTT

ACTCTACAAAGCC

GAATCGGGATGAAA

TCCACCACAAAACA

AACGGTC

AGCCTTG

ACAATCAAACTGGG

GGTTTTGCAATTGA

GCTGGCAAATCAGG

AAACGGTGAAACTT

GCCTGG

AAAATCTG

ACGGGTCCAAGA

GCGCTCGGACAAC

TTTCCGACCTGCTTT

CCGTGATCCGAAGG

TGTTG

TATATCTTTG

ACTGGCTATACA

ATCATACAATGGA

CTAGCCATTCCCATA

AAGCAGCCTCCTGTT

GCTGTGGG

GACGTTAC

GACCTAACC

TGCGAAACTTCACT

CCAGAGAAGCAAGA

CAACCCATGGCTGTA

AGGGATG

GAAAATCATAAG

CCTTTGTTTTCA

GCATTTCTACCCAC

CAGCTTGTTCCGAAG

AGGCTCACCTAACAA

CTTTACTGAG

TTAAATCTC

TTCAAAACCAACC

GGACCACTCTTACA

TTTTCTATTAACTGC

TGTCACTCCGTTCAA

TAACTAGAATAGC

CTGGTTTCTTT

GTCGACAACC
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Table 2.4. RT-qPCR oligos
Name

Forward

Reverse

GAL10

GAGGTCTTGACCAAGCATCACA

TTCCAGACCTTTTCGGTCACA

GAL7

CCATTCCACAAATGAAACAATCA

GGAGAGATCGTCAGTCAATGCT
T

ACT1

TGGATTCCGGTGATGGTGTT

TCAAAATGGCGTGAGGTAGAG
A

ADE3

CCCGTGATATCGCATCATACTTAC

18S rRNA CGAATCGCATGGCCTTGT

GGCCGATGGCAACGACTA
CGAAAGTTGATAGGGCAGAAA
TTT

PGK1

GTTTTGGAACACCACCCAAGA

TCACCGTTTGGTCTACCCAAGT

Table 2.5. The opening and closing rate constants of the RNA hairpin
kopening (s-1)

kclosing (s-1)

4.1 ± 0.2

3.3 ± 0.3

10 nM Dbp2 and 100 µM ATP 6.3 ± 0.5

5.9 ± 0.4

10 nM Dbp2
10 nM Dbp2, 20 nM GSTyra1C and 100 µM ATP

4.8 ± 0.4

5.5 ± 0.3
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CHAPTER 3
RNA HELICASE DEAD BOX PROTEIN 5 REGULATES
POLYCOMB REPRESSIVE COMPLEX 2/HOX TRANSCRIPT
ANTISENSE INTERGENIC RNA FUNCTION IN HEPATITIS B VIRUS
INFECTION AND HEPATOCARCINOGENESIS.

3.1

Introduction
Chronic Hepatitis B Virus (HBV) infection is a major factor in development of

hepatocellular carcinoma (HCC)(1), and the 16.5kDa HBx protein encoded by HBV is a cofactor in HCC pathogenesis (2, 3). Despite the HBV vaccine, the World Health Organization
estimates 250 million people globally are chronically infected with HBV. Moreover, the HBV
vaccine is not always protective; children born of infected mothers become chronically infected.
Current treatments include antiviral nucleoside analogs, efficient in suppressing HBV
replication, but having no impact on persistence of the viral mini-chromosome, or production of
the HBV oncoprotein HBx by the integrated viral DNA (4). In advanced stage HCC, sorafenib
therapy provides survival improvement, delaying tumor progression (5, 6). Thus, new and
effective mechanism-based therapies are needed to inhibit deleterious effects of HBx protein on
cell homeostasis, by targeting essential mechanisms of viral replication and HCC pathogenesis.
Herein, we have identified such a molecular mechanism, having a role both in HBV
replication and hepatocarcinogenesis. It involves the RNA helicase DDX5, regulating stability
and function of the chromatin modifying Polycomb Repressive Complex 2 (PRC2). SUZ12, an
essential subunit of PRC2, is downregulated in HBV replicating cells and liver tumors of animals
modeling Hepatitis B virus (HBV)-induced liver cancer (7, 8). SUZ12 downregulation involves
proteasomal degradation initiated by phosphorylation of SUZ12 by mitotic polo-like-kinase1
(PLK1) (9) which is activated by HBx (10). Intriguingly, SUZ12 degradation is accelerated by
the long noncoding RNA (lncRNA) HOTAIR (9), suggesting the E3 ligase that ubiquitinates
SUZ12 also binds to HOTAIR.
The PRC2 complex regulates lineage selection during embryonic development and stem
cell differentiation (11, 12) by trimethylation of H3 on K27 (H3K27me3), a transcription
silencing modification. PRC2 associates with more than 9,000 lncRNAs (13, 14) and represses
transcription of >1000 genes in ESCs (11). LncRNAs are proposed to recruit PRC2 to specific
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gene loci for repression through direct protein-RNA interactions (15, 16). However, neither
association with chromatin nor with RNA is sufficient for gene repression (17, 18). Specific gene
repression may require active remodeling of PRC2-lncRNA complexes by RNA helicases (19).
One family of RNA helicases is the DEAD box helicases which function as RNA-dependent
ATPases and ATP-dependent RNA helicases (20, 21), unwinding RNA duplexes, displacing
proteins from RNA, and remodeling RNA-protein (RNP) complexes (20, 21).
Here we provide evidence that SUZ12 interacts with DEAD box RNA helicase
DDX5/p68 (22). Mammalian DDX5 acts as a transcriptional regulator (22) by associating with
different transcriptional effectors (23, 24). The yeast homolog of DDX5 functions in lncRNAdependent gene regulation (25-28), supporting DEAD box RNA helicases can influence lncRNA
function in vivo. Here we show that DDX5 has a role in RNA-protein complexes formed with
HOTAIR. HOTAIR binds to PRC2 complex and represses transcription of specific genes (29),
and also associates with RNA-binding E3 ligases, serving as ubiquitination scaffold (30).
In this study, we dissected the role of RNA helicase DDX5 in PRC2-mediated repression
of transcription both of cellular genes and the HBV mini-chromosome (31). Histone
modifications of the viral mini-chromosome determine the rate of viral transcription and in turn,
the rate of viral replication (32). We provide evidence that DDX5 by regulating PRC2 stability
and function, has a dual role in infected hepatocytes; namely, regulation of HBV replication, and
expression of specific host genes involved in HBV-mediated hepatocarcinogenesis. These genes
include EpCAM and pluripotency genes expressed in hepatic cancer stem cells (hCSCs) (33, 34).
Importantly, analyses of DDX5 expression in liver tumors from X/c-myc bitransgenic mice (2)
and chronically HBV infected patients identify DDX5 as an important molecule in pathogenesis
of poor prognosis HBV-mediated liver cancer.

3.2

Materials and Methods

Cell culture, transfections, plasmids, siRNAs and synchronization protocols
HEK293T, HepG2 cells and mouse hepatocyte AML12 cell lines were purchased from
ATCC. Tetracycline regulated HBx-expressing 4pX-1 cells, derived from AML12 cell line were
grown as described (35), with tetracycline (5µg/ml) or without tetracycline for 16-18h to allow
HBx expression. HBx expression was confirmed by RT-PCR. Synchronization of 4pX-1 cells in
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G1/S by the double thymidine block (dTB) was as described (10). Transient transfections
employed Lipofectamine 2000 (Invitrogen), with 2µg each of the following plasmids: pcDNA
empty vector, pcDNA-DDX5-D248N-Flag, pcDNA-DDX5-K149N-Flag, pcDNA-DDX5-Flag,
SUZ12-HA, Plk1CA-GFP, Ubiquitin-FLAG, and pcDNA3-HOTAIR (22). siRNAs for DDX5,
Mex3b and scrambled control siRNA (siCtrl) were transfected using Lipofectamine®
RNAiMAX (Invitrogen). Cell lines were routinely tested for mycoplasma.
Biochemical ATPase Assays
In vitro ATP hydrolysis assays were performed using an enzyme-coupled absorbance
assay (36). ATP hydrolysis rate was measured using 400 nM purified, recombinant MBP-DDX5GST or mutants in the presence and absence of 250 ug/ml total yeast RNA (Sigma). kobs values
were calculated using the formula: V0 = (A340/min × 2.5)/(6.22 × 10−3µM), where kobs(min−1)
= V0/protein concentration. DDX5 fused to an N-terminal MBP and C-terminal GST tag (MBPDDX5-GST) was expressed in E.coli and purified by affinity chromatography. DDX5 mutants
were purified by the same method. N=3, error bars represent standard deviation.
Fluorescence Anisotropy (FA) Assay
5’ 6-FAM-labeled RNA 5′-AGCACCGUAAAGACGC-3′ was purchased from IDT.
Reaction mixtures (40 µl) contained 40 mM Tris-HCl (pH 8.0), 30 mM NaCl, 2.5 mM MgCl2,
2mM AMPPNP, 2 mM DTT, 40 U Superase-in (Life Technologies), 10 nM fluorescent RNA,
and purified recombinant proteins. Binding reactions were incubated at 25 °C for 30 min and
assays were performed in black 96-well microplates (Corning Incorporation, #3686) by
measuring FA signals of 6-FAM (λex = 495 nm and λem = 520 nm) utilizing BioTek Synergy 4
plate reader. Data were fitted to Y = Bmax*X/(Kd+X) equation.
Ribonucleoprotein Immunoprecipitation (RIP) Assays
RIP were performed as described (30). Whole cell extracts (WCE) prepared in lysis
buffer (Cell signaling) were incubated on ice for 30 min, followed by centrifugation at 10,000Xg
for 15 min at 4ºC. Supernatants were incubated with antibodies for DDX5 (Millipore), Mex3b
(Santa Cruz Biotechnology), or control IgG (Cell signaling) for 1 hr at 4ºC, followed by addition
of protein A/G beads (40 µl) and overnight incubation at 4ºC. Beads were washed with RIP
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buffer (150 mM KCl, 25 mM Tris pH 7.4, 5 mM EDTA, 0.5 mM DTT, 0.5% NP40), complexes
were treated with 20 units of RNase-free DNase I (15 min at 37 ºC) and incubated with 0.1%
SDS and 0.5 mg ml-1 Proteinase K (15 min at 55 ºC) to remove DNA and proteins, respectively.
RNA was isolated from IP by PureLinkTM RNA mini kit (Invitrogen) and quantified by RTqPCR (primer sequences are listed in Supporting Data section, Table S1).
Chromatin immunoprecipitation assays (ChIP)
ChIP were performed employing Millipore ChIP Assay Kit (Cat. No. 17-295) and
antibodies for Histone H3 (tri methyl K27) (ab6002), H3 (Active Motif), SUZ12 (Cell
Signaling), and DDX5 (Millipore) were used and listed in Supporting Data section, Table S2.
Sequence of primers used are listed in Supporting Data section, Table S1.
Immunoblots and immunoprecipitations assays
Immunoblots and immunoprecipitations were performed by standard protocols;
antibodies used are listed in Supporting Data section, Table S2.
Reverse Transcription and Quantitative Real-Time PCR
RNA was isolated employing PureLinkTM RNA Mini Kit (12183018A, Invitrogen). Liver
tissues from chronic HBV patients with HCC, tumor and peritumoral tissue, were obtained from
the French National Biological Resources Centre following approved consent from the French
Liver Tumor Network Scientific Committee. cDNA was synthesized from 2.0 µg total RNA
isolated using iScript™ cDNA Synthesis Kit (170-8891, Bio-Rad). Q RT-PCR reactions were
performed in triplicates and normalized to GAPDH employing FastStart Essential DNA Green
Master (06924204001, Roche), SYBR green (Roche), and Roche LightCycler 96. 2-ΔΔCt
method was used for analysis. Primer sequences are listed in Supporting Data section, Table S1.

3.3

Results

3.3.1 DDX5 is a SUZ12 interacting protein
DDX5 was identified by mass spectrometry as a SUZ12 interacting protein (Supporting
Table. S3). We validated these results by immunoprecipitations of HepG2 lysates with antibodies
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(Ab) to each PRC2 core subunits, i.e., EZH2, SUZ12 and EED (Fig. 1A and Supporting Fig.
S1A). Endogenous DDX5 co-immunoprecipitated with each PRC2 subunit, showing a strong
signal with SUZ12. Knockdown of SUZ12 by siRNA transfection significantly reduced co-IP of
endogenous DDX5 with other core PRC2 subunits, suggesting DDX5 interacts preferentially
with SUZ12 (Fig. 1B and Supporting Fig. S1B). Furthermore, RNase treatment of lysates failed
to disrupt DDX5/SUZ12 association, supporting this interaction is not RNA dependent
(Supporting Fig. S1C, D).
3.3.2 Role of DDX5 in PRC2-mediated target gene repression
To determine whether the DDX5/PRC2 interaction is functional, we examined the effect
of DDX5 knockdown on expression of known PRC2 target genes (8, 11). Knockdown of DDX5
in our model hepatocyte 4pX-1 cell line (35) increased expression of some but not all PRC2repressed genes, including EpCAM, IGFII and pluripotency genes Nanog, Oct4, and Sox2 (Fig.
1C). Importantly, EpCAM is re-expressed in hCSCs (33, 34), and IGFII is a known DDX5
regulated gene, serving as positive control (37).
Since DDX5 interacts with SUZ12 (Fig. 1A), the PRC2 complex binds HOTAIR (29),
and SUZ12 down-regulation is facilitated by HOTAIR (9), we examined whether DDX5 binds
endogenous HOTAIR. Ribonucleoprotein immunoprecipitation (RIP) assays showed that DDX5
bound endogenous HOTAIR (Fig. 1D). Next, we knocked down HOTAIR by siRNA
transfection in 4pX-1 cells and observed enhanced EpCAM expression, quantified by RT-PCR
(Fig. 1E) and verified by EpCAM immunoblots (Supporting Fig. S2A). Knockdown of HOTAIR
also resulted in statistically significant induction of Nanog, Oct4 and Sox2 but not IGFII and
DKK2 mRNAs, suggesting HOTAIR in association with DDX5 is involved in PRC2-mediated
repression of specific genes (Fig. 1E). Combined knockdown of HOTAIR and DDX5 did not
have an additive effect on EpCAM expression, supporting these two molecules act in the same
pathway (Fig. 1E). Chromatin immunoprecipitation (ChIP) assays showed that HOTAIR
knockdown reduced SUZ12 occupancy at the EpCAM, Nanog, Oct4 and Sox2 promoters
(Supporting Fig. S2C) but not DLK1 and CCND2 promoters (Supporting Fig. S2B). Taken
together (Fig. 1), these results identify DDX5 and HOTAIR as necessary partners for PRC2mediated transcriptional repression of specific genes.
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3.3.3 DDX5 is downregulated in HBV-induced HCCs and HBV replicating cells
Next, we examined DDX5 mRNA expression in liver tumors from the HBx/c-myc
animal model of HBV-mediated hepatocarcinogenesis (2). We observed statistically significant
reduction in DDX5 mRNA levels in liver tumors vs. normal liver (Fig. 2A). Interestingly, DDX5
expression was also significantly reduced in Group A of human liver tumors from chronically
HBV infected patients compared to peritumoral tissue (Fig. 2B).
Since chronic HBV infection is linked to HCC pathogenesis, we reasoned cellular
mechanisms deregulated during HBV-induced hepatocarcinogenesis must provide an advantage
for viral growth. Accordingly, we examined DDX5 protein levels in HBV replicating cells. We
employed lysates from the HBV replication model of HepAD38 cells (38), HBV infection
models of HepG2-NTCP cells (39), and primary human hepatocytes (PHH)(40) (Fig. 2C). The
HBV core antigen HBc is used as a marker of HBV replication (Fig. 2C), while quantification of
viral RNA and DNA was used to monitor HBV infection in HepG2-NTCP cells (Supporting Fig.
S3A). HepAD38 cells, derived from the HepG2 cell line, contain integrated HBV genome under
control of the Tet-off promoter, and support HBV replication by tetracycline removal (38). The
HBV infection model of HepG2-NTCP cells, over-expresses sodium taurocholate cotransporting peptide (NTCP) that binds the HBV large envelope protein (39) and exhibits high
infection efficiency (39). In HepG2-NTCP cells, as well as in PHHs, which is the most
physiologically relevant HBV infection model, the viral pgRNA is transcribed only from the
viral mini-chromosome that assembles on HBV circular covalently closed DNA (cccDNA) (31).
In all cellular models of HBV replication, DDX5 protein levels were reduced concurrently with
SUZ12 (Fig. 2C). We quantified a statistically significant reduction in DDX5 mRNA levels in
HBV infected cells, while SUZ12 mRNA levels were unaltered (Supporting Fig. S3B).
Interestingly, knockdown of DDX5 in HBV replicating HepAD38 cells by transfection of DDX5
siRNAs, enhanced viral replication, determined by a 2-fold increase in HBc protein (Fig. 2D).
Conversely, overexpression of DDX5 in HBV replicating cells restored SUZ12 protein levels,
while HBc levels became reduced (Fig. 2E). We interpret these results to mean that reduction of
DDX5 is advantageous for viral replication.
To further confirm these results, we established the DDX5 knockdown cell line, HepG2NTCP-DDX5KD (Fig. 3A). HBV infection of HepG2-NTCP and HepG2-NTCP-DDX5KD cells
showed that DDX5 knockdown increased viral transcription, based on enhanced expression of
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pgRNA and viral HBe antigen (HBeAg), quantified by ELISA (Fig. 3B). Since pgRNA is
template for HBV DNA synthesis, we quantified increased total HBV DNA and cccDNA in the
presence of DDX5 knockdown (Supporting Fig. S3C). In agreement with increased pgRNA
transcription in HepG2-NTCP-DDX5KD cells, ChIP assays quantified reduced occupancy of
SUZ12 and EZH2 associated with the viral mini-chromosome and reduced occupancy by
H3K27me3 (Fig. 3C). By contrast, ChIP assays of SUZ12 and EZH2 at the promoters of cellular
genes not targeted by the DDX5/PRC2 complex do not exhibit significant difference in their
occupancy between the two cell lines (Supporting Fig. S3D). To directly link PRC2 function to
transcription from the viral mini-chromosome, we examined the effect on HBV infection of the
SUZ12 mutant (SUZ12-3A) that does not undergo proteasomal degradation (9). Ectopic
expression of SUZ12-3A in infected HepG2-NTCP cells reduced levels of pgRNA (Fig. 3D),
total HBV DNA, cccDNA and HBeAg (Supporting Fig. S3E), supporting PRC2-mediated
repression inhibits transcription form the viral mini-chromosome, and in turn, HBV replication.
Interestingly, RIP assays show that in the absence of HBV replication in HepAD38 and HepG2NTCP cells DDX5 bound to HOTAIR (Fig. 3E). However, DDX5 association with HOTAIR
was significantly reduced in the presence of HBV replication, and notably, DDX5 did not bind
viral RNA (Fig. 3E).
3.3.4 DDX5 regulates SUZ12 stability
We were intrigued by the concurrent reduction of DDX5 and SUZ12 protein levels in
HBV replicating cells (Fig. 2C). Since SUZ12 undergoes proteasomal degradation (9), we
examined the effect of proteasome inhibitor MG132 on SUZ12 protein levels, as a function of
DDX5 depletion or overexpression in HepG2 and HEK293T cells (Fig. 4A, and Supporting Fig.
S4A). DDX5 knockdown reduced SUZ12 protein levels, while overexpression restored SUZ12
levels in the absence of MG132. By contrast, MG132 stabilized SUZ12, irrespective of DDX5
(Fig. 4A). Indeed, under conditions of SUZ12 degradation, i.e., with overexpression of
constitutively active PLK1 and HOTAIR (9), SUZ12 exhibited increased ubiquitination upon
knockdown of DDX5, while DDX5 overexpression suppressed ubiquitination (Supporting Fig.
S4B). By contrast, DDX5 knockdown did not affect ubiquitination of the SUZ12-3A mutant that
cannot be phosphorylated by PLK1(9) to initiate its proteasomal degradation (Supporting Fig.
S4C).
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To determine whether the DDX5 effect on SUZ12 stability was dependent on its
enzymatic activity, we utilized two DDX5 mutants, DDX5-K144N and DDX5-D248N (41) (42).
To date only the ATPase activity of DDX5-K144N has been studied biochemically (43). Here,
employing purified recombinant DDX5 proteins (Supporting Fig. S5A), we determined the
ATPase and RNA binding activity of these DDX5 mutants (Fig. 4B and C). In vitro ATP
hydrolysis assays demonstrated the K144N mutation (in Walker A motif) abolished ATPase
activity (Fig. 4B). In contrast, the D248N mutant (in Walker B motif) retained some RNAdependent ATPase activity, albeit with a ~6-fold reduced kobs. Consistently, RNA binding
quantification by fluorescent anisotropy (44) showed that DDX5-D248N retained RNA-binding
affinity at levels similar to WT-DDX5, whereas DDX5-K144N exhibited nearly 4-fold reduced
binding affinity (Fig. 4C). These results are consistent with effects of similar mutations in
Walker A and B motifs of other DEAD-box proteins, suggesting K144N abolishes ATP binding
(and thus hydrolysis and ATP-dependent RNA binding) whereas the D248N retains ATP and
RNA-binding but is less efficient at hydrolysis.
Next, we examined the effect of WT and mutant DDX5 proteins on SUZ12 levels, under
conditions of SUZ12 degradation, i.e., with overexpression of constitutively active PLK1 and
HOTAIR. WT-DDX5 and DDX5-D248N increased SUZ12 protein levels by more than 50%,
while DDX5-K144N, which cannot hydrolyze ATP and cannot bind RNA (Fig. 4B and C) did
not (Fig. 4D). These DDX5 mutants had the same effect on SUZ12 levels in the context of HBV
replication (Supporting Fig. S5B). Interestingly, RIP assays demonstrated association of
endogenous DDX5 with endogenous HOTAIR (Fig. 4E). Furthermore, a 5-fold increased
enrichment of HOTAIR was quantified with transfected DDX5-D248N mutant vs. DDX5K144N (Fig. 4E), consistent with their demonstrated enzymatic activities (Fig. 4B-C).
To directly demonstrate the role of DDX5 and HOTAIR on SUZ12 degradation, we
quantified the half-life (t1/2) of SUZ12 following treatment with cyclohexamide (CHX). Upon
knockdown of DDX5, t1/2 of SUZ12 was quantified as 2.5 h, in comparison to t1/2 > 6h with
overexpression of DDX5 (Fig. 4F, Supporting Fig. S5C). Likewise, overexpression of DDX5D248N enhanced SUZ12 stability, while DDX5-K144N mutant had no effect (Fig. 4F,
Supporting Fig. S5D). We conclude DDX5-mediated stabilization of SUZ12 involves its helicase
activity, evidenced by the distinct effects of DDX5-K144N vs. DDX5-D248N.
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3.3.5 HOTAIR-binding E3 ligase Mex3b antagonizes DDX5 in SUZ12 stabilization
HOTAIR functions both in PRC2-mediated gene repression (29) and protein
ubiquitination and degradation by associating with RNA binding E3 ligases Mex3b and Dzip3
(30). Since Dzip3 is localized in the cytoplasm (30), we focused our studies on nucleus-localized
Mex3b as a likely E3 ligase ubiquitinating nuclear SUZ12. Overexpression of Mex3b in HepG2
or HEK293T cells decreased SUZ12 levels, whereas knockdown of Mex3b by siRNA
transfection increased SUZ12 protein levels (Fig. 5A). Furthermore, knockdown of Mex3b
reduced SUZ12 ubiquitination (Fig. 5B). Co-expression of WT-DDX5 or DDX5-D248N, but not
DDX5-K144N, antagonized the Mex3b effect on SUZ12 protein levels (Fig. 5C). To determine
whether HOTAIR is involved in the antagonism between DDX5 and Mex3b, we carried out RIP
assays employing Abs to IgG, Myc epitope or Flag. HOTAIR binding to Myc-Mex3b increased
by 2-fold in the presence of endogenous DDX5 (Fig. 5D). By contrast, co-expression of DDX5D248N-Flag and Myc-Mex3b lead to significant reduction in HOTAIR binding to Myc-Mex3b,
whereas HOTAIR exhibited more than 4-fold increased binding to DDX5-D248N-Flag. These
results demonstrate antagonism between DDX5 and Mex3b in regulating SUZ12 stability, by
binding HOTAIR.
3.3.6 HBx promotes Mex3b and HOTAIR-mediated SUZ12 degradation during cell cycle
progression in hepatocytes
HBx induces proteasomal degradation of SUZ12 in a cell cycle and PLK1-dependent
manner (9), shown in the tetracycline-regulated HBx-expressing murine hepatocyte 4pX-1 cell
line (35). To determine whether cell cycle downregulation of SUZ12 involves antagonism
between DDX5 and Mex3b for HOTAIR binding, 4pX-1 cells were synchronized in G1/S by the
double thymidine block (dTB), lysates collected at 0hr (G1 phase) and 8hr (G2) after release
from dTB, and as a function of HBx expression by tetracycline removal (10). In G2 phase, the
amount of SUZ12 that co-immunoprecipitated with DDX5 was reduced by 70% in the presence
of HBx, whereas Mex3b co-immunoprecipitated nearly 80% of SUZ12 (Fig. 6A). Under the
same conditions, the amount of HOTAIR bound to endogenous DDX5 or Mex3b was quantified
by RIP assays (Supporting Fig. S6A). As cells progressed from G1 to G2 in the presence of HBx,
the amount of HOTAIR bound to DDX5 decreased by nearly 3-fold, whereas the amount of
HOTAIR bound to Mex3b increased (Supporting Fig. S6A). Sequential ChIP assays employing
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SUZ12 Ab followed by tandem IP with DDX5 Ab showed decreased SUZ12 and DDX5
occupancy at the EpCAM promoter as cells progressed to G2 in the presence of HBx
(Supporting Fig. S6B). Likewise, the silencing modification H3K27me3 mediated by PRC2 was
also decreased in G2 phase with HBx expression (Supporting Fig. S6C), while expression of
EpCAM, Nanog, Oct4 and Sox2 increased, as quantified by RT-PCR (Fig. 6B), and detected by
immunoblots (Fig. 6C). Since these genes are repressed by PRC2 (8, 11) and knockdown of
HOTAIR or DDX5 enhanced their expression (Figure 1), we interpret these results to mean that
in G2 phase, Mex3b-mediated ubiquitination and proteasomal degradation of SUZ12 relieved
PRC2-mediated transcriptional repression.
3.3.7 Role of DDX5 in HBV-mediated hepatocarcinogenesis
To confirm the relevance of this mechanism in vivo, we quantified mRNA levels of
EpCAM and pluripotency genes in HBx/c-myc liver tumors, demonstrating statistically
significant increase in their expression vs. normal liver (Fig. 7A). To determine the clinical
relevance of this mechanism, we compared expression of EpCAM and pluripotency genes in
liver tumors from chronically HBV infected patients (Group A) expressing 2-fold less DDX5
mRNA vs. Group B (from Fig. 2B). Statistically significant induction of these genes was
observed in Group A tumors with 2-fold less DDX5 mRNA (Fig. 7B). Additionally, statistically
significant negative correlation (r value) was quantified between mRNA levels of DDX5 vs.
those of EpCAM or pluripotency genes in HBV-related HCCs (Fig. 7C). Interestingly, Fisher’s
exact test also showed a negative correlation (r = -0.49) between low DDX5 expression (less
than 2-fold vs. peritumoral tissue) and presence of well-differentiated tumors (p=0.016), an
indicator of poor prognosis. Immunohistochemistry of DDX5 using an independent cohort of
HBV-related HCCs showed reduction or absence of nuclear DDX5 immunostaining in poorly
differentiated, Edmonson’s grade 3 tumors (Fig. 7D), thereby validating our observations
regarding DDX5 levels and differentiation status of hepatocytes. Lastly, Kaplan-Meier survival
curves demonstrated a trend for poor outcome after tumor resection for patients from Group A
(low DDX5 expression) vs. those of Group B (Fig. 7E). Taken together, these results strongly
correlated reduction of DDX5 expression in HBV-related liver tumors to re-expression of the
hCSC marker EpCAM (34) and pluripotency genes, likely linked to poor patient prognosis.
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3.4

Discussion
In this study we identified a novel epigenetic mechanism involving the RNA helicase

DDX5 and its role in HBV biosynthesis and poor prognosis HBV-mediated liver cancer. We
show, RNA helicase DDX5 regulates RNP complexes formed with lncRNA HOTAIR (see
model Fig. 8). First, we show that DDX5 interacts with SUZ12 (Fig.1), the core subunit of the
chromatin modifying PRC2 complex, and in association with HOTAIR represses transcription of
hCSC marker EpCAM (38), and pluripotency genes Nanog, Oct4 and Sox2 (Fig. 1). These
results establish for the first time the role of the mammalian RNA helicase DDX5, functioning
together with lncRNA HOTAIR and the PRC2 complex, in transcriptional repression of specific
cellular genes.
Second, we show DDX5 expression is reduced in liver tumors of HBx/c-myc
bitransgenic mice (2) and in a group of HBV-associated HCCs (Fig. 2). Significantly, reduced
DDX5 expression is associated with re-expression of EpCAM and pluripotency genes, and
reduced patient survival after surgical resection of tumors (Fig. 7E). Furthermore, meta-analysis
of transcriptomic data by Boyault et al (45) showed that DDX5 expression was reduced in the G1
subgroup of HBV-related HCCs (data not shown). G1 tumors, associate with poor prognosis,
overexpress fetal liver genes controlled by parental imprinting (45), including EpCAM and
IGFII. Interestingly, aberrant imprinting of IGFII in human tumor cell lines involves loss of
SUZ12 protein by an unknown mechanism (46). Thus, our mechanistic studies together with
clinical data strongly suggest that DDX5 is an important player in development of poor
prognosis HBV-related liver cancer.
Third, it is well-established deregulation of cellular mechanisms by viral oncoproteins
confers an advantage to viral growth (47). Indeed, downregulation of DDX5 facilitates viral
transcription and in turn, HBV replication (Figs. 2 and 3). HBV infected cells with stable DDX5
knockdown exhibited reduced PRC2 occupancy at the viral mini-chromosome and association
with repressive H3K27me3, resulting in increased pgRNA transcription and viral replication.
Interestingly, both DDX5 and SUZ12 protein levels were reduced in the context of HBV
replication. The mechanism of DDX5 downregulation by HBV infection is presently under
investigation, involving miRNA-mediated downregulation (Mani et al, unpublished results).
Furthermore, neither HOTAIR nor Mex3b ligase exert an effect on DDX5 stability (Supporting
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Fig. S7), and no significant correlation exists between HOTAIR and DDX5 expression levels in
Group A vs. Group B tumors (Supporting Fig.S8).
Fourth, we established a connection between DDX5 and SUZ12 stability, by identifying
the E3 ligase that regulates SUZ12 half-life. We had shown that SUZ12 undergoes proteasomal
degradation facilitated by HOTAIR, but the E3 ligase was not identified. Here we show
HOTAIR-binding E3 ligase Mex3b ubiquitinates SUZ12. For these studies we used key DDX5
mutants which we characterized biochemically (Fig. 4). In particular, DDX5-D248N which binds
RNA but has significantly reduced ATPase activity, bound nearly 2-fold more HOTAIR and
increased SUZ12 stability by displacing Mex3b from HOTAIR. These results directly
demonstrate the enzymatic activity of DDX5 regulates the RNP complexes formed with
HOTAIR, i.e., the complex with PRC2 vs. Mex3b.
Importantly, the RNP complex comprised of DDX5/PRC2-bound HOTAIR identified a
mechanism of transcriptional silencing of specific cellular genes. These include EpCAM and
pluripotency genes, upregulated in G2 phase of HBx expressing cells (Fig. 6), although global
gene targets remain to be determined. Considering that SUZ12 undergoes degradation in G2
phase of HBx expressing cells (9), here we show that Mex3b, by displacing DDX5 from
HOTAIR, ubiquitinates SUZ12 inducing its degradation. Thus, the interplay of RNP complexes
with HOTAIR, regulated by DDX5, results in transcriptional de-repression of specific genes
PRC2-silenced genes. Whether the enzymatic activity of DDX5 is cell cycle-regulated is
unknown and presently under investigation. Furthermore, little is known about Mex3b regulation
(48), additional Mex3b substrates, or interaction with other lncRNAs.
Regarding expression of EpCAM and pluripotency genes in G2 phase (Fig. 6), our results
are consistent with recent studies that identified epigenetic factors acting in G2 phase as essential
for maintenance of pluripotency in human embryonic stem cells (49). Specifically, it was shown
that transcriptional induction of pluripotency genes occurs in G2 phase (49), as we also show
herein. Notably, these mechanistic conclusions are consistent with in vivo and clinical data (Fig.
7), demonstrating strong negative correlation between DDX5 expression, expression of
pluripotency genes, and differentiation status of HBV-induced liver tumors.
In summary, the data provided herein establish a novel epigenetic mechanism (model Fig.
8), involving the antagonism between DDX5 and Mex3b in regulating SUZ12/PRC2 stability, by
binding HOTAIR. This mutually exclusive binding to HOTAIR between the DDX5/PRC2
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complex and the E3 ligase Mex3b is deregulated by HBV infection resulting in de-repression of
transcription both from the HBV mini-chromosome and select cellular genes expressed in
hCSCs. Accordingly, our studies identify the RNA helicase DDX5 and E3 ligase Mex3b as
important cellular targets for design of novel, epigenetic therapies to combat HBV infection and
STpoor prognosis HBV-associated liver cancer.
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Figure 3.1. DDX5 is a SUZ12 interacting protein involved in PRC2-mediated target gene
repression.
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Figure 3.2. continued
A. Lysates from HepG2 cells co-immunoprecipitated (IP) with antibodies to individual PRC2
subunits, followed by immunoblot (IB) analyses with indicated antibodies (n=3). B. IPs of
HepG2 lysates transfected with control (siCtrl) or SUZ12 (siSUZ12) siRNAs with DDX5 Ab,
followed by IB with indicated Abs. C. Q-PCR of indicated genes following transfection of
siRNAs, control (siCtrl) or DDX5 (siDDX5), in a murine, tetracycline regulated HBx-expressing
hepatocyte cell line, the 4pX-1 cell line (35). N=3, error bars, s.d.m.; * P<0.05 using Student’s ttest. D. Association of HOTAIR with endogenous DDX5 assessed by RNA immunoprecipitation
(RIP) assays using IgG or DDX5 Ab and lysates from 4pX-1 cells. E. Q-PCR of indicated genes
in 4pX-1 cells transfected with siCtrl and HOTAIR siRNA (siHOTAIR) or combination of
siHOTAIR and siDDX5 (right panel). N=3, error bars, s.d.m.; * P<0.05 using Student’s t-test.
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Figure 3.3. DDX5 levels in HBV-induced HCCs and HBV replicating cells
A. Q-PCR of DDX5 mRNA in liver tumors from X/c-myc bitransgenic vs. normal (ctrl) mice. B.
Q-PCR of DDX5 mRNA in liver tumors from patients chronically infected by HBV, relative to
peritumoral tissue. C. Immunoblots of indicated proteins using HepAD38 lysates +/- HBV
replication for 5 days, lysates of HepG2-NTCP cells infected with 100 HBV vge (virus genome
equivalents) for 0 and 7 days (D0-D7), and primary human hepatocytes lysates +/- HBV
infection for 3 and 6 days (D3, D6). D, E. Immunoblots of indicated proteins in HepAD38
lysates transfected with 2 different DDX5 siRNAs, siDDX5-1 and siDDX5-2, or WT DDX5
vector, for 48h prior to cell harvesting on day5 of HBV replication.
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Figure 3.4. DDX5 knockdown enhances HBV infection in HepG2-NTCP cells
A. Immunoblots of DDX5 and SUZ12 using lysates from HepG2-NTCP and HepG2-NTCPDDX5KD cells. B. HepG2-NTCP and HepG2-NTCP-DDX5KD cells infected with 100 vge (virus
genome equivalents) of HBV. Quantification of pgRNA by RT-PCR and HBe (S/CO=
signal/cut-off) by ELISA. C. ChIP assays of HepG2-NTCP and HepG2-NTCP-DDX5KD cells
with indicated Abs, on day7 of HBV infection, using cccDNA primers (50). D. Overexpression
in HBV-infected HepG2-NTCP cells of SUZ12-3A mutant: quantification of pgRNA by RT
PCR. E. RIP assays: quantification by RT-PCR of HOTAIR binding to IgG or DDX5 in
HepAD38 cells +/- HBV replication for 5 days, and HepG2-NTCP cells +/- HBV infection for 7
days. Quantification by RT-PCR of HBV pgRNA binding to IgG or DDX5 in HBV replicating
(day 5) HepAD38 cells and HepG2-NTCP cells infected with HBV for 7 days. Error bars, s.d.m.
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Figure 3.5. DDX5 regulates SUZ12 stability
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Figure 3.6. continued
A. Immunoblots of SUZ12 and DDX5 using lysates from HepG2 cells transfected with siRNAs
for DDX5 (siDDX5-1 and siDDX5-2), control siRNA (siCtrl), or DDX5-WT plasmid, treated
with +/- MG132 (10µM). B. ATPase assays using 400nM of purified, recombinant WT-DDX5
(MBP-DDX5-GST) or mutants DDX5-D248N and DDX5-K144N in the presence (+) and
absence (-) of 250 ug/ml total yeast RNA, performed as described(36). Error bars, s.d. C.
Fluorescence anisotropy assays to measure RNA binding affinity were conducted as
described(44) using 10nM 5’ 6-FAM-labeled single-stranded RNA and increasing amount of
WT-DDX5 (MBP-DDX5-GST) or tagged mutants DDX5-D248N and DDX5-K144N. D.
Immunoblots of SUZ12 and DDX5 using lysates from HEK293T cells transfected with pcDNA3
empty vector (-), DDX5-WT, DDX5-D248N, DDX5-K144N, PLK1 or HOTAIR expression
vectors (all in pcDNA3). E. RIP assays for quantification by RT-PCR of HOTAIR binding to
endogenous DDX5 (left panel), and employing lysates from HEK293T cells transfected with
DDX5-WT-Flag, DDX5-D248N-Flag and DDX5-K144N-Flag vectors and immunoprecipitated
with IgG or Flag Ab (right panel). N=3, error bars, s.d.m. F. Quantification of SUZ12 half-life
(% protein remaining), in a time course (0-6h) after cyclohexamide (CHX) addition. siDDX5,
DDX5-WT, DDX5-D248N and DDX5-K144N encoding vectors were transfected in HEK293T
cells, and CHX (20µg/ml) was added 24h after transfection. WCE were harvested 0-6h after
CHX addition. Results represent the average from three independent experiments. N=3, error
bars, s.d.
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Figure 3.7. Mex3b antagonizes DDX5 in SUZ12 downregulation
A. Immunoblots of SUZ12 and Mex3b using lysates from HepG2 (upper panels) or HEK293T
(bottom panels) cells transfected with expression vector Myc-Mex3b or Mex3b siRNA
(siMex3b). B. Ubiquitination assays of SUZ12-HA in HEK293T cells co-transfected with
indicated plasmids and siRNAs. WCE (0.5mg) immunoprecipitated with HA Ab and
immunoblotted with Flag Ab. C. Immunoblots of SUZ12, DDX5 and Mex3b using lysates from
HEK293T cells transfected with expression vectors encoding Myc-Mex3b, DDX5-WT, DDX5248N and DDX5-K144N. D. RIP assays for quantification by RT-PCR of HOTAIR binding to
Mex3b or DDX5 with overexpressed (OE) Myc-Mex3b, in combination with empty vector,
DDX5-D248N-Flag, or DDX5-K144N-Flag. RIP assays were performed using Abs for IgG, Myc
epitope or Flag. N=3, error bars, s.d.m.
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Figure 3.8. HBx promotes Mex3b- and HOTAIR-mediated SUZ12 degradation during cell
cycle progression in hepatocytes
A. 4pX-1 lysates collected at 0hr (G1 phase) and 8hr (G2) after release from dTB, as a function
of HBx expression by tetracycline removal, were co-immunoprecipitated with DDX5 or Mex3b
Abs, followed by immunoblot (IB) analyses with SUZ12 Ab. B. RT-PCR quantification of
indicated genes in 4pX-1 cells after release from dTB. N=3, error bars, s.d.m. p<0.05. C.
Immunoblots of synchronized 4pX-1 lysates, +/- HBx expression by tetracycline removal, with
indicated Abs.N=3
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Figure 3.9. Quantification of mRNA levels of EpCAM and pluripotency genes
A. In HBx/c-myc liver tumors vs. normal liver. B. Quantification of EpCAM and pluripotency
gene expression in liver tumors from chronically infected HBV patients with HCC, comparing
Group A vs. Group B from Figure 2B. C. Scatter plots of mRNA levels of DDX5 vs. those of
EpCAM or pluripotency genes in HBV-related HCCs. D. Immunhistochemistry of human HBVrelated HCCs employing DDX5 Ab. E. Kaplan-Meier curves for overall survival analysis of
patients with HBV-related HCCs from Group A vs. Group B. Log-rank test assessed survivals.
(P=0.17).
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Figure 3.10. Model
The DDX5/PRC2/HOTAIR complex represses transcription of specific genes. Upon expression
of HBx in HBV infected cells, HBx-mediated activation of PLK1(10) phosphorylates SUZ12 in
G2 phase (9), resulting in DDX5 downregulation by an unknown mechanism, indicated by ?, and
preferential association of HOTAIR with Mex3b, a HOTAIR-binding E3 ligase (30). Mex3b
ubiquitinates SUZ12 leading to its proteasomal degradation. This results in transcriptional reactivation of PRC2/HOTAIR target genes including EpCAM, pluripotency genes, and HBVcccDNA encoded genes.
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CHAPTER 4
CHARACTERIZATION OF THE MAMMALIAN DEADBOX PROTEIN DDX5 REVEALS FUNCTIONAL CONSERVATION WITH
S. CEREVISIAE ORTHOLOG DBP2 IN TRANSCRIPTIONAL CONTROL
AND GLUCOSE METABOLISM

4.1

Introduction
RNA helicases resolve RNA secondary structures to remodel RNA and ribonucleoprotein

complexes (RNPs) in an ATP-dependent manner (Jarmoskaite and Russell 2014). Some RNA
helicases use the energy from ATP hydrolysis to translocate on the substrate and processively
disrupt RNA duplexes, whereas DEAD-box protein family members do not due to a lack of
processivity (Jarmoskaite and Russell 2014). Instead, this class of enzymes utilizes ATP binding
and hydrolysis to catalyze localized changes to RNA structure and/or RNA-protein interactions.
This activity translates into a broad array of biochemically distinct roles from acting as RNA
chaperones to serving as ATP-regulated platforms for formation of macromolecular complexes
(Jarmoskaite and Russell 2014). Members of this class of enzymes share 12 common sequence
motifs, which couple ATP binding and hydrolysis to RNA binding and enzyme release,
respectively (Cordin et al. 2006). Seemingly subtle differences in the helicase core sequence and
structure between family members, such as altered degrees of inter-domain communication, have
drastic impacts on both thermodynamic interactions and the kinetics of duplex unwinding
(Garbelli et al. 2011; Samatanga and Klostermeier 2014). N and/or C-terminal extensions can
also influence enzymatic activity of individual members through various mechanisms, such as
enhanced substrate selection, allosteric regulation, or nucleic acid tethering (Wang et al. 2006;
Samatanga et al. 2017; Mallam et al. 2011; Banroques et al. 2011; Rudolph and Klostermeier
2015). Interestingly, 70% of DEAD-box protein genes in yeast are essential and provide nonredundant functions in vivo ranging from ribosome processing to translation and RNA decay
(Rocak and Linder 2004). Moreover, orthologous DEAD-box proteins can be identified across
species through phylogenetic searches, suggesting that specialized DEAD-box protein roles are
conserved (Sharma and Jankowsky 2014). This is somewhat perplexing, however, because
DEAD-box proteins lack sequence specificity in vitro (Sengoku et al. 2006; Schutz et al. 2010),
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leading to questions of how much conservation of function(s) truly exists between orthologous
DEAD-box protein enzymes.
The DEAD-box protein Dbp2 is an active ATPase and RNA helicase in Saccharomyces
cerevisiae (Cloutier et al. 2012; Ma et al. 2013; Ma et al. 2016). Dbp2 functions in gene
regulation by promoting mRNP assembly, repressing cryptic intragenic transcription initiation,
and by antagonizing long non-coding RNA (lncRNA) activity, indicative of a central role as a
co-transcriptional RNA chaperone (Cloutier et al. 2012; Ma et al. 2013; Cloutier et al. 2013;
Cloutier et al. 2016). This role appears to be specific for genes linked to energy homeostasis, as
deletion of DBP2 results in aberrant expression of glucose metabolic genes in S. cerevisiae
(Beck et al. 2014). Moreover, Dbp2 protein localization is responsive to glucose availability
(Beck et al. 2014), suggesting that Dbp2 may integrate nutritional status with cellular
metabolism.
DDX5 is the human ortholog of Dbp2, which is involved in organismal development and
tissue differentiation (Iggo et al. 1991; Stevenson et al. 1998; Kitamura et al. 2001; Abdelhaleem
M 2005). Whereas DDX5 can unwind RNA duplexes in vitro in end-point assays (Hirling et al.
1989; Rossler et al. 2001; Huang and Liu 2002), refined kinetic and thermodynamic analyzes
have not been performed to date. Despite this, extensive studies have established that this
enzyme functions in multiple aspects of RNA metabolism including pre-mRNA splicing (Zonta
et al. 2013), alternative splicing (Kar et al. 2011), microRNA processing (Salzman et al. 2007),
and ribosomal RNA processing (Jalal et al. 2007). DDX5 also binds to several transcription
factors and acts as a transcriptional co-factor to activate or repress transcription (Fuller-Pace FV
2013). Overexpression of DDX5 has also been frequently correlated with disease states,
especially cancers, with overexpression in breast, colon, prostate cancers and acute myeloid
leukemia (Fuller-Pace FV 2013; Mazurek et al. 2014). However, the underlying molecular basis
for DDX5 in promoting uncontrolled cell growth is not well understood.
Employing a combination of biochemical, biophysical and genetic approaches, we now
provide a comprehensive characterization of DDX5 and comparison with Dbp2. Interestingly,
we find that the mammalian/avian specific C-terminal extension increases the in vitro unwinding
activity of DDX5. Despite this enhanced enzymatic activity, DDX5 fully complements the role
of DBP2 in yeast growth, transcriptional fidelity, and glucose import. Finally, we show that
DDX5 promotes glucose uptake and glycolysis in mammalian cells, a process that is upregulated
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in cancers (Vander Heiden et al. 2009), suggesting a novel entry point for future targeting of
cancer-specific metabolism.

4.2

Materials and Methods
Plasmids and oligonucleotides are listed in Table 4.1 and Table 4.2. Yeast Strains are

listed in Table 4.3. Quantitative (q) PCR primers are listed in Table 4.4.
Plasmids and Cloning
The fully-sequenced human DDX5 (Gene ID: 1655) cDNA was obtained from the
Mammalian Gene Collection (MGC) (Dharmacon, clone ID: 3528578), DDX5 was subcloned
using PCR primers with a 5' FseI site (DDX5-FseI F) and a 3' SacI site (DDX5-SacI R) leaving
out the stop codon. GST was subcloned from the pGEX-5X-3 vector using GST-SacI F and GSTAscI R primers, with the reverse primer adding in 2 extra stop codons. The resulting DDX5 and
GST coding sequences were subcloned in place of DBP2 in the pMAL-TEV-DBP2 (Ma et al.
2013) to construct pMAL-TEV-DDX5-GST. Expression of human DDX5 in E. coli without the
C-terminal tag resulted in a truncated DDX5 lacking the last 90 amino acids, a region that
coincides with the CTE (data not shown). We used this to inform us on construction of the
DDX5∆CTE, which was then constructed using PCR primers DDX5-FseI F and DDX5∆CTEAscI R (or DDX5∆CTE-SacI R) to correspond to the truncated protein.
To construct yeast expression plasmids, DDX5 and DDX5∆CTE were subcloned into
DBP2-PL-ADH-p415 using bacterial expression vectors as templates and primers DDX5-XbaI F
and DDX5-SacI R, or DDX5-XbaI F and DDX5∆CTE-SacI R. GFP was then subcloned from
pCP-MS2-GFP using primers GFP-SacI F and GFP-XhoI R. Site-directed mutagenesis of p415DDX5-GFP were conducted using mutation primer pairs K144N F and K144N R, or D248N F
and D248N R.
Recombinant Protein Expression and Purification
pMAL-TEV-DBP2 was expressed and Dbp2 was purified as described (Ma et al. 2013).
Expression of pMAL-TEV-DDX5-GST or pMAL-TEV-DDX5∆CTE-GST in Rosetta E. coli
(DE3) cells (Novagen) was induced using 0.2 mM IPTG at 16˚C overnight. Cells were lysed in
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buffer containing 50 mM HEPES (pH 7.5) and 50 mM NaCl. MBP-DDX5-GST was purified
from the soluble lysate using glutathione resin (GE healthcare) followed by cation-exchange
chromatography using SP sepharose (Sigma), and eluted with elution buffer 1 (50 mM Tris–HCl
(pH 8.0), 300 mM NaCl, 20% glycerol). Full-length DDX5 is not soluble when expressed with
an N-terminal His tag, and undergoes proteolysis without a C-terminal tag (data not shown).
MBP-DDX5∆CTE-GST was purified the same way but eluted with elution buffer 2 (50 mM
Tris-HCl (pH 8.0), 500 mM NaCl, 20% glycerol). pMAL-TEV-DDX5∆CTE were expressed and
purified as above, except that amylose resin (NEB) was used for affinity chromatography. The
MBP tag was cleaved from MBP-DDX5∆CTE by overnight digestion with Tev protease (Life
Technologies) at 16˚C. DDX5∆CTE was then purified using SP sepharose and eluted with
elution buffer 2. The protein concentrations were measured using Bradford Assays according to
the manufacturer instructions (Thermo Scientific, 1856209). All proteins were stored at -80˚C
until use without freeze and thaw cycles.
Helicase Unwinding Assays
The unwinding assays of purified recombinant MBP-DDX5-GST, MBP-DDX5∆CTEGST, DDX5∆CTE, and Dbp2 were conducted as described using the same 16-bp blunt-end RNA
duplex (Ma et al. 2013). The top strand (5’-AGCACCGUAAAGACGC-3’) (IDT) of the duplex
was 5’ radiolabeled and annealed to an unlabeled bottom strand (5’-GCGUCUUUACGGUGCU3’) (IDT) (Jankowsky and Putnam 2010). Reactions were conducted in 60 µl mixtures containing
40 mM Tris-HCl (pH 8.0), 2.5 mM MgCl2, 2 mM DTT, 120 U Superase-in (Life Technologies),
0.1 nM RNA duplex. “Low salt” condition contains 30 mM NaCl and indicated concentrations of
protein. “Near-physiological salt” condition contains 100 mM NaCl and 500 nM protein. The
reactions were pre-incubated at either 19˚C (low salt) or 30˚C (near-physiological) for 10 min
prior to addition of 2 mM or indicated concentrations of ATP/MgCl2. Aliquots were taken at the
indicated time points and resolved on 10% native polyacrylamide gels for phosphor-imaging. To
determine the observed unwinding rates, the fractions of single-stranded RNAs at each time
points were quantified and fitted to the following equation: Y=Ymax*(1-exp(-kobs(Unw) *X)). In the
enzyme titration experiment, Kobs(Unw) determined as above were plotted as a function of the
enzyme concentration and fitted using the sigmoidal equation: Y=Kobs(max)(Unw)*Xh/(Kd(Unw)h +
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Xh) to yield the functional binding curves. The ATP titration curves were fitted to the following
equation: Y=Kobs(max)*X/Km(unw)+X.
Annealing Assays
RNA annealing assays were conducted similarly to helicase unwinding assays, as
described previously (Ma et al. 2013). Briefly, the RNA duplex used in the unwinding assay was
denatured at 95˚C for 2 min to generate ssRNA substrates for annealing assays. Annealing assays
were performed in the “low salt” condition above with no nucleotide, 2 mM ATP/MgCl2 or 2
mM ADP/MgCl2 as indicated. The observed annealing rates were determined using the
following equation: Y=1/(1+ kobs(Ann) *X).
Fluorescence Anisotropy Assays
Fluorescence anisotropy assays were performed in 40 µl reactions containing 40 mM
Tris–HCl (pH 8.0), 2.5 mM MgCl2, 2 mM DTT, 40 U Superase-in (Life Technologies), 30 mM
NaCl, 2 mM AMPPNP, 10 nM 16-nt fluorescent RNA oligonucleotide (5′-6-FAMAGCACCGUAAAGACGC-3′) (IDT), and varying amount of purified proteins. The reaction
mixtures were incubated at room temperature for 60 min in black, half-area 96-well microplates
(Corning) to reach equilibrium. The anisotropy signals of 6-FAM (λex = 495 nm and
λem = 520 nm) were measured using a Biotek Synergy 4 plate reader, and fitted to the quadratic
equation for 2 analytes:1 ligand binding model using Prism: Y=Bmin+(BmaxBmin)*((X+2[RNA]+KD)-((X+2[RNA]+KD)2-8*X*[RNA])0.5)/4.
Bio-layer Interferometry
The on rates of purified recombinant MBP-DDX5-GST, DDX5∆CTE, and Dbp2 were
analyzed using an Octet Red384 instrument (Pall Fortebio) at 30˚C. The High Precision
Streptavidin Biosensors (Pall ForeBio) were equilibrated in the reaction buffer containing
40 mM Tris–HCl (pH 8.0), 2.5 mM MgCl2, 2 mM DTT, 40 U Superase-in, 2 mM AMPPNP, and
30 mM NaCl for 60 s, loaded with a 16-nt biotinylated ssRNA (5′-biotinAGCACCGUAAAGACGC-3′) for 120 s, and equilibrated again in reaction buffer for 120 s. The
association and dissociation steps were performed by dipping the loaded sensors in wells
containing increasing amounts of purified proteins for 800 s, and then transferring them to wells
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containing reaction buffer for 800 s. The binding kinetics were calculated using the ForteBio
Data Analysis software (Pall Fortebio). The on rates were determined by locally fitting the
association data to a 2:1 (2 analytes:1 ligand) model.
Multicopy Suppressor Screening of dbp2∆ Growth Defects
HAS1 was isolated by screening a 2µ S. cerevisiae genomic library (AB320, ATCC
37323) (Kaelin et al. 1992) for genes that suppress the slow growth of dbp2∆ at 25˚C. This
resulted in 6 suppressors. Rescuing plasmids were isolated from colonies and subjected to
sequencing using primers YEp13 F (5’-TGCTCGCTTCGCTACTTGGA-3’) and YEp13 R (5’ATACCCACGCCGAAACAAGC-3’). Plasmids containing HAS1 were isolated from 5 of the 6
plasmids suggesting saturation of the screen.
Yeast Growth Analysis
Serial dilution assays were conducted as described (Cloutier et al. 2012). Yeast strains
were grown in SC-LEU+2% glucose to mid-log phase and spotted in 5-fold serial dilutions onto
SC-LEU+2% glucose agar plates, and incubated at 16˚C, 25˚C, 30˚C, 35˚C, or 37˚C until wild
type cells were fully grown.
RT-qPCR Analysis
RT-qPCR analysis was conducted as described (Cloutier et al. 2012). Transcript levels
were normalized to ACT1 transcript levels, and the relative expression level of DBP2 in WT +
vector strain was arbitrarily set to 1. The qPCR primers used are listed in Table 4.
Northern Blot
Yeast strains were grown in SC-LEU+2% glucose to mid-log phase and RNA was
isolated using acid-phenol extraction. 30 µg total RNA was resolved on a 1.2% formaldehydeagarose gel and transferred to a nylon membrane (Invitrogen) overnight. Northern blotting was
conducted as previously described (Cloutier et al. 2012). The targeted transcripts were visualized
using PhosphoImager (GE healthcare) and quantified by densitometry using ImageQuant (GE
healthcare).
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Mammalian Cell Culture and shRNA Knockdown
Mouse hepatocyte AML12 cells were grown in DMEM/F12 media (Gibco) supplemented
with 10% FBS, 1X Penicillin-Streptomycin (Life Technologies), 0.4X Insulin-TransferrinSelenium-Ethanolamine (ITS-X) (Life Technologies). To knockdown the mouse Ddx5 (Gene ID:
13207) gene expression, the GIPZ DDX5 shRNA (Dharmacon) was transfected into AML12
cells using the Lipofectamine 2000 (Thermo Fisher) according to the manufacturer’s
instructions. Stable expression of shDDX5 in AML12 cells was maintained by 4 µg/ml
puromycin (Thermo Fisher). Western blotting analysis were conducted as described (Zhang et al.
2016) to confirm knockdown using a DDX5 (05-850, Millipore) and a Beta-actin (A5441,
Sigma) primary antibodies.
2-NBDG Uptake Assay in Yeast and AML12 Cells
2-NBDG (2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose, Thermo
Fisher #N13195) uptake assays were conducted as described (Zhang et al. 2015; Blodgett et al.
2011) with some modifications. Yeast strains were grown to log phase in 25-ml cultures and
shifted to YP+0.1% glucose+100 µM 2-NBDG for 1 h at 30˚C. After 2-NBDG uptake, cells
were washed with 1X Tris-EDTA (TE) buffer, and lysed using zymolyase and sonication in 200
µl lysis buffer containing 20 mM Tris (pH 7.4), 1% sodium deoxycholate, and 40 mM KCl
(Blodgett et al. 2011). 2-NBDG levels were determined by fluorescence of 2-NBDG (λex=465
nm, λem=540 nm) in the resulting cell lysate after normalization to cell density. AML12 cells
were plated at 4 x 105 cells/well in a 6-well culture the day prior to the experiment. Cells were
washed twice in PBS and incubated with the uptake media (growth media+100 µM 2-NBDG) for
30 min at 37˚C in a standard CO2 incubator. Media was aspirated and cells were trypsin digested
and counted. Cells were then collected by centrifugation and lysed by sonication with 400 µl
lysis buffer containing 20 mM Tris (pH 7.4), 1% sodium deoxycholate, and 40 mM KCl.
Fluorescence intensity of 2-NBDG in the cell lysate was measured (λex=465 nm, λem=540 nm),
and normalized to cell count. Data show the mean ± SD of three independent biological
replicates.
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Glycolysis and Respiration Analysis
AML12 cells were seeded in a 24-well microplate (Seahorse Bioscience) at 20000
cells/well and incubated in a standard 37˚C CO2 incubator overnight. Prior to the experiment,
cells were washed twice with Assay Media (Seahorse Bioscience) and transferred to a 37˚C nonCO2 incubator with 575 µl Assay Media/well for 1 h. The glycolysis profile was analyzed by
measuring the extracellular acidification rates at basal level and following injections of various
compounds that trigger different states of glycolysis using the Glycolysis Test Kit (Seahorse
Bioscience). The first injection is glucose to induce glycolysis under basal conditions. The
second injection is oligomycin, an ATP synthase inhibitor that shifts the energy production to
glycolysis and reveals glycolytic capacity (Hao et al. 2010). The final injection is 2-deoxy-Dglucose, a glucose analog that competitively inhibits glucose hexokinase and shuts down
glycolysis (Brown J 1962). The mitochondrial profile was analyzed by measuring the oxygen
consumption rates at basal level and after injections of drugs that each targets a component of the
electron transfer chain using the Mito Stress Test Kit (Seahorse Bioscience). First, oligomycin
inhibits ATP synthase and decreases basal oxygen consumption, showing that oxygen
consumption measured in this experiment is coupled with ATP synthesis. FCCP (carbonyl
cyanide-p-(trifluoromethoxy) phenylhydrazone) is an uncoupling agent that allows unlimited
electron flow through the electron transfer chain (Park et al. 2002), and reveals maximal oxygen
consumption. The third injection is a mix of rotenone, a complex I inhibitor, and antimycin A, a
complex III inhibitor. This combination shuts down mitochondrial respiration and enables the
measurement of non-mitochondrial respiration. The metabolic rates at different stages of
glycolysis and mitochondrial respiration were determined using the Seahorse XF Stress Test
Report Generator (Seahorse Bioscience).

4.3

Results

4.3.1 DDX5 Encodes a Mammalian/Avian-specific C-terminal Extension (CTE)
DBP2 was identified as the S. cerevisiae homolog of DDX5 in 1991 through low
stringency hybridization screening (Iggo et al. 1991). Human DDX5 and S. cerevisiae Dbp2
share 55% sequence identity and 70% similarity (Fig. 1A). Amino acid alignment of S.
cerevisiae Dbp2, C. elegans DDX17, G. gallus DDX5, and human DDX5 shows conservation of
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an arginine and glycine rich (RG-rich, or RGG) region in these orthologs (Fig. 1B). RG-rich
regions are found in many DEAD-box proteins (Yang and Jankowsky 2005) and are implicated
in RNA binding, protein-protein interactions, and/or protein localization (Thandapani et al.
2013). The C-termini of G. gallus and human DDX5 share a C-terminal extension (CTE), which
is not present in S. cerevisiae or C. elegans, suggesting addition of this accessory domain after
divergence of these lineages.
4.3.2 DDX5 is A More Active RNA Helicase in vitro than Dbp2
Dbp2 is a bona fide RNA helicase and ATPase in vitro (Ma et al. 2013; Cloutier et al.
2012), with an unwinding rate constant of ~ 0.22 min-1 on a 16-bp blunt-end RNA duplex (Ma et
al. 2013). This unwinding rate is in the range of other DEAD-box proteins analyzed in vitro
(Yang et al. 2007; Mallam et al. 2014). Human DDX5, on the other hand, has only been assayed
for unwinding in end-point assays (Hirling et al. 1989; Rossler et al. 2001; Huang and Liu 2002).
To directly compare the enzymatic activities of human DDX5 with S. cerevisiae Dbp2 and to
determine if the presence of a CTE impacts these activities, we conducted a series of in vitro
assays with recombinant purified DDX5, DDX5∆CTE, and Dbp2. Note that DDX5 contains a Nterminal MBP-tag and a C-terminal GST-tag, which were found to be essential for protein
solubility and stability, respectively (data not shown). Unwinding assays were performed using a
16-bp blunt-end RNA duplex at “low salt” (30 mM NaCl) conditions to parallel prior studies of
Dbp2 (Ma et al. 2013). We first titrated ATP in the helicase unwinding reactions for MBPDDX5-GST, DDX5∆CTE, and Dbp2. This revealed that all three enzymes share similar
functional Km’s for ATP (i.e. Km(Unw)) (Fig. 2A), suggesting similar ATP binding affinities. We
then titrated in the enzymes in the presence of saturating (2 mM) ATP and found that MBPDDX5-GST unwinds the RNA duplex faster than Dbp2, as evidenced by a ~ 10-fold higher
maximum observed unwinding rate (6.47 min-1 versus 0.66 min-1) (Fig. 2B (1)). In addition,
Dbp2 has a higher functional Kd of unwinding (i.e. Kd(Unw)) (Fig. 2B (2)), indicating that the
RNA substrate is saturated by Dbp2 at higher enzyme concentrations as compared to MBPDDX5-GST. Interestingly, deletion of CTE (DDX5∆CTE) reduced the unwinding rate of DDX5
by 6-fold to 1.06 min-1 without appreciably altering the functional Kd (Fig. 2B). Enhanced
unwinding activity of DDX5 as compared to DDX5∆CTE is not due to the tags as MBP-
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DDX5∆CTE-GST displayed similar unwinding rates to untagged DDX5∆CTE in vitro (Fig. 2B).
This suggests that the CTE itself confers a higher rate of duplex unwinding to DDX5.
Given the robust activity of MBP-DDX5-GST in “low salt” conditions, we tested its
unwinding activities in “near-physiological salt” conditions (100 mM NaCl) (Pasic et al. 2001).
MBP-DDX5-GST is active (kobs(Unw) ~ 0.15 min-1) in the presence of 100 mM NaCl, while
DDX5∆CTE and Dbp2 displayed reduced activities (Fig. 2C). The latter is evidenced by the nonconvergent unwinding curves of DDX5∆CTE and Dbp2 (Fig. 2C). This indicates that the duplex
unwinding activity of DDX5 is more tolerant to high salt. Together, this shows that DDX5
unwinds a blunt-end RNA duplex faster than Dbp2, and that the CTE contributes to higher
activity.
4.3.3 DDX5 Lacks RNA Annealing Activity
DEAD-box helicases also facilitate duplex annealing, an activity proposed to assist with
RNA chaperone activity in vivo (Jarmoskaite and Russell 2014; Ruminski et al. 2016). To ask if
DDX5, DDX5∆CTE, and Dbp2 have different annealing activities, we performed annealing
assays with the single-stranded components of the 16-bp duplex. These assays were conducted in
the presence of ATP, in the absence of ATP (Apo), or in the presence of ADP. Spontaneous
annealing of the substrate was not observed in the absence of enzymes under any conditions (Fig.
3). In agreement with previous studies (Ma et al. 2013), we observed minimal annealing (less
than 10%) in the presence of Dbp2 and ATP (Fig. 3A & 3D). However, Dbp2 displayed
appreciable annealing activity in both the Apo and ADP-bound states with observed annealing
rates of ~ 0.4 min-1 and ~ 0.05 min-1, respectively (Fig. 3B-3D). In contrast, MBP-DDX5-GST
did not facilitate strand annealing at any nucleotide state (Fig. 3A-3D), suggesting that DDX5
lacks annealing activity all together. Removal of the CTE from DDX5 restores some annealing
activity in the Apo state (kobs(Ann) ~ 0.03 min-1) (Fig. 3B & 3D), but not to levels equal to Dbp2.
This suggests that subtle changes in the core in addition to occurrence of the CTE have altered
the biochemical parameters of Dbp2 from fungi to mammals.
4.3.4 DDX5 Has Higher RNA Binding Affinity than Dbp2
DEAD-box RNA helicases are ATP-dependent RNA binding proteins (Jarmoskaite and
Russell 2014). To further characterize the biochemical parameters of DDX5, DDX5∆CTE and
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Dbp2, we conducted fluorescence anisotropy experiments to measure the RNA-binding affinities
using a 6-carboxyfluorescein (6-FAM) labeled 16-nt ssRNA and the non-hydrolyzable ATP
analog, AMPPNP. Because DEAD-box proteins release bound RNA upon ATP hydrolysis,
AMPPNP “locks” these enzymes onto the RNA to enable measurements of binding affinities
(Liu et al. 2014; Samatanga and Klostermeier 2014). Time courses were performed to ensure that
the binding reactions reached equilibrium for calculation of dissociation constants (KD’s) (Fig.
4A). Changes in anisotropy were then measured across a range of protein concentrations,
revealing that all three proteins bind ssRNA within a similar range, but with full length DDX5
(MBP-DDX5-GST) binding slightly (~ 4-fold) tighter than Dbp2 (Fig. 4B). This is in line with
the ~ 2-fold higher Kd(Unw) of Dbp2 (Fig. 2A). Similarly, DDX5∆CTE bound ssRNA with a KD
between that of DDX5 and Dbp2 (Fig. 4A), suggesting that the CTE only moderately impacts the
RNA-binding affinity of DDX5. We then utilized bio-layer interferometry to analyze the RNAbinding kinetics of MBP-DDX5-GST, DDX5∆CTE, and Dbp2 by monitoring the association and
dissociation of these enzymes to a biotinylated 16-nt ssRNA. Consistent with high ssRNA
binding affinities, this revealed faster on rates for full length DDX5, followed by DDX5∆CTE,
and then Dbp2 (Fig. 4C).
4.3.5 Ectopic Expression of Human DDX5
Transcriptional Fidelity Defects in S. cerevisiae

Complements dbp2∆

Growth and

Dbp2 functions in ribosome biogenesis, repression of cryptic transcriptional initiation,
and lncRNA-dependent gene regulation in S. cerevisiae (Bond et al. 2001; Cloutier et al. 2012;
Cloutier et al. 2013; Cloutier et al. 2016). To ask if DDX5 is functionally equivalent to Dbp2
despite different biochemical parameters, we asked if ectopic expression of human DDX5 and/or
DDX5∆CTE could rescue the slow growth and cold sensitivity of dbp2∆ cells. To this end, we
cloned DDX5 and DDX5∆CTE into CEN yeast expression vectors under the control of pADH1
promoters, to enable expression at levels near endogenous DBP2. To aid in protein stability, we
added a C-terminal GFP tag to both DDX5 and DDX5∆CTE constructs (data not shown). We
then conducted serial dilution analysis of wild type and dbp2∆ cells harboring either an empty
vector or the CEN plasmids with DBP2, DDX5-GFP, or DDX5∆CTE-GFP (Fig. 5A). We also
included dbp2∆ cells harboring a high copy 2µ plasmid expressing HAS1, a DEAD-box protein
involved in ribosome biogenesis in S. cerevisiae (Emery et al. 2004) and the sole isolate of a
saturating multicopy suppressor screen of dbp2∆ cells. This revealed that DDX5 and
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DDX5∆CTE rescue both the slow growth and cold sensitivity defects of dbp2∆ to levels similar
to plasmid-based expression of DBP2, whereas HAS1 only partially rescues dbp2∆ cells even
when vastly overexpressed (Fig. 5A & 5C). The expression levels of DDX5 and DDX5∆CTE are
higher than endogenous DBP2 but are similar to plasmid-based expression of DBP2 (Fig. 5C).
This shows that DDX5 or DDX5∆CTE specifically complements dbp2∆ growth defects.
Next, we tested the ability of enzymatically-deficient DDX5 mutants to rescue dbp2∆
growth defects. ATPase-deficient mutants DDX5(K144N)-GFP and DDX5(D248N)-GFP (Zhang
et al. 2016) harboring amino acid substitutions within Motif I (Walker A motif) or Motif II
(Walker B motif), respectively, were expressed on CEN plasmids in dbp2∆ cells. The growth of
these two strains was compared to dbp2∆ cells transformed with empty vector or wild type
DDX5-GFP in serial dilution spot assays. Neither of the DDX5 mutants rescued the growth
defects of dbp2∆ (Fig. 5B), suggesting that the enzymatic activities of DDX5 are required for
complementation.
To determine if ectopic expression of human DDX5 rescues dbp2∆ defects in
transcriptional fidelity, we asked if expression of DDX5 and/or DDX5∆CTE could repress
cryptic intragenic initiation at the FLO8 locus (Cloutier et al. 2012). The FLO8 gene is
transcribed into a single, full-length transcript (2.4 kb) in wild type cells (Fig. 5D). In the
elongation factor mutant strain spt6-1004 or dbp2∆ cells, however, a short FLO8 transcript (~
0.8 kb) is also transcribed due to usage of a cryptic TATA site within the open reading frame
(Kaplan et al. 2003; Cloutier et al. 2012). Consistent with prior studies, we observed an increase
in the amount of the short transcript expressed in spt6-1004 or dbp2∆ cells harboring vector
alone as compared to wild type cells (Fig. 5D). In line with our observed growth rescue above,
ectopic expression of DBP2, DDX5-GFP, or DDX5∆CTE-GFP repressed the cryptic
transcription in dbp2∆ cells, as evidenced by the decrease in the percentage of short transcript
(Fig. 5D). This suggests that DDX5 functions in transcriptional fidelity similar to Dbp2.
4.3.6 DBP2 and DDX5 are Required for Efficient Glucose Import in Yeast and Mammalian
Cells, Respectively
Glucose import is the first and rate-limiting step of glycolysis (Hatanaka M 1974), a
central pathway in primary metabolism for energy production and homeostasis. In cells lacking
DBP2, hexose transporter genes (HXTs) and associated lncRNAs are misregulated, suggesting
that Dbp2 may control glucose import (Beck et al. 2014). To test this, we measured the ability of
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wild type and dbp2∆ cells to import the fluorescent glucose analog 2-(N-(7-nitrobenz-2-oxa-1,3diazol-4-yl)amino)-2-deoxyglucose (2-NBDG) (Zhang et al. 2015). Consistent with HXT gene
misregulation, we observed a ~ 3-fold decrease in 2-NBDG import in dbp2∆ cells as compared
to wild type, a defect that was rescued by ectopic expression of DBP2 (Fig. 6A). Next, we asked
if this import defect could be rescued by ectopic expression of human DDX5 or DDX5∆CTE.
Strikingly, expression of DDX5 or DDX5∆CTE not only rescued the import defect of
dbp2∆ cells, but also stimulated import above the levels of wild type cells (~ 50% increase, Fig.
6A). Although we do not know the nature of stimulated glucose import, it is possible that this
increase is directly related to the increased helicase activity of the human DDX5 variants as
compared to Dbp2.
To determine if DDX5 promotes glucose import in mammalian cells, we knocked-down
DDX5 in a non-transformed mouse hepatocyte cell line (AML12) using a small hairpin RNA
targeting DDX5 mRNA (shDDX5). This resulted in ~ 50% knockdown of DDX5 protein levels
in two independent clones stably expressing the shDDX5 (Fig. 6B). We then conducted 2-NBDG
uptake assays in AML12 cells expressing the non-targeting control shRNA (shCtr) or shDDX5.
Interestingly, DDX5 knockdown reduced 2-NBDG import to approximately 30% of the wild
type levels (Fig. 6C), suggesting that Dbp2 and DDX5 share conserved roles in promoting
glucose import in S. cerevisiae and mammalian cells. This is surprising given the distinct modes
of glucose metabolism between fungi and animal cells (see Discussion).
4.3.7 Knockdown of DDX5 Decreases Glycolysis and Increases Respiration in Mammalian
Cells
To determine if DDX5 promotes cellular metabolism, we analyzed the rates of basal
glycolysis, maximal glycolytic capacity, and non-glycolytic acidification by measuring
extracellular acidification rates (Chen et al. 2016). This reveals that DDX5 knockdown in
AML12 cells downregulates both basal and maximal glycolysis rates, whereas non-glycolytic
acidification is not affected (Fig. 7A). Importantly, these changes are comparable to
downregulation of established metabolic regulators in hepatocytes, such as the circadian
regulator Bmal1 (Jacobi et al. 2015; Cheng et al. 2015). Next, we measured respiration by
determining the oxygen consumption rates at basal and maximal levels, as well as the nonmitochondrial oxygen consumption rate. Interestingly, this reveals that the basal and maximal
oxygen consumption rates are upregulated in cells expressing shDDX5 (Fig. 7B). This
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upregulation is presumably due to the need to balance energy production, due to reduced
glycolytic activity. Thus, DDX5 promotes glycolysis in mammalian cells, consistent with
promoting glucose import as the first step of glycolysis. Taken together, this suggests that both
Dbp2 and DDX5 promote glucose metabolism in yeast and mammalian cells.

4.4

Discussion
DEAD-box RNA helicases are the largest group of RNA helicases in all forms of life

(Jarmoskaite and Russell 2014). Despite this, the precise biochemical roles of individual DEADbox proteins and whether these roles are conserved across organisms are largely unknown. We
have provided a comprehensive comparison of the biochemical and biological roles between two
DEAD-box helicase orthologs and show that mammalian DDX5 and S. cerevisiae Dbp2 are
functionally conserved, despite enzymatic differences. We also provide evidence demonstrating
conserved roles for Dbp2/DDX5 in glucose metabolism, revealing unique biological function for
a DEAD-box helicase family branch.
Human DDX5 (or p68) was one of the first members of the DEAD-box helicase family to
be shown to have duplex unwinding activity in vitro (Hirling et al. 1989). Despite the ~ 30 years
since this study, there has been no kinetic analysis of duplex unwinding by DDX5. Instead, end
point assays using different RNA substrates have provided conflicting reports of processivity and
activity for this enzyme (Huang and Liu 2002; Rossler et al. 2001). Our studies provide a kinetic
and thermodynamic analysis of DDX5 along with comparison to its yeast counterpart. These
studies now show that DDX5 and Dbp2 have subtle differences in enzymatic activities. First,
DDX5 is a more active RNA helicase than Dbp2, even at near-physiological salt concentrations.
Second, DDX5 lacks annealing activity all together. Finally, the mammalian/avian-specific CTE
of DDX5 contributes to these activities.
While we do not know the precise role of the CTE, one possibility is that the CTE alters
the conformation of the helicase core and/or RNA substrate, rendering the full-length DDX5
more productive in unwinding cycles. For example, the CTE may help DDX5 adopt a
conformation in the Apo and ADP-bound states that is incompatible with stable binding of an Aform RNA duplex, decreasing annealing activity during a round of unwinding. Consistent with
this notion, there are major differences in the spatial organizations of the two RecA-like domains

116
among different DEAD-box proteins. For example, the RecA-like domains of eIF4A exhibit an
“open” conformation due to a lack of inter-domain interactions. (Caruthers et al. 2000), whereas
Dhh1 is more compact with extensive interactions between the two domains, even in the absence
of nucleotide (Cheng et al. 2005). This results in very different biochemical activities between
these two DEAD-box helicases (Dutta et al. 2011). The CTE may also modulate the
conformation of the bound RNA. Structural studies of the S. cerevisiae DEAD-box protein
Mss116 reveal that the C-terminal extension of Mss116 induces a bend at the 5’ end of a bound
RNA (Del Campo and Lambowitz 2009). Such a bend may block strand annealing. Although
there are no obvious structural similarities between the CTEs of Mss116 and DDX5; the CTE of
Mss116 has α-helical structure (Del Campo and Lambowitz 2009), whereas the CTE of DDX5 is
predicted to be unstructured; these differences do not preclude analogous roles for these
accessory domains in modulating enzymatic activity.
Despite the differences between yeast Dbp2 and human DDX5 in vitro, ectopic
expression of either DDX5 or DDX5∆CTE fully complements dbp2∆ defects including slow
growth, cold sensitivity, cryptic transcription, and impaired glucose import. This suggests that
DDX5 may function in transcription through mechanisms similar to Dbp2, including regulating
lncRNA activities or facilitating mRNP assembly. In fact, DDX5 has been linked to lncRNAregulated gene expression in several recent studies (Huang et al. 2015; Wongtrakoongate et al.
2015; Zhang et al. 2016). Moreover, the DDX5 ortholog in Drosophila melanogaster facilitates
RNA release from the chromatin and nuclear export, two processes requiring efficient mRNP
assembly (Buszczak and Spradling 2006). These roles are not mutually exclusive as both
lncRNAs and mRNAs are transcribed, processed, and packaged by similar cellular machineries
in vivo (Quinn and Chang 2016).
On the surface, the ability of DDX5 to fully rescue dbp2∆ is surprising because S. cerevisiae and
humans have diverged about 1 billion years ago (Douzery et al. 2004). Dbp2 works in concert
with the protein co-factor Yra1 in vivo (Cloutier et al. 2012; Ma et al. 2013), an interaction which
seems to be conserved in mammalian cells (Zonta et al. 2013). This suggests that certain proteinprotein and/or protein-RNA interfaces may be preserved during the course of evolution.
Consistently, a large-scale screen reveals that 200 human genes out of 424 tested complement
their yeast orthologs in growth analyses (Kachroo et al. 2015). Eight DEAD-box protein genes
were included in this screen, among which the ribosome biogenesis factors FAL1 and DBP6
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(Kressler et al. 1997; Kressler et al. 1998) were complemented by their human orthologs EIF4A3
and DDX51. In addition, DDX3X rescues the growth defects of a Schizosaccharomyces pombe
strain lacking its ortholog ded1 (Epling et al. 2015), which functions in translation initiation (Iost
et al. 1999; Senissar et al. 2014). This suggests that orthologous complementation maybe a
feature of DEAD-box protein genes.
Our studies show that both Dbp2 and DDX5 promote glycolysis in yeast and mammalian
cells, respectively, indicating that both of these enzymes regulate common mRNAs and/or
lncRNAs linked to cellular metabolism. This is further supported by the fact that genes involved
in glycolysis are specifically misregulated upon DDX5 knockdown in acute myeloid leukemia
cells (Mazurek et al. 2014) and documentation of a DDX5 polymorphism (S480A) linked to
metabolic syndrome (Guo et al. 2010). The conserved role in glucose metabolism is surprising,
since fungi and mammalian cells have distinct modes of glucose metabolism. After glucose is
catabolized to pyruvate, yeast cells undergo ethanol fermentation to convert pyruvate to ethanol
and CO2. This allows yeast to use glycolysis and fermentation as their only energy production
source when glucose is present (Barnett JA 2003). In contrast, most mammalian cells use
respiration to convert pyruvate to acetyl-CoA, which enters the Kreb cycle and feed electrons to
oxidative phosphorylation (Berg et al. 2002). Although the fate of pyruvate is different between
yeast and mammalian cells, the upstream steps of glycolysis are conserved. For example, both
require sugar transporters to import glucose into the cell, the first and rate-limiting step of
glucose metabolism (Hatanaka M 1974; Ozcan and Johnston 1999).
Both fungi and mammals encode numerous high and low affinity glucose transporters
whose expression and activity are controlled by the extracellular concentrations of specific
sugars (Ozcan and Johnston 1999; Mueckler and Thorens 2013). Our studies show that both
Dbp2 and DDX5 promote glucose uptake, consistent with a specific role in promoting the first
step of glycolysis. This is also consistent with prior studies showing misregulation of hexose
transporter genes (HXTs) and associated lncRNAs in the absence of DBP2 in S. cerevisiae (Beck
et al. 2014). It is possible that DDX5 regulates the analogous glucose transporters (GLUTs)
similarly in mammalian cells, genes which are also upregulated in cancers (Macheda et al. 2005).
Cancer cells frequently acquire glucose dependence due to high levels of glycolytic activity (i.e.
Warburg effect) (Vander Heiden et al. 2009). This “cancer cell metabolism” fulfills the need for
massive macromolecule synthesis of fast-growing cells while reducing mitochondria-dependent
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apoptosis (Vander Heiden et al. 2009). Thus, inhibition of DDX5 may be a novel way to target
cancer metabolism in the future.

4.5
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Figure 4.1. DDX5/Dbp2 orthologs share common DEAD-box core motifs but differ at the Ctermini
(A) Schematic of human DDX5 and S. cerevisiae Dbp2 proteins. The N-terminus, 12 DEAD-box
protein motifs, and RG-rich (or RGG) region are conserved. DDX5 has a C-terminal extension
(CTE) that is not conserved with Dbp2. DDX5 and Dbp2 protein sequences have 55% identity
and 70% similarity. (B) The CTE is specific to mammalian/avian DDX5. Amino-acid alignment
of the C-terminal ends of Saccharomyces cerevisiae Dbp2 (NP_014287), Caenorhabditis elegans
DDX17 (NP_001041134), Gallus gallus DDX5 (NP_990158), and Homo sapiens DDX5
(NP_004387), from motif VI through the CTE. Multiple sequence alignment was performed
using the ClustalW alignment tool (Thompson et al. 1994) with 40 open gap penalty in
MacVetor 11.1.2. Numbers correspond to the alignment, not the amino acid sequences of
Dbp2/DDX5. The RG-rich region is highlighted with a green box. The CTE of DDX5 is marked
with a blue box.
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Figure 4.2. The CTE confers higher duplex unwinding activity to human DDX5 over S.
cerevisiae Dbp2
(A) MBP-DDX5-GST, DDX5∆CTE, and Dbp2 have identical functional Km’s for ATP in
unwinding assays. RNA unwinding assays were conducted using 300 nM recombinant, purified
proteins and the indicated amount of ATP/MgCl2 in the presence of 30 mM NaCl at 19˚C. The
curves for observed unwinding rates versus [ATP] were fitted to a binding isotherm:
Y=Kobs(max)*X/Km(unw)+X. (B) DDX5 shows higher unwinding activity than DDX5∆CTE or Dbp2
in “low salt” conditions. (1) Helicase unwinding assays were conducted at 19˚C in the presence
of 30 mM NaCl with indicated concentrations of purified recombinant MBP-DDX5-GST,
DDX5∆CTE, Dbp2, or MBP-DDX5∆CTE-GST. (2) Table of maximum observed unwinding
rates and the functional dissociation constants. First, the observed rates (kobs(Unw)) were
determined by plotting the fraction of single-stranded (ss) RNA against reaction time and fitting
the unwinding curves to the following equation: Y=Ymax*(1-exp(-kobs(Unw) *X)). To calculate the
maximum observed rates (Kobs(max)(Unw)) and functional dissociation constants (Kd(Unw)), we
plotted the observed rates as a function of the protein concentration and fitted the data to a
sigmoidal binding isotherm (Y=Kobs(max)(Unw)*Xh/(Kd(Unw)h+Xh) to generate functional binding
curves. The hill coefficients for these enzymes range from 1.5 to 1.8. (C) DDX5 is an active
helicase in “near-physiological salt” conditions. Unwinding assays using 500 nM purified
recombinant MBP-DDX5-GST, DDX5∆CTE, or Dbp2 were performed in the presence of 100
mM NaCl at 30˚C. The observed rates were determined as above. n.d. means not determined,
when unwinding curves were not convergent. Data above show the mean ± standard deviation
(SD) of 2-3 independent replicates.
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Figure 4.3. DDX5 lacks annealing activity in vitro, irrespective of the nucleotide-binding
state, and this is partially due to the CTE
(A) DDX5 lacks annealing activity in the presence of ATP. Duplex annealing assays were
conducted as above, but with 0.1 nM radio-labeled 16-nt top strand RNA and 0.1 nM cold
complementary RNA in the presence of 30 mM NaCl and 2 mM ATP/MgCl2. (B-C) DDX5 also
lacks annealing in the absence of nucleotide or in the presence of ADP, in contrast to Dbp2.
Duplex annealing assays using purified recombinant MBP-DDX5-GST, DDX5∆CTE, Dbp2, or
no enzyme, in the absence of ATP (Apo state) (B) or in the presence of 2 mM ADP/MgCl2 (C).
(D) Table of the observed annealing rates of DDX5, DDX5∆CTE, Dbp2, and the no enzyme
control in the presence or absence of different nucleotides. The observed annealing rates were
determined using the following equation: Y=1/(1+kobsAnn*X). n.d.=not determined. Data are
shown as the mean ± SD of 2-3 independent replicates.
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Figure 4.4. Comparison of RNA-binding affinities and RNA on rates reveals tighter RNA
binding by DDX5
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Figure 4.5. continued
(A) RNA binding reactions reach equilibrium within 60 min. Fluorescence anisotropy assays
were conducted using 20 nM indicated proteins, 10 nM 5’-6-FAM labeled 16-nt ssRNA,
and AMPPNP. Anisotropy measurements (λex=495 nm/λem=520 nm) were taken using a
Biotek Synergy 4 plate reader at indicated time points. (B) DDX5, DDX5∆CTE, and
Dbp2 bind ssRNA within a similar range, but with full length DDX5 binding slightly
tighter than DDX5∆CTE and Dbp2. Fluorescence anisotropy assays were conducted
using increasing amounts of MBP-DDX5-GST, DDX5∆CTE, or Dbp2, 10 nM 16-nt
ssRNA, and AMPPNP. Binding reactions were incubated for 60 min before taking
anisotropy measurements. Binding data were fitted to the quadratic equation for 2 site
binding: Y=Bmin+(Bmax-Bmin)*((X+2[RNA]+KD)-((X+2[RNA]+KD)2-8*X*[RNA])0.5)/4.
Data show the mean ± SD of 3 independent replicates. (C) DDX5 and DDX5ΔCTE show
higher on rates than Dbp2 for ssRNA. Bio-layer interferometry (BLI) experiments were
conducted to determine the binding kinetics of MBP-DDX5-GST (C1), DDX5∆CTE
(C2) and Dbp2 (C3) on a biotinylated 16-nt ssRNA in the presence of the nonhydrolyzable ATP analog, AMPPNP. Data are shown in background-corrected
sensograms depicting the association and dissociation of proteins onto the ssRNA across
a range of concentrations. The on-rates of MBP-DDX5-GST, DDX5∆CTE, and Dbp2
were determined by fitting the real-time binding data with the 2:1 model using the Data
Analysis Software (Pall Fortebio) by local fitting (C4). Off rates can’t be determined
from this experiment due to the slow disassembly of DEAD-box helicase-AMPPNPRNA complexes (Liu et al. 2014).
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Figure 4.6. Ectopic expression of human DDX5 or DDX5∆CTE rescues the growth and
cryptic transcription defects of dbp2∆ in S. cerevisiae
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Figure 4.5 continued
(A) Ectopic expression of DDX5-GFP or DDX5∆CTE-GFP fully rescues dbp2∆ cold sensitivity
and slow growth defects. Wild type (WT) cells transformed with empty vector or dbp2∆ cells
transformed with vector only, CEN plasmids expressing DBP2, DDX5-GFP, or DDX5∆CTEGFP, or a 2µ HAS1 plasmid were spotted in 5-fold serial dilutions on selective media and grown
at respective temperatures. HAS1 was isolated from a saturating suppressor screen of dbp2∆ cold
sensitivity and was the sole isolate of the screen. HAS1 is a DEAD-box protein gene whose
product functions in ribosome biogenesis (Emery et al. 2004). (B) The enzymatic activities of
DDX5 are required for growth complementation of dbp2∆. Serial dilution assays were conducted
as above with dbp2∆ cells transformed with vector and CEN-plasmid expressing DDX5-GFP,
DDX5(D248N)-GFP, and DDX5(K144N)-GFP. DDX5(K144N) and DDX5(D248N) have
mutations in the Walker A and Walker B motifs, respectively, which affect ATP binding and
hydrolysis (Cordin et al. 2006), and are shown to be required for the ATPase activities of DDX5
(Zhang et al. 2016). (C) RT-qPCR of DBP2, DDX5, or HAS1 genes in strains above shows
similar expression of pDBP2, pDDX5-GFP, and pDDX5∆CTE-GFP and overexpression of
HAS1. Transcript levels were normalized to ACT1 with DBP2 expression in the in wild type +
vector strain set to 1. Data show the mean ± SD of three independent biological replicates. (D)
Ectopic expression of DDX5-GFP or DDX5∆CTE-GFP rescues the cryptic transcription
initiation defect in dbp2∆ cells. Northern blotting of endogenous FLO8 transcripts was
performed as described (Cloutier et al. 2012). Full-length (2.4 kb) and the short, cryptic (0.8 kb)
FLO8 transcripts were visualized by autoradiography and quantified by densitometry. % Short is
the percentage of short transcript versus total FLO8 transcripts (Full length + Short).
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Figure 4.7. Both Dbp2 and DDX5 promote glucose import in S. cerevisiae and mammalian
cells, respectively
(A) Ectopic expression of DDX5 or DDX5∆CTE rescues glucose import defects in dbp2∆ cells.
Glucose import was determined using 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2deoxyglucose (2-NBDG) uptake assays (Blodgett et al. 2011), which measure the fluorescence
intensity of 2-NBDG in cells after lysis. A.U.=arbitrary units. Data show the mean ± SD of three
independent biological replicates. (B) Western blots show shRNA knockdown levels of DDX5 in
mouse hepatocytes (AML12). Western blotting of DDX5 or Beta-actin was performed from cell
lysates from two independent AML12 clones stably expressing a shRNA targeting DDX5
(shDDX5) or a non-targeting control shRNA (shCtr). The percent of knockdown of DDX5 was
quantified by densitometry relative to Beta-actin loading control. (C) DDX5 promotes glucose
uptake in AML12 cells. 2-NBDG uptake assays in mouse AML12 cells expressing shDDX5 or
shCtr. Cells were incubated at 37˚C with fully supplemented culture media containing 100 µM 2NBDG for 30 min. 2-NBDG uptake was measured as above.
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Figure 4.8. DDX5 promotes glycolysis in mammalian cells
(A) Metabolic profiles of AML12 mouse hepatocytes with DDX5 knockdown reveals defects in
glycolytic capacity. The glycolysis profile of cells expressing shDDX5 or shCtr were analyzed
using the Seahorse XFe24 Analyzer as described (Chen et al. 2016). Extracellular acidification rate,
which correlates with the rate of glycolysis, was measured following addition of compounds that
trigger various stages of glycolysis. The first injection is glucose that induces glycolysis. The
second injection is oligomycin, an ATP synthase inhibitor that abolishes mitochondrial ATP
production and thus shifts the energy production to glycolysis (Hao et al. 2010), revealing the
maximum glycolytic capacity. The final injection is 2-deoxy-D-glucose, which competitively
inhibits glucose hexokinase and blocks glycolysis (Brown J 1962). The basal, maximal, and nonglycolytic acidification rates were determined using the Seahorse XF Stress Test Report Generator
(Seahorse Bioscience). (B) DDX5 knockdown increases respiration in AML12 cells. The
respiration profile of AML12 cells was analyzed by measuring the oxygen consumption rates at
basal levels and following injection of compounds that target the electron transport chain.
Oligomycin decreases basal respiration (Hao et al. 2010). FCCP (carbonyl cyanide-p(trifluoromethoxy) phenylhydrazone) is an uncoupling agent that dissipates proton gradient (Park
et al. 2002), as a result, oxygen is maximally consumed. The third injection is rotenone and
antimycin A, which shut down mitochondrial respiration and enables the calculation of nonmitochondrial respiration. Respiration rates were determined using the Seahorse XF Stress Test
Report Generator. All Data is shown as the mean ± SD of 3 independent biological replicates. *
means p-value < 0.05, *** means p-value < 0.001.
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Table 4.1. Yeast and bacterial plasmids
Name

Description

Source/Reference

BTP22

pMAL-TEV-DBP2

(Ma et al. 2013)

BTP48

pMAL-TEV-DDX5∆CTE

This study

BTP58

pMAL-TEV-DDX5-GST

This study

BTP76

pMAL-TEV-DDX5-MBP

This study

BTP63

P415-DDX5-GFP

This study

BTP64

P415-DDX5∆CTE-GFP

This study

BTP79

P415-DDX5(K144N)-GFP

This study

BTP80

P415-DDX5(D248N)-GFP

This study

BTP81

pMAL-TEV-DDX5∆CTE-GST

This study

pRS315

CEN/LEU empty vector

(Sikorski and Hieter 1989)

pDBP2

DBP2-PL-ADH-p415

(Banroques et al. 2008)

pHAS1

YEp13-HAS1-ABE2

(ATCC 37323)

pGEX-5X-3

pGEX-5X-3

(Kaelin et al. 1992)

pCP-MS2-GFP

pCP-MS2-GFP(X3)

(Haim et al. 2007)

pRS425

2µ/LEU empty vector

(Christianson et al. 1992)
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Table 4.2. PCR oligonucleotides
F is forward and R is reverse
Name

Sequence

DDX5-FseI F

AAAGGCCGGCCAATGTCGGGTTATTCGAGTGAC

DDX5-SacI R

TGGCGCGCCTTATTGGGAATATCCTGTTGGCATT

DDX5∆CTE-AscI R

GGGGCTCGAGTTATTATCTTTTAAGCAGG

GST-SacI F

GCGAGCTCCAGGAAACAGTATTCATGTCCC

GST-AscI R

AGGCGCGCCAGGCAGATCGTCAGTCAGTC

DDX5-XbaI F

GCTCTAGAATGTCGGGTTATTCGAGTGAC

DDX5∆CTE-SacI R

GGGAGCTCTCTTTTAAGCAGGCTACAGTAACC

GFP-SacI F

GCGAGCTCCTGCAGGAATTCGATATCGTGTCT

GFP-XhoI R

GGGGCTCGAGTTTGTACAATTCATCCATACCATG

K144N F

TGGATCTGGGAACACATTGTCTTATTTGCTTCCTG

K144N R

GCAAATAGACAATGTGTTCCCAGATCCAGTCTG

D248N F

TGTCCTTAATGAAGCAGATAGAATGCTTGAATGG

D248N R

GCATTGTATCTGCTTCATTAAGGACAAGGTAGGT

Table 4.3. Yeast strains
Strain

Genotype

Source/Reference

Wild type (BY4741)

MATa his3∆1 leu2∆0 met15∆0 ura3∆0

Open Biosystems

spt6-1004

MAT FLAG-spt6-1004 ura3-52 leu2∆1

(Prather et al. 2005)

lys2-128∂
dbp2∆

MATa dbp2::KanMx ura3∆0 leu2∆0 (Cloutier et al. 2012)
his3∆0 TRP1 met- lys?
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Table 4.4. qPCR oligonucleotides
F is forward and R is reverse
Name

Sequence

ACT1 F

TGGATTCCGGTGATGGTGTT

ACT1 R

TCAAAATGGCGTGAGGTAGAGA

DBP2 F

CGGACAGTGAGATTGCTCAGTT

DBP2 R

TTGGAATATCGTGTCCGGAAA

DDX5 F

GCTTGCTGAAGATTTCCTGAAAGAC

DDX5 R

TCTCACTCATGATCTCTTCCATTAGAC

HAS1 F

CTGAGACCGGGCCCTCTT

HAS1 R

CCATCTGCGGTGGAGTTGT
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CHAPTER 5
METABOLIC ADAPTATION TO NUTRIENTS
INVOLVES CO-REGULATION OF GENE EXPRESSION BY THE RNA
HELICASE DBP2 AND THE CYC8 CO-REPRESSOR IN
SACCHAROMYCES

5.1

Introduction
Rapidly proliferating cells, such as exponentially growing budding yeast S. cerevisiae,

must meet high demands on both energy production and biosynthesis of anabolic precursors.
Budding yeast thrive in a wide range of environments with different nutrient availability. In
order to optimize cell growth, yeast can adjust their metabolism in response to nutrient
availability to balance the energy production and biomass synthesis. Signaling pathways such as
protein kinase A (PKA)/Ras, AMP-activated protein kinase (AMPK)/Snf1, and target of
rapamycin (TOR) pathways are involved in sensing nutrient availability and regulating metabolic
decisions at transcriptional, posttranscriptional, translational and posttranslational levels (Broach
2012; Kayikci and Nielsen 2015). How cells integrate information about environmental nutrients
with the gene expression program has long been an active area of research as it not only has huge
implications on the chemical industry but also sheds light on the metabolism in human diseases
(Diaz-Ruiz et al. 2011; Borodina and Nielsen 2014).
The budding yeast S. cerevisiae preferentially uses glucose as carbon source. In the
presence of high levels of glucose, yeast cells prefer to ferment glucose into ethanol instead of
respiration despite the presence of oxygen (Broach 2012). In the presence of glucose, genes
involved in gluconeogenesis, respiration, and utilization of alternative carbon sources are
repressed, a process referred to as carbon catabolite or glucose repression (Gancedo 1998;
Kayikci and Nielsen 2015). Glucose repression depends on transcription factors Mig1 and Cyc8Tup1 co-repressor complex as well as the inactivation of the kinase Snf1 (Gancedo 1998;
Kayikci and Nielsen 2015). However, budding yeast has the capability to utilize alternative
fermentable carbon sources, such as galactose and sucrose, or nonfermentable carbon sources,
such as ethanol and acetate (Schüller 2003; Turcotte et al. 2010). A shift from glucose to a
nonfermentable carbon source leads to reprogramming of gene expression such that
gluconeogenic, respiratory, and alternative carbon source utilization genes are induced (DeRisi

138
1997; Soontorngun et al. 2007). This switch is achieved through transcriptional activators such
as Cat8 and the Hap2/3/4/5 complex as well as the activation of the kinase Snf1 (Schüller 2003;
Broach 2012). Activated Snf1 influences transcription in many aspects, including
phosphorylating the repressor Mig1 (Treitel et al. 1998; Broach 2012). The phosphorylation of
Mig1 leads to its relocalization from the nucleus to the cytoplasm, thus derepressing its target,
glucose-repressed genes (De Vit et al. 1997; DeVit and Johnston 1999).
Dbp2, a member of the DEAD-box RNA helicase family, functions as a key player in
gene expression programs related to cellular metabolism in S. cerevisiae (Cloutier et al. 2012;
Beck et al. 2014). We have previously reported that the nuclear localization of Dbp2 is
dependent on glucose availability, suggestive of a broad role in regulating gene expression in
response to nutrient availability (Beck et al. 2014). However, the mechanism of Dbp2 in
regulating a specific cellular pathway was unknown. Herein, we show that Dbp2 co-represses
Cyc8-targeted genes, representing a major branch of the metabolic pathway, and that loss of
DBP2 correlates with derepression of respiration and gluconeogenesis. This suggests that Dbp2
integrates nutrient availability with metabolic adaptation through regulation of Cyc8-targeted
genes.

5.2

Materials and Methods

Bioinformatics Analyses
RNA Sequencing Data Processing and Differential Gene Expression Analyses
RNA-seq data was previously deposited in the Gene Expression Omnibus (GSE58097,
(Beck et al. 2014)). Color space reads were mapped to the yeast reference genome (R64-2-1)
using the SHort Read Mapping Program 2 (SHRiMP2, ver. 2.2.3) with the option --single-bestmapping (David et al. 2011). The aligned reads were processed as previously described (Cloutier
et al. 2016) with the following modifications. Briefly, the aligned reads were imported into R
using Rsamtools and GenomicAlignments (Morgan M, Pagès H 2010; Lawrence et al. 2013; R
Development Core Team 2016). The first mapped read in a proper pair (flags = 83, 99) with a
mapping quality mapq ≥ 40 was retained. Reads overlapping rDNA regions were excluded from
the analysis. Remaining reads were counted against the genomic features using
GenomicAlignments from Bioconductor to determine the number of reads for sense RNA
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transcripts (Gentleman et al. 2004; Lawrence et al. 2013). The mode of “IntersectionNotEmpty”
was used for the summarizeOverlaps function. EdgeR was used to determine differential gene
expression (Robinson et al. 2010; McCarthy et al. 2012; GSE99097). Genes with very low
counts (< 10) across all samples were filtered from the analysis. Transcripts with gene expression
change over 2.2-fold and FDR ≤ 0.01 were determined as differentially expressed.
Comparison of Differentially Expressed Genes in dbp2∆ and Other Strains with Genetic
Perturbations
The gene expression profiles of 700 responsive deletion mutants identified in Kemmeren
et al. 2014 that have at least four differentially expressed transcripts compared to wild type strain
were used for transcription profile analysis. As previously described, a cutoff of fold change
(FC) > 1.7 and p < 0.05 was applied to determine the list of significantly changed genes of each
of the 700 deletion mutants (Kemmeren et al. 2014). To look for the genes that may act in
concert with DBP2 in gene expression, the list of up- and down-regulated genes in each of the
700 deletion mutants was compared to the up- and down- regulated sense (protein coding)
transcripts in dbp2∆. In addition, dbp2∆ strain has a slow growth phenotype. This phenotype was
also observed for many other deletion mutant, and a slow growth signature was identified
(O’Duibhir et al. 2014). The slow growth-related genes (SGGs, n = 633) identified from
O’Duibhir et al. 2014 were filtered from the lists of differentially expressed genes (DEGs) to
avoid identifying genes that are affected by the slow growth phenotype. One-sided Fisher’s exact
tests were conducted for each comparison using R. Bonferroni correction was applied to correct
for multiple comparisons. Lists of genes that have an effect similar to DBP2 (p ≤ 0.05 after
correction) in repressing (share common up-regulated genes between dbp2∆ and the deletion
mutant) or activating (share common down-regulated genes between dbp2∆ and the deletion
mutant) gene expression were extracted and p-values from the Fisher’s exact tests are presented
as a heatmap (Fig 1).
Comparison of Differentially Expressed Genes in dbp2∆ and upon Glucose Deprivation
RNA-seq data of wild type cells cultivated in the presence or absence of glucose was
retrieved from the NCBI’s Gene Expression Omnibus (GSE43747, (Freeberg et al. 2013)). Data
was processed as previously described (Freeberg et al. 2013) with the following modifications.
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First, nucleotides with low quality (< 30) were trimmed from the end of the reads using FASTXToolkit (http://hannonlab.cshl.edu/fastx_toolkit/). Next, sequences of the barcodes and adaptors
were trimmed from the reads using Cutadapt (Martin 2011). Reads shorter than 18 nucleotides
were removed at the same time. The processed reads were mapped to the reference yeast genome
(R64-2-1) using Tophat and Bowtie2 (Trapnell et al. 2009; Langmead and Salzberg 2012). The
aligned reads were read in R using Rsamtools (Morgan M, Pagès H 2010). Only reads with a
mapping quality mapq ≥ 40 were kept. Read counts per feature were determined using
GenomicAlignments from Bioconductor (Gentleman et al. 2004; Lawrence et al. 2013). EdgeR
was used to determine differential gene expression between strains grown in the glucose-replete
or -deprived media (Robinson et al. 2010; McCarthy et al. 2012). Genes with very low counts (<
10) across all samples were filtered. A cutoff of FC > 2.2 and FDR ≤ 0.01 was used to
determined the significant change in gene expression. In addition, as the cells used for the RNAseq above were treated with 4sU, the effects of 4sU were removed by removing genes that are
significantly changed upon 4sU treatment (FC > 2.2 and FDR ≤ 0.01, n = 41) from the DEG lists
upon glucose deprivation (Freeberg et al. 2013). SGGs were then filtered from the DEG lists.
One-sided Fisher’s exact test was used to estimate the significance of the intersection between
the lists of DEGs in dbp2∆ and that upon glucose deprivation. Venn Diagram was generated by
the online program Biovenn (Hulsen et al. 2008).
Functional Annotation Clustering Analysis
Functional annotation clustering of biological processes was conducted using DAVID
(v6.7) (Huang et al. 2009a; b). Functional clusters with enrichment score ≥ 1.3 (equivalent to p ≤
0.05) are shown.
Experimental Procedures
Plasmids and Strains
Yeast strains were constructed using classical yeast genetics and are listed in Table 1. To
construct the CYC8/CEN plasmid, a DNA fragment with 888bp upstream and 460bp downstream
of the CYC8 ORF was produced with a 5’ SmaI and a 3’ BamHI restriction sites flanking the
fragment using genomic DNA as templates. The fragment was then cloned into pRS315 using
standard molecular cloning method. The TUP1/CEN plasmid was constructed in the same way
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except that the inserted DNA fragment was flanked with 1000bp upstream and 499bp
downstream of the TUP1 ORF with a 5’ SmaI and a 3’ SpeI restriction sites. Oligos used for
cloning are listed in Table 2.
Respiration Profile Measurements
The oxygen consumption assays were conducted as described (Yao et al. 2016). Briefly,
yeast strains were grown to log phase in YPD and shifted to assay medium (1.67% yeast nitrogen
base, 0.5% ammonium sulfate, and 2% ethanol or glucose). Cells were seeded in the 24-well
microplate (Seahorse Bioscience) at 5 x 105 cells/well and incubated at 30˚ for 1 h. The oxygen
consumption rates were measured using the Seahorse XFe24 analyzer. The cyc8∆ and tup1∆
strains were confirmed with plasmid-based complementation. Briefly, yeast cells were grown in
SC-LEU media to mid-log phase and spotted on the SC-LEU agar plates in 5-fold serial
dilutions. Plates were incubated at 37˚ until wild type cells were fully-grown.
Gene Induction Analyses
Yeast cells were first grown at 30˚ to an OD600 of 0.4-0.6 in SC + 2% glucose medium.
The cells were then spun at 3,000 rpm, washed twice with SC and transferred to SC medium
containing 1% potassium acetate and grown for another 6 h. 15 OD units were collected prior to
(0 min) and at 30, 60, 90, 120, 240 and 360 min after the nutritional shift. Cells were flash frozen
and stored at -80˚ before use.
RNA Isolation and Northern Blotting
RNA was isolated from cells using standard acid phenol purification. 30 µg total RNA
was resolved on a 1.2% formaldehyde-agarose gel and transferred to a nylon membrane
(Brightstar Hybond N+, Invitrogen). Northern blotting was performed as previously described
(Cloutier et al. 2012). Radiolabeled double-stranded DNA probes were generated using PCR
products using wild type genomic DNA as a template. Oligos used for Northern blotting probes
are listed in Table 3. Target transcripts were visualized using a PhosphorImager (GE Healthcare)
and quantified by densitometry using ImageQuant (GE Healthcare).
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Chromatin Immunoprecipitation (ChIP)
ChIP was performed as described previously (Cloutier et al. 2013) with the following
modifications. Chromatin from ~5 x 106 cells was immunoprecipitated with 2 µL of FLAG M2
monoclonal antibody (F3165, Sigma) and 24 µL of Protein G Dynabeads (30 mg/mL,
Invitrogen) at 4˚ for 2 h. Immunoprecipitated DNA was isolated and quantitative PCR was
performed using PrimeTime Assay primers listed in Table 4 and TaqMan qPCR mix
(Invitrogen). All ChIP experiments were performed with three biological replicates. Error bars
represent the SD from the mean.
Data Availability
Data reference numbers deposited in the Gene Expression Omnibus are as follows:
GSE58097 (Beck et al., 2014), GSE42527 (Kemmeren et al., 2014), GSE43747 (Freeberg et al.,
2013) and GSE99097.

5.3

Results

5.3.1 Analysis of Transcription Profiles Reveals Similarities Between DBP2 and other Gene
Regulatory Factors
Nutritional status and gene expression programs are highly integrated in yeast (Broach
2012). Gene expression profiling has revealed that genes necessary for nutrient utilization and
metabolism require DBP2 for normal expression (Beck et al. 2014). This specificity suggests
that Dbp2 may function similar to or in concert with known transcription factors involved in
nutrient utilization. A recent study of 1,484 yeast deletion strains used gene expression profiling
by microarray to identify 700 genes that affect gene expression in S. cerevisiae (Kemmeren et al.
2014). To test our hypothesis, we compared lists of differentially expressed genes (DEGs) in
dbp2∆ to those for each of the 700 strains from this study. Importantly, as the dbp2∆ strain has a
slow growth phenotype that is also observed for other deletion strains (O’Duibhir et al. 2014),
we removed slow growth-related genes (SGGs) from the DEG lists to avoid analysis of indirect
effects from the growth defects (O’Duibhir et al. 2014). The remaining DEGs were then
compared and one-sided Fisher’s exact tests were used to determine the significance of the
observed intersection of the lists between dbp2∆ and other deletion strains. This analysis
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identified 77 deletion strains that have similar up- or down-regulated genes to dbp2∆ (Fig 1, p
value ≤ 0.05 after a Bonferroni correction). Interestingly, strains harboring the deletion of CYC8
or TUP1 share the most up-regulated genes with dbp2∆, with cyc8∆ and tup1∆ sharing 124 and
91 up-regulated ones with dbp2∆, respectively (Fig 1, left). Cyc8 and Tup1 form a
heteropentameric complex required for transcriptional repression of various genes, including
glucose-repressed genes, cell-type-specific genes and hypoxic genes (Williams and Trumbly
1990; Keleher et al. 1992; Balasubramanian et al. 1993; Varanasi et al. 1996; Smith and Johnson
2000). Whereas tup1∆ significantly shares both up- and down-regulated genes with dbp2∆,
cyc8∆ only significantly shares up-regulated genes. This suggests that TUP1 and CYC8 may not
always act in concert.
Besides tup1∆, only a small subset of deletion strains that share similar up-regulated
genes with dbp2∆ also share down-regulated genes. These include strains harboring deletions of
the RNAPII mediator complex (SSN2, SSN3, SSN8), , a component of SCF ubiquitin-ligase
complex (GRR1), ribosome biosynthesis genes (SFP1, YVH1) and a component of the CAAX
farnesyltransferase complex (RAM1) (Fig 1, left and right, (He et al. 1991; Hengartner et al.
1995; Skowyra et al. 1997; Marion et al. 2004; Kemmler et al. 2009; Lo et al. 2009)). We also
observed common up-regulated genes between dbp2∆ and strains with deletions in components
of the Rpd3 histone deacetylase complex, such as RPD3, SIN3, and DEP1, as well as RNA decay
factor XRN1 (Fig 1, left; (Larimer and Stevens 1990; Hengartner et al. 1995; Carrozza et al.
2005)). This suggests that DBP2 represses gene expression through regulating transcription
and/or RNA stability. Interestingly, SSN3, SSN8 and SRB8 are involved in glucose repression
(Balciunas and Ronne 1995). Several other genes required for glucose repression, such as REG1,
GRR1, and HXK2, were also identified as similar to DBP2 (Fig 1, left; (Flick and Johnston 1991;
Gancedo 1998)). The overlap between genes repressed by DBP2 and those repressed by factors
involved in glucose repression is consistent with a link between DBP2 and glucose metabolism
(Beck et al. 2014).

5.3.2 CYC8 and TUP1 Share Co-repressed Genes with DBP2
The GAL protein-coding genes are part of the galactose metabolic switch that allows
yeast cells to utilize galactose when glucose is absent (Sellick et al. 2008). Our prior studies
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demonstrated that Dbp2 maintains Cyc8-dependent repression of the GAL cluster genes (Cloutier
et al. 2013). The fact that deletion of CYC8 or TUP1 also results in a similar set of derepressed
genes as loss of DBP2, however, suggests that this role may be more widespread than just at this
locus. To see how many genes are commonly up-regulated between dbp2∆, cyc8∆, and tup1∆, a
Venn diagram was plotted using the lists of up-regulated genes in each deletion strain. This
revealed that 82 genes are co-repressed by CYC8, TUP1, and DBP2 (Fig 2A). To determine if
loss of CYC8 or TUP1 affects gene expression to a similar extent as loss of DBP2, we plotted the
log2FC (log2(fold change)) of all genes in dbp2∆ against those of cyc8∆ and tup1∆ (Fig 2B).
Consistent with a function in gene repression, the majority of the common DEGs in dbp2∆ and
cyc8∆ (Fig 2B, left) or dbp2∆ and tup1∆ (Fig 2B, middle) are up-regulated in the mutants.
However, the common up-regulated genes between dbp2∆ and tup1∆ or dbp2∆ and cyc8∆ do not
show a linear relationship. This is in contrast to TUP1 and CYC8, whose co-repressed genes
show a linear relationship in the deletion strains (Fig 2B, right). This suggests that even though
TUP1 and CYC8 share co-repressed genes with DBP2, Dbp2 and Cyc8 or Tup1 act in a
biochemically distinct manner. Alternatively, the lack of correlation could be due to the different
methods of gene expression profiling, i.e., microarray versus RNA-seq (Zhao et al. 2014). We
also observed that many genes are specifically repressed by CYC8 but not TUP1 (Fig 2B, cyc8∆
log2FC > log2(1.7) and tup1∆ log2FC < log2(1.7)), suggesting that these two factors may not
always function in concert. This is consistent with a prior study showing additive effects from
simultaneous deletion of CYC8 and TUP1 (Williams and Trumbly 1990).
5.3.3 CYC8, TUP1, and DBP2 Co-repressed Genes Are Enriched in Monosaccharide
Metabolism and Transcriptional Regulation Processes
To determine if genes co-repressed by CYC8, TUP1, and DBP2 fall into common
biological processes, we conducted functional annotation clustering analyses using DAVID
(Huang et al. 2009a; b). This revealed enrichment of transcripts whose products function in
monosaccharide metabolic processes or regulation of transcription (Table 5, Table S1).
Interestingly, MIG1, THI2, ROX1, and SMP1, which have been shown to regulate genes involved
in metabolism and stress response were also identified (Nehlin et al. 1991; Zitomer and Lowry
1992; de Nadal et al. 2003; Nosaka et al. 2005). This suggests that CYC8, TUP1, and DBP2 may
regulate cellular metabolism and response to stress, possibly through regulating gene expression.
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DBP2 also shares unique co-repressed genes with CYC8 and TUP1, individually (Tables
6-7, Table S2-3). Out of the 124 genes co-repressed by CYC8 and DBP2, we observed
enrichment of six functional annotation clusters including oxidative phosphorylation and ion
transport, generation of precursor metabolites and energy and cell death, regulation of
transcription, carbohydrate transport and transmembrane transport (Table 6, Table S2). The
TUP1 and DBP2 co-repressed genes (n = 91), on the other hand, showed enrichment of clusters
including monosaccharide metabolic processes and regulation of RNAPII transcription (Table 7,
Table S3). This suggests that Cyc8 and Tup1, although thought to act exclusively as a complex,
may have different functions individually in gene regulation. This is consistent with our prior
observation that loss of CYC8 and TUP1 has different effects at some different gene loci (Fig 2B,
right).
5.3.4 DBP2 and CYC8, but not TUP1, Repress Cellular Respiration
Yeast cells preferentially utilize glucose as a carbon source for energy production through
aerobic fermentation (Broach 2012). The presence of glucose suppresses respiration,
gluconeogenesis, and usage of nonfermentable carbon sources, referred to as carbon catabolite or
glucose repression (Gancedo 1998; Broach 2012). It is known that CYC8 and TUP1 function as
key components in glucose repression (Gancedo 1998). To determine if DBP2 is also required
for glucose repression, we estimated the degree of overlap between genes up-regulated in dbp2∆
and upon glucose deprivation by comparing the list of genes from our dbp2∆ RNA-seq to a
previously published study of glucose-deprived wild type cells (Freeberg et al. 2013). This
revealed an overrepresentation of glucose-repressed genes in dbp2∆ cells (Fig 3A, one-sided
Fisher’s exact test, p < 2.2 x 10 -16). We also compared up-regulated genes in cyc8∆ or tup1∆ to
those in glucose-deprived cells (Fig 3B-C). In agreement with roles for CYC8 and TUP1 in
glucose repression, carbon catabolite-repressed genes are also overrepresented in both cyc8∆ and
tup1∆ cells (Fig 3B-C). Interestingly, functional annotation clustering revealed several
commonly repressed gene categories between glucose deprived cells and dbp2∆ (Fig 3A, Table
S4) or cyc8∆ (Fig 3B, Table S5), including generation of precursor metabolites and cellular
respiration. In contrast, genes up-regulated in tup1∆ and glucose-deprived cells are enriched in
sexual reproduction, cell wall organization, and carboxylic acid and ion transport categories (Fig
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3C, Table S6). This suggests that Cyc8 and Dbp2 may modulate glucose repression of different
cellular pathways than Tup1.
To test whether DBP2, CYC8, and/or TUP1 repress respiration in the presence of glucose,
we measured the oxygen consumption rate in wild type, dbp2∆, cyc8∆, and tup1∆ cells as a
readout for cellular respiration (Fig 3D). Strains harboring CYC8 or TUP1 deletion were
obtained from the null collection and were confirmed by PCR (data not shown) and plasmidbased complementation (Fig 3E). We also assayed the oxygen consumption in the absence of
DBP3, an unrelated DEAD-box protein involved in rRNA processing (Weaver et al. 1997).
Briefly, yeast cells were cultivated in media with glucose to log phase and shifted to assay
medium with 2% ethanol or 2% glucose, to promote respiration or fermentation, respectively.
Cells were then seeded in a microplate, incubated at 30˚ for 1h and the oxygen consumption rates
were measured using a Seahorse XFe24 analyzer to measure metabolic flux. Interestingly, the
oxygen consumption rate in both dbp2∆ and cyc8∆ was higher than in wild type cells in the
presence of glucose, indicating active respiration (Fig 3D, up). We then measured the oxygen
consumption rate in the presence of ethanol to stimulate cellular respiration (Fig 3D, bottom).
Similar to glucose, both dbp2∆ and cyc8∆ showed increased oxygen consumption as compared
to wild type. In contrast, neither tup1∆ nor dbp3∆ showed differences as compared to wild type
in either carbon source (Fig 3D), suggesting that Dbp2 and Cyc8 play specific roles in glucose
repression of respiration in dependent of Tup1.
5.3.5 DBP2, CYC8 and TUP1 Co-repressed Genes Are Enriched in Overlapping lncRNAs
Besides respiration, genes involved in gluconeogenesis and utilization of non-fermentable
carbon sources are also repressed in the presence of glucose and are corepressed by DBP2 and
CYC8 or TUP1 (Table 5-7; (Gancedo 1998; Broach 2012)). These include PCK1, SFC1, YAT1,
and JEN1 (Valdés-Hevia et al. 1989; Schmalix and Bandlow 1993; Palmieri et al. 1997; Casal et
al. 1999; Akita et al. 2000; Turcotte et al. 2010). Work from our lab has shown that DBP2
promotes Cyc8-dependent repression at the GAL genes by antagonizing lncRNAs that would
otherwise promote induction (Cloutier et al. 2013, 2016). Interestingly, annotated lncRNAs are
found at the promoter and/or 5’ regions of glucose-repressed genes in dbp2∆ cells including
PCK1, SFC1, YAT1, and JEN1 (Fig 4A-D). For example, the 5’ region of PCK1 is overlapped
with XUT1463 in dbp2∆ (Fig 4A, dbp2∆ minus strand) whereas this transcript is not readily
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detected in wild type (Fig 4A, wt minus strand). Similarly, the promoter and/or 5’ regions of
SFC1, YAT1, and JEN1 are overlapped with annotated lncRNAs including CUT696 (SFC1, Fig
4B, dbp2∆ minus strand), XUT0944 (YAT1, Fig 4C, wt and dbp2∆ minus strands) and SUT657
(JEN1, Fig 4D, wt and dbp2∆ minus strands). To determine if there is a propensity for lncRNAs
to cover the promoter and/or 5’ regions of genes co-repressed by DBP2, CYC8, and TUP1, we
analyzed the distribution of lncRNAs across the co-repressed genes in comparison to unaffected
genes. This revealed that ~40% of the co-repressed genes are overlapped with annotated
lncRNAs within the promoter and/or 5’ end (Fig 4E). This ratio is significantly higher than that
observed in genes not co-repressed by CYC8, TUP1, and DBP2 (Fig 4E, proportion test, p =
2.146 x 10 -7). This suggests that the expression of CYC8, TUP1 and DBP2 co-repressed genes
may be regulated by lncRNAs similarly to the GAL gene cluster (Cloutier et al. 2016).
5.3.6 Loss of DBP2 results in Increased Expression of Non-fermentable Carbon Utilization
Genes Upon A Nutrient Shift
Up-regulation of GAL lncRNAs in the absence of DBP2 causes reduced Cyc8 binding
and derepression of the GAL cluster genes (Cloutier et al. 2013, 2016). To determine if these corepressed genes are also derepressed in the absence of DBP2, we conducted transcription
induction assays prior to and at different time points following a nutritional shift from glucose to
the non-fermentable carbon source acetate (Fig 5A-D). This revealed increased expression of all
four genes in dbp2∆ cells as compared to wild type, consistent with derepression. We also
observed induction of a larger transcript overlapping JEN1 in dbp2∆ cells, presumably
corresponding to XUT1417 (Fig 5D, arrow; see Fig 4D). Interestingly, levels of this transcript
are inversely proportional to JEN1 mRNA, suggesting that transcription of these two RNAs is
mutually exclusive.
To determine if loss of Cyc8 at gene promoters could account for derepression, ChIP of
Cyc8-3xFlag was conducted in wild type and dbp2∆ (Fig 5E). Consistent with our prior findings
at the GAL gene cluster (Cloutier et al. 2016), we observed reduced Cyc8 binding to the
promoter of PCK1, SFC1, YAT1, and JEN1 in dbp2∆ cells as compared to wild type (Fig 5E).
This suggests that Dbp2 promotes efficient Cyc8 binding at target genes, providing a mechanism
for co-regulation of glucose repression. In conjunction with our prior studies showing that Dbp2
localization is responsive to nutrient availability (Beck et a., 2014), we propose that Dbp2
integrates nutritional status with metabolic gene regulation by maintaining Cyc8-dependent
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repression of lncRNA-targeted genes in the presence of glucose. This provides a putative
mechanism for regulation of cellular metabolism by an RNA helicase, suggestive of a unique
mechanism to regulate energy homeostasis in rapidly growing cells.

5.4

Discussion
Cells fine-tune their metabolic programs according to nutrient availability in order to

maintain homeostasis. Here, we demonstrate that the DEAD-box RNA helicase Dbp2 is a key
component of this metabolic network, mediating glucose repression of metabolic genes through
modulating Cyc8 association to the chromatin, and this role may involve lncRNAs. DEAD-box
proteins are the largest group of RNA helicases in the helicase enzyme family and have been
found in all domains of life (Linder and Jankowsky 2011). Dbp2, a DEAD-box protein in S.
cerevisiae, functions as a key player of proper gene expression (Cloutier et al. 2012; Beck et al.
2014). It is proposed that Dbp2 promotes assembly of proteins onto nascent RNA during
transcription (Ma et al. 2013), a role that may involve active remodeling of RNA secondary
structure and/or RNA-protein complexes. Interestingly, Dbp2 is actively shunted to the
cytoplasm upon glucose deprivation or a switch to another carbon source (Beck et al. 2014),
suggesting that Dbp2 may have a much more widespread role in metabolism and its effects
allow yeast cells to rapidly adapt to the environmental change.
The Cyc8-Tup1 complex in S. cerevisiae represses hundreds of genes including glucoserepressed genes, oxygen-regulated genes, and cell-type-specific genes (DeRisi 1997; Green and
Johnson 2004). Mutation or deletion of CYC8 or TUP1 leads to pleotropic effects including
defects in carbon catabolite repression (Gancedo 1998; Smith and Johnson 2000). Interestingly,
our study shows that CYC8 and DBP2, but not TUP1, repress respiration, one of several
pathways that is repressed in the presence of sufficient extracellular glucose. This is surprising as
Cyc8 and Tup1 are thought to function primarily as a complex. This suggests that Cyc8 may
have functions outside of Tup1, a role supported by the unique distribution of transcript
abundance between cyc8∆ and tup1∆ cells outside of those identified as co-regulated (Fig 2B,
right). A previous study has shown that simultaneous deletion of CYC8 and TUP1 results in
higher invertase activity, as a result of SUC2 derepression, than either of the single deletions
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alone (Williams and Trumbly 1990). This suggests that these two factors have independent as
well as shared activities.
Long noncoding RNAs (lncRNAs) are RNA polymerase II (RNAPII) products that lack
an open reading frame and are longer than 200 nucleotides in length (Kornienko et al. 2013).
Emerging evidence suggests many lncRNAs function in gene regulation of protein-coding gene
transcripts by acting as decoy, guide or scaffold of other regulatory factors or through
transcription interference (Wang and Chang 2011; Kornienko et al. 2013). We have previously
reported that Dbp2-dependent repression of the GAL cluster genes is dependent on expression of
lncRNAs associated with the GAL cluster (Cloutier et al. 2016). By analyzing the presence of
lncRNAs at co-repressed genes by DBP2 and CYC8, we now show that a significant fraction of
these genes are overlapped by lncRNAs encoded in cis, suggesting a genome wide link between
Dbp2, lncRNAs, and glucose repression. Interestingly, recent studies have connected several
lncRNAs to glucose homeostasis in mammalian cells (Sun and Wong 2016). For example, H19
functions in glucose homeostasis through the bioavailability of microRNA let-7 that inhibits the
expression of insulin receptor and lipoprotein lipase genes (Kallen et al. 2013; Gao et al. 2014).
Another example is the lncRNA UCA1, which has been shown to promote glycolysis by
activating mTOR-STAT3 and repressing miRNA143 in cancer cells (Li et al. 2014). A recent
genome study has revealed more than 350 metabolically sensitive lncRNAs in mice (Yang et al.
2016). This suggests that lncRNAs can act as key regulators in metabolism.
Taken together, our study suggests that Dbp2 integrates nutritional availability with
metabolic adaptation. This may also be the case for DDX5, the mammalian ortholog of Dbp2, as
knockdown effects glucose metabolic genes, reduces glycolysis and facilitates respiration in
mammalian cells (Mazurek et al. 2014; Xing et al. 2017). Future studies are necessary to
determine if the role of Dbp2 in cellular metabolism is conserved in mammalian cells. High
fermentation rate suppresses the respiratory network, a phenomenon referred to as Crabtree
effect (De Deken 1966). Many tumor cells, on the other hand, exhibit enhanced glycolic
activities and impaired respiratory activities, similar to the preference of S. cerevisiae in
undergoing aerobic fermentation (Diaz-Ruiz et al. 2011). This drastic change in metabolic
activities, which is referred to as Warburg effect, is a hallmark of many cancer cells (Diaz-Ruiz
et al. 2011). Thus, understanding how yeast cells control their metabolism has great implications
on human diseases.
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Figure 5.1. Dbp2 and other gene regulatory factors share co-regulated genes
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Figure 5.1 continued
A heatmap of p-values of the transcriptional profile comparisons between dbp2∆ and other
deletion strains is shown and sorted by the number of intersected genes. Lists of differentially
expressed genes in dbp2∆ were compared to that of 700 deletion strains (Beck et al. 2014;
Kemmeren et al. 2014). One-sided Fisher’s exact test was used to estimate the significance of the
observed intersection (Bonferroni correction). Common genes between the two studies (Beck et
al. 2014; Kemmeren et al. 2014) were used as background. Slow growth-related genes (SGGs)
(O’Duibhir et al. 2014) were filtered from the DEG lists to help identify more direct effects of
the deleted genes. A heatmap of the p-values indicating significant similarities (p ≤ 0.05, light to
dark red, color key) or no similarities (p > 0.05, light to dark blue, color key) of the co-regulated
genes between deletion strains and dbp2∆ was generated. Deletion strains sharing significant upand/or down-regulated genes with dbp2∆ are included in the heatmap. The heatmap was sorted
by the number of intersected up- (left) or down-regulated (right) genes between dbp2∆ and the
number of intersected genes in each comparison is listed on the right side of each heatmap.

Figure 5.2. TUP1 and CYC8 share co-repressed genes with DBP2
(A) Venn diagram showing the numbers of genes up-regulated upon loss of CYC8, TUP1 and
DBP2. The Venn diagram was generated by BioVenn (Hulsen et al. 2008). SGGs were removed
from the gene lists. (B) CYC8 and TUP1 repress a common subset of genes with DBP2, but to a
different extent. The log2FC of all genes except SGGs in cyc8∆ and tup1∆ was plotted against
that of dbp2∆ as well as of each other. Genes that are significantly up-regulated between dbp2∆
and cyc8∆ (left), dbp2∆ and tup1∆ (middle) or cyc8∆ and tup1∆ (right) are colored in red.
Dashed lines mark the log2FC cutoff in dbp2∆ (+/- log2(2.2)), cyc8∆ and tup1∆ (+/- log2(1.7)).
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Figure 5.3. DBP2 and CYC8, but not TUP1 are linked to cellular respiration
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Figure 5.3 continued
(A-C) Glucose repressed genes are enriched in DBP2 (A), CYC8 (B) and TUP1 (C) targets. A
Venn diagram showing the number of genes up-regulated in dbp2∆, cyc8∆, tup1∆ and upon
glucose deprivation for 2 h is shown (Freeberg et al. 2013). The p-value originates from one-sided
fishers exact tests conducted to estimate the significance of the intersection. Descriptions of
enriched GO clusters for the intersected genes in each Venn diagram are listed below each of the
Venn diagram. See Table S4-6 for complete results of the functional annotation clustering analysis.
(D) Loss of DBP2 or CYC8 leads to increased respiration, even in the presence of glucose. Oxygen
consumption in wild-type cells and indicated mutant cells was measured using the Seahorse XFe24
analyzer in the presence of 2% glucose or 2% ethanol. The dbp3∆ strain harbors a deletion of the
DEAD-box protein Dbp3 involved in rRNA processing, and serves as a negative control. Data
show the mean ± S.D. of three independent biological replicates. *p < 0.05, **p < 0.01, ,*** p <
0.001. (E) Ectopic expression of CYC8 or TUP1 from a CEN plasmid rescues the heat sensitivity
of cyc8∆ and tup1∆, respectively. Serial dilutions of wild type, cyc8∆ and tup1∆ strains harboring
an empty vector (pRS315), cyc8∆ strain harboring pCYC8 and tup1∆ strain harboring pTUP1 were
spotted on SC-LEU plate and incubated at 37˚.
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Figure 5.4. DBP2/CYC8/TUP1 co-repressed genes are overlapped by long non-coding RNAs
(A-D) Genomic tracks of PCK1, SFC1, YAT1, JEN1 and associated lncRNAs from dbp2∆ and
wild type. Normalized strand-specific genome tracks of PCK1 (A), SFC1 (B), YAT1 (C) and
JEN1 (D) in wild type and dbp2∆ are presented at the bottom (GSE99097). Gene and annotated
lncRNA (CUTs, SUTs and XUTs) tracks (Xu et al. 2009; Wery et al. 2016) are shown at the top.
The names of short transcripts are listed above the corresponding arrow. (E). Gene start region of
co-repressed genes are frequently overlapped by lncRNAs. Gene start region is defined as the
region of 100bp upstream plus the first 100bp of ORF. The p-value indicates significant
enrichment of genes overlapped with annotated lncRNAs among all of the co-repressed genes
(proportional test, one-sided).
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Figure 5.5. Loss of DBP2 results in reduced Cyc8 binding and rapid induction of genes
involved in utilizing non-fermentable carbon source
(A-D) Transcriptional induction assays of PCK1 (A), SFC1 (B), YAT1 (C) and JEN1 (D) were
conducted by shifting wild type and dbp2∆ cells from SC+2% glucose to SC+1% potassium
acetate media. RNA was collected from cells prior to (0 min) and at 30, 60, 90, 120, 240 and 300
min following nutritional shift. Transcripts were detected by northern blotting using 32P-labeled,
double-stranded DNA probes. SCR1 serves as an internal control. Resulting transcript profiles
from two biological replicates (error bars indicate ± S.D.) were normalized to SCR1 and plotted
overtime (right). The normalized expression of the time points with maximum transcript levels in
each induction profile was set to 1. The transcript, presumably XUT1417, is label with arrow.
(E) ChIP of Cyc8-3xflag in wild type and dbp2∆ cells. Wild type and dbp2∆ strains harboring
3xFLAG-tagged CYC8 at the endogenous locus were cultivated in YP+2% glucose. ChIP was
conducted using an anti-flag antibody. A wild type strain with untagged CYC8 was used as
negative control. Results were represented as percentage of immunoprecipitated DNA over input
and shown as mean ± S.D. of three independent biological replicates. *p < 0.05; **p < 0.01.
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Table 5.1. Yeast strains
Strains

Genotype

Source

Wild type (BY4741)

MATa his3∆1 leu2∆0 met15∆0 ura3∆0

Open Biosystems

dbp2∆
CYC8-3xFLAG
dbp2∆ CYC8-3xFLAG
cyc8∆
tup1∆
dbp3∆

MATa dbp2::KanR ura3∆0 leu2∆0 his3∆0
TRP1 met- lys?
MATa his3∆1 leu2∆0 met15∆0 ura3∆0
CYC8-3xFLAG
MATa

dbp2::HygB

his3∆1

leu2∆0

met15∆0 ura3∆0 CYC8-3xFLAG
MATa

cyc8::KanR

his3∆1

leu2∆0

his3∆1

leu2∆0

his3∆1

leu2∆0

met15∆0 ura3∆0
MATa

tup1::KanR

met15∆0 ura3∆0
MATa

dbp3::KanR

met15∆0 ura3∆0

(Cloutier et al. 2012)
(Cloutier et al. 2013)
(Cloutier et al. 2013)
Open Biosystems
Open Biosystems
Open Biosystems

Table 5.2. Oligos used for plasmid construction
SmaI-CYC8 F

TCCCCCGGGCTAAAGCACATCCGATCTGAG

BamHI-CYC8 R

CGCGGATCCCGTAGAACCCAAAGCATTAGG

SmaI-TUP1 F

TCCCCCGGGGTAAGTCTGCGGAATCGATCTG

SpeI-TUP1 R

GGACTAGTAAGTGCGACGTGGACGAATC
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Table 5.3. Oligos used for northern blotting (dsDNA probes).
PCK1 F

ATGGTCTATCAACCGTGAAAGAGC

PCK1 R

TCAACAATCTATGTGGGTCTGCG

SFC1 F

CATCCAGCCATCAATCTCATGG

SFC1 R

TAGTATCCAATGGAGCGTTGGA

JEN1 F

CTGGTGAACAGCAACAACCTG

JEN1 R

GGTGCATCTTCAATCGCTGTT

YAT1 F

ATACATCGAGCAGTTCTGGTATGAC

YAT1 R

GGATCGAGTCTGTGTAGATGTCTG

SCR1 F

GGATACGTTGAGAATTCTGGCCGAGG

SCR1 R

AATGTGCGAGTAAATCCTGATGGCACC

Table 5.4. Primetime assays for ChIP
Name
PCK1
SFC1
YAT1
JEN1

Forward

Reverse

Probe

ATTATGGATAGG

ACGTACCATTGTC

CCCAAACAGGATTGT

CGGATAAAGGG

CAACCAG

AAAGCTTAGACGC

CTGCTCGAGGTG

TGTGACATTACGG

CTTTGAGATTCTTGTC

CTATCTTTT

TTTGTAAAAGG

GCCACGGAGT

GCGGAATGACA

TCCTTGCCCCTTTA CACGATCTCTCCAGTC

AAACCATCAG

CTTTGG

ACAATGGCAA

CTTCTGCACACC

ACCAGGTAACGTT

TCTTCACTTAACGGTC

ATCCGG

CTAATGCAT

TTTTGCCCCC

164

Table 5.5. Gene co-repressed by CYC8, TUP1, and DBP2 (82)
Annotatio

Enrichme

Description of

n cluster

nt score

GO terms

2.35

e

Unique genes

Coun
t

Monosaccharid
1

Gene

metabolic

process

GAC1, ERR3, GAL3, YHR210C,
NDE2, YNR071C, PCK1, SGA1

8

ROX1, GAC1, YOR338W, RPM2,
2

2.07

Regulation
transcription

of

CSR2, VHR1, YAP6, REG2, SMP1,
MIG1, THI2, RGM1, SUT1, HAL1, 21
GAL3, YPR196W, ACA1, CUP9,
GIS1, POG1, ASK10

Table 5.5. Table of GO term clusters of CYC8, TUP1, and DBP2 commonly repressed genes.
Functional annotation clustering analysis was conducted with the 82 genes co-repressed by
CYC8, TUP1 and DBP2 in Figure 2A. aGene ontology clusters with significant enrichment score
of at least 1.3 (p ≤ 0.05). bGO term descriptions for the corresponding function annotation
cluster. cUnique genes included in each GO cluster. dNumber of unique genes in each cluster.
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Table 5.6. Genes co-repressed by CYC8 and DBP2 (124)
Annotatio

Enrichme

Description

n cluster

nt score

GO terms

of

Gene
Unique genes

Coun
t

Phosphate

1

2.31

metabolic

ATP1,

ATP6,

COX9,

CYC1,

process/Oxidativ

COX8, QCR6, ATP19, ATP18,

e

GAL3, MRK1, VHS1, KIN82,

phosphorylation/

FRK1, SKS1, SFC1, JEN1, FRE7

17

Ion transport
Generation

of

precursor
2

1.87

metabolites and
energy/

ATP1,

ATP6,

COX9,

CYC1,

COX8, QCR6, ATP19, ATP18,
GAC1, YBR238C, ERR3, ISF1,

16

NDE2, YJL045W, SGA1, FRE7

Cell death

ROX1, GAC1, YOR338W, RPM2,

3

1.64

Regulation

of

transcription

CSR2,

VHR1,

YAP6,

REG2,

SMP1,

MIG1,

THI2,

MIG2,

RGM1,

SUT1,

HAL1,

SKS1, 25

GAL3, YPR196W, ACA1, SOK2,
CUP9, MET32, GIS1, POG1,
ASK10

4

5

1.63

1.58

Sulfur metabolic
process

1.55

VHR1, MET32, ADI1, PET18, 9
YAT1

Carbohydrate

MAL11, STL1, HXT4, HXT1,

transport

SKS1

Monosaccharide
6

THI2, MET17, THI22, SNZ1,

metabolic
process

GAC1, ERR3, GAL3, YHR210C,
NDE2, YNR071C, PCK1, SGA1

5

8

166

Table 5.7. Genes co-repressed by TUP1 and DBP2 (91)
Annotatio

Enrichme

Description of

n cluster

nt score

GO terms

Gene
Unique genes

t

Monosaccharid GAC1,
1

3.30

e

Coun

ERR3,

metabolic YHR210C,

process

TOS3,

NDE2,

GAL3,
PFK27, 10

YNR071C, PCK1, SGA1
ROX1, GAC1, YOR338W, RPM2,

2

3.12

Regulation
transcription

of

CSR2, VHR1, YAP6, REG2, SMP1,
MIG1, THI2, RGM1, SUT1, HAL1, 22
GAL3, ZNF1, YPR196W, ACA1,
CUP9, GIS1, POG1, ASK10

Regulation
3

1.55

transcription

of ROX1, GAC1, YOR338W, RPM2,
CSR2, VHR1, YAP6, REG2, SMP1,

from RNAPII MIG1, THI2, RGM1, SUT1, HAL1,
promoter

15

GAL3

Table 5.7. Table of GO term clusters of TUP1, and DBP2 commonly repressed genes. Functional
annotation clustering analysis was conducted with the 91 genes co-repressed by TUP1 and DBP2
in Figure 2A.

167

CHAPTER 6

6.1

PERSPECTIVES AND UNPUBLISHED RESULTS

Perspectives
Enzyme kinetic analyses reveal that DDX5 unwinds RNA duplexes faster as compared to

its S. cerevisiae counterpart, Dbp2 (Xing et al. 2017). This is dependent on the mammalian specific
C-terminal extension (CTE) of DDX5 (Xing et al. 2017). The CTE is dispensable for the ability
of DDX5 to complement DBP2 in S. cerevisiae, however, biological functions of this region in
mammalian cells is unclear. Investigating the significance of the CTE in mammalian cells may tell
us if higher unwinding activity of DDX5 is required in vivo.
We also showed that DDX5 fully rescues the growth defects and cryptic transcription of
dbp2∆ (Xing et al. 2017). This indicates that DDX5 and Dbp2 share similar protein/RNA partners
and perform similar activities in yeast. It will be interesting to further test if the cellular localization
of DDX5 is dependent on glucose availability, or if DDX5 also regulates R-loop formation.
Last but not least, the implication of DDX5 in glucose metabolism suggests that DDX5
may function in diseases involving deregulated glucose metabolism. For example, many types of
cancer cells display defects in glucose metabolism despite their heterogeneity in other aspects
(Liberti and Locasale 2016). DDX5 may not necessarily be a driver for cancers, instead, it may be
required to maintain the fast and continuous growth of malignant cells. This hypothesis can be
tested by knocking down DDX5 in cancer cells and overexpressing DDX5 in non-disease cells
followed by examination of the cell growth phenotypes. Furthermore, the precise molecule targets
and mechanism of action underlying DDX5’s roles in glucose metabolism need to be elucidated.

6.2

Unpublished Results and Future Plans

6.2.1 DDX5 is overexpressed in SCLC cell lines and is required for the growth of SCLC
cell lines in vitro.
Small cell lung cancer (SCLC) accounts for 15% of all lung cancer cases (Gazdar et al.
2017). SCLC shows good initial response to chemotherapies, but develops resistance rapidly,
resulting in a relapse of the disease (Asai et al. 2014). However, this malignant disease is largely
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under characterized, meaning that effective treatment is lacking (Rudin and Poirier 2017). To
address this, a current funding initiative has been put forward to promote the investigation of SCLC
by the National Cancer Institute (NCI).
DDX5 is an RNA helicase that is frequently overexpressed in cancers (Dai et al. 2014).
DDX5 acts as a co-factor for transcription factors whose activities promote cancers (Fuller-Pace
2013). Moreover, DDX5 activates the oncogenic Wnt signaling pathway through facilitating the
nuclear translocation of b-catenin (Yang et al. 2006; Arun et al. 2012). My research recently
revealed that DDX5 promotes glycolysis ((Xing et al. 2017), Chapter 4), a process that is
commonly upregulated in cancers (i.e. the Warburg effect) (Vander Heiden et al. 2009). This
finding suggests that cancer cells may acquire dependence on DDX5 due to the requirement of
elevated glycolysis. Similar to other cancers, the Warburg effect is prominent in SCLC, as
evidenced by a positive correlation between the rate of glycolysis and the severity of the disease
(Tripathi et al. 2017). This leads us to hypothesize that DDX5 may be required for the survival of
SCLC.
To test this hypothesis, we analyzed the expression levels of DDX5 in SCLC cell lines and
evaluated the role of DDX5 in the growth of a chemo-resistant SCLC cell line H69AR in vitro. We
showed that DDX5 is overexpressed in SCLC cells lines, but not the non-disease lung epithelial
cell line HBEC, or the non-small cell lung cancer cell lines (Fig. 6.1).
To determine if DDX5 is required for the growth and survival of SCLC cell lines in vitro,
we generated stable H69AR cell lines that express DDX5-specific short-hairpin RNAs (shRNAs)
upon doxycycline addition. Downregulation of DDX5 expression reduces the growth rate in
standard H69AR culture conditions, and inhibits the colony formation ability of H69AR cells in
soft agar (Fig. 6.2). This means that DDX5 is required for both normal growth and anchorage
independent growth of H69AR cells in vitro. The growth inhibition is not likely to be an off-target
effect since we observe similar phenotypes with two different shRNAs.
6.2.2 DDX5 knockdown in the SCLC H69AR cells leads to respiration defect.
DDX5/Dbp2 is linked to metabolism in yeast and in humans(Xing et al. 2017; Wang et al.
2017). To study the mechanism of growth inhibition in H69AR cells, we analyzed the effect of
DDX5 knockdown in glycolysis and respiration using the Seahorse metabolic analyzer. We
showed that cellular respiration is significantly reduced upon DDX5 knockdown (Fig. 6.3),
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whereas glycolysis is not impaired. This is different from what we observed in the hepatocyte
AML12 cells (Xing et al. 2017). In AML12 cells, DDX5 knockdown leads to downregulation of
glycolysis and upregulation of respiration (Xing et al. 2017). These seemingly controversial
observations may be due to cell-type specific expression of metabolic genes or genes that encode
metabolic regulators. For example, GLUT2 encodes a glucose transporter and is specifically
expressed in a subset of cell types including hepatocytes, such as the AML12 cells (Karim et al.
2012). Moreover, long non-coding transcripts are less conserved in mouse and human (Necsulea
et al. 2014). Therefore, lncRNA-mediated functions of DDX5 may differ between mouse cell lines
(e.g. AML12) and human cell lines (e.g. H19AR). Nevertheless, our results indicate that metabolic
pathways required for cell growth are impaired.
6.2.3 Future Plan – To define the changes in gene expression and metabolomics in SCLC
cell lines upon DDX5 knockdown.
In order to understand the global changes in gene expression and cellular metabolism in
H69AR upon DDX5 knockdown, we have sent samples for RNA-sequencing and metabolites
profiling. Combing the genomics and metabolomics datasets not only will help us identify the
specific metabolic processes targeted by DDX5, but will also pinpoint the genes responsible for
DDX5’s role in such processes.
6.2.4 Future Plan - To determine if DDX5 is required for SCLC cell growth in vivo.
We have showed above that DDX5 are required for the growth of SCLC cell lines in vitro
, suggesting that inhibition of DDX5 may be a novel treatment for SCLC. However, essential in
vivo studies are lacking to further this notion.
We will implant H69AR cells with or without the DDX5-shRNA into nude mice and
measure the ability of them to grow tumor. We hypothesize that induction of the shRNA targeting
DDX5 will inhibit tumor growth in immunodeficient mice. In addition, because the H69AR is a
chemo-resistant SCLC cell line, we will test if inhibition of DDX5 sensitizes the H69AR-xenograft
to chemotherapy.
For initial in vivo assessment of targeting DDX5 with small molecule, a patient-derived
xenograft (PDX) model will be employed. Four models are available for purchase from The
Jackson Laboratory and are licensed for expansion. Histologic slides are available for each one,
which will be purchased for testing the expression of DDX5 to select the best model for
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investigation. Using the desired PDX model, we will test the efficacy of the DDX5 inhibitor RX5902, which specifically inhibits the activities of DDX5 phosphorylated at Y593 (Kost et al. 2015).
The Biological Evaluation Facilities at Purdue University Center for Cancer Research will
conduct these experiments and help me evaluate the results.

6.3
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Figure 6.1. DDX5 is overexpressed in SCLC cell lines
A. Western blotting analysis shows that DDX5 is overexpressed in SCLC cell line H69 (ATCC)
and its chemo-resistant variant H69AR (ATCC), but not the non-disease lung epithelial cell line
HBEC (ATCC), or the three non-small cell lung cancer (NSCLC) cell lines tested (Whole cell
extract of NSCLC cell lines were generously provided by the Kasinski lab at Purdue University).
B. Western blotting analysis conducted by Dr. Owonikoko’s lab (collaborator) at Emory
University shows that DDX5 is expressed in most small cell lung cancer cell lines tested. DDX5
and b-Actin antibodies are commercially available (a-DDX5: Millipore 05-850, a-b-Actin: Sigma
A5441).
A. Western Blot

B. Growth Curve Analysis

C. Colony Formation Assay
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Figure 6.2. DDX5 knockdown inhibits the growth of H69AR cells
A. Western blot shows that DDX5 is efficiently knocked-down in H69AR cells. shRNA expression
was induced by adding 1 µg/ml doxycycline for 3 days. B. Cell count measurement using
fluorescent DNA stain (Thermo Fisher, CyQUANT® Direct Cell Proliferation Assay Kit) shows
that knocking down DDX5 reduces the growth rate of H69AR cells. Briefly, 300 cells were seeded
per well in five 96-well plates on day 0, and one plate were stained and measured at indicated time.
Error bars indicate SD from 4 replicates. C. Soft agar colony formation assays show that knocking
down DDX5 reduces the anchorage independent growth of H69AR cells. Soft agar assays were
conducted as described (Borowicz et al. 2014). 1000 or 5000 cells were seeded in the upper layer
per well in 6-well plates with two layers of agar. The lower layer contains 0.5% agar and the upper
layer contains 0.3% agar. These plates were incubated in a 37˚C CO2 incubator for 21 days and
stained with nitroblue tetrazolium. Colonies were counted using the OpenCFU software
(Geissmann 2013). Error bars indicate SD from 3 replicates.
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Figure 6.3. DDX5 knockdown inhibits respiration
A. Fluorescent glucose analog 2-NBDG uptake assay shows that DDX5 knockdown in H69AR
cells results in reduction in H69AR cells. Cells were seeded in 6-well plate the day before the
uptake assay. The next day, the culture media was replaced with fresh culture media containing
100 µM 2-NBDG and cell were incubated in a 37˚C CO2 incubator for 30 min. in 200 µl lysis
buffer containing 20 mM Tris (pH 7.4), 1% sodium deoxycholate, and 40 mM KCl (Blodgett et al.
2011). 2-NBDG levels were determined by fluorescence of 2-NBDG (λex=465 nm, λem=540 nm).
B. DDX5 knockdown does not significantly change the rate of glycolysis in H69AR cells. 200000
H69AR cells were seeded in the Seahorse XFe24 Cell Culture Microplates the day prior to the
experiment. Basal and maximal glycolysis rates were measured using the Seahorse metabolic
analyzer with the Glycolysis Stress Test Kit according to manufacturer's instruction. Glycolytic
reserve is the difference between maximal and basal rates. C. DDX5 knockdown leads to
downregulation of cellular respiration. 200000 H69AR cells were seeded in the Seahorse XFe24
Cell Culture Microplates the day prior to the experiment. Basal and maximal oxygen consumption
rates were measured using the Seahorse metabolic analyzer with the Mito Stress Test Kit according
to manufacturer's instruction. Spared capacity represents the difference between maximal land
basal rates. Error bars indicate SD of at least 5 biological replicates.
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CONTRIBUTION STATEMENT

My scientific contribution to the field the broader scientific community
My research is in the field of RNA helicases, which are a class of enzymes that modulate
RNA structures. In the course of my research, I have developed skills that make me the expert
biochemist in the lab. Using these skills, I have helped my colleagues further their research by
performing key biochemical experiments, and thus earned co-authorship on multiple papers (see
Vita). For my own research project, I compared the biochemical activities and biological
functions of a yeast DEAD-box RNA helicase Dbp2, and its human ortholog DDX5.
Surprisingly, this showed that they are functionally conserved, despite 1 billion years of
evolution (Xing et al., 2017). This validated the notion that critical ancestral functions of many
essential genes are resilient to drift in sequences, and that protein interaction interfaces are likely
being retained. Moreover, I showed that DDX5 is an active RNA helicase that has higher
unwinding activities as compared to Dbp2, validating that DEAD-box proteins possess bona fide
RNA unwinding activities (Xing et al., 2017). Last but not least, I showed that DDX5 and Dbp2
both promote glycolysis, suggesting a novel mechanism of metabolic regulation through RNA
helicases (Xing et al., 2017).
Given that cancer cells display misregulated glucose metabolism, the link between
Dbp2/DDX5 and glucose metabolism has lead us to study the roles of DDX5 in cancer,
specifically, in small cell lung cancer (SCLC). Small cell lung cancer is a largely
undercharacterized malignancy, the five-year survival rate of which is less than 10%. I have now
shown that DDX5 is overexpressed in SCLC cell lines and downregulation of DDX5 inhibits
SCLC cell growth in vitro. My current research may facilitate the identification of RNA
helicases as targets for small cell lung cancer treatment.
My work not only creates new research directions in the Tran lab, but also facilitates
collaborations. I have 4 on-going collaborations with laboratories at Purdue University, Case
Western Reserve University, and Emory University. These collaborations are rewarding as they
have translated into collaboration on a national research grant, a peer-reviewed publication in the
Hepatology journal, and a manuscript in preparation (see Vita).
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Due to the importance of tightly controlled metabolism to all cell types and human wellbeing, my studies have broad impact to the scientific community. The American Heart
Association funded my predoctoral fellowship application acknowledging the contribution of my
research to the field of cardiovascular diseases. Furthermore, my work is cited in journals from
different fields including G3, Journal of Molecular Biology, and Nature Immunology.
Overall, my research represents the most thorough biochemical characterization of the
human DEAD box helicase DDX5, and provides the first evidence of an RNA helicase involving
in metabolism. This work is well recognized by researchers both in my field and in the broader
scientific community.

Declaration of collaborative work
Chapter 1. Introduction
I wrote the majority of this chapter. Section 1.3 is modified from a section in Dr. Wai Kit
Ma’s thesis. Dr. Elizabeth Tran provided extensive comments and edited this chapter.
Chapter 2. Recruitment, duplex unwinding and protein-mediated inhibition of the DEAD
box RNA helicase Dbp2 at actively transcribed chromatin
Chapter 2 is a version of the research article published in the Hepatology journal entitled
“Recruitment, duplex unwinding and protein-mediated inhibition of the DEAD box RNA
helicase Dbp2 at actively transcribed chromatin”. This paper is authored by Wai Kit Ma, Bishnu
P. Paudel, Zheng Xing, Ivan G. Sabath, David Rueda, and Elizabeth J. Tran. This article is
distributed under the terms of the This article is distributed under the terms of Elsevier noncommercial user license.
I conducted the fluorescence anisotropy experiments (Fig 2.7A and Fig 2.8).
I made the figure and wrote the section describing the experiments.
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Chapter 3. RNA helicase DEAD-box protein 5 regulates PRC2/HOTAIR function in
Hepatitis B Virus infection and hepatocarcinogenesis
Chapter 3 is a version of the research article published in the Hepatology journal entitled
“RNA helicase DEAD-box protein 5 regulates PRC2/HOTAIR function in Hepatitis B Virus
infection and hepatocarcinogenesis”. This paper is authored by Hao Zhang, Zheng Xing,
Saravana Kumar Kailasam Mani, Brigitte Bancel, David Durantel, Fabien Zoulim, Elizabeth J.
Tran, Philippe Merle, and Ourania Andrisani. This article is distributed under the terms of the
Creative Commons Attribution-NonCommercial-NoDerivs License.
I conducted the biochemical (in vitro) experiments (Fig 4B and 4C).
I made the figure and wrote the section describing the experiments.
I generated critical reagents for Fig 2D, 3E, 4A, 4D, 4E, 4F, 5C, and 5D.
Chapter 4. Characterization of the mammalian DEAD-box protein DDX5 reveals
Functional conservation with S. cerevisiae ortholog Dbp2 in transcriptional control and
glucose metabolism.
Chapter 4 is a version of the research article published in the RNA journal entitled
“Characterization of the Mammalian DEAD-box protein DDX5 Reveals Functional
Conservation with S. cerevisiae ortholog Dbp2 in Transcriptional Control and Glucose
Metabolism”. This paper is authored by Zheng Xing, Siwen Wang, and Elizabeth Tran. This
article is distributed under the terms of the Creative Commons License (AttributionNonCommercial 4.0 International License)
I conduced all experiments, wrote the paper, made all figures, and conducted all revision
experiments. Dr. Elizabeth Tran provided extensive comments and editing.
Chapter 5. Metabolic adaptation to nutrients involved co-regulation of gene expression by
the RNA helicase Dbp2 and the Cyc8 co-repressor in Saccharomyces cerevisiae.
Chapter 5 is a version of the research article published in Journal G3: Genes, Genomes,
Genetics entitled “Metabolic Adaptation to Nutrients Involves Coregulation of Gene Expression
by the RNA Helicase Dbp2 and the Cyc8 Corepressor in Saccharomyces cerevisiae”. This paper
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is authored by Siwen Wang, Zheng Xing, Pete Pascuzzi and Elizabeth Tran. This article is
distributed under the terms of Genetics Society of America LICENSE # 4336580381613.
I conducted the metabolic profile measurements (Fig 3D). I Made the figure (Fig 3D) and
wrote the section describing this figure.
Chapter 6. Perspectives and unpublished results
I produced data for this section and wrote this section. Dr. Elizabeth provided extensive
comments and editing.
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Education
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2018
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Bird Stair Fellowship, Purdue University, US **

2017

Beach Travel Award, Purdue University, US

2016
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** The Bird Stair Fellowship funds innovative research in the biochemistry department.
*** The Bird Stair Research Funding funds collaborative research projects proposed by two
students in the Biochemistry department.
Publications
1. Wang S, Xing Z, & Tran EJ. (2017) Metabolic Adaptation to Nutrients Involved Co-regulation of
Gene Expression by the RNA Helicase Dbp2 and the Cyc8 Co-repressor in Saccharomyces cerevisiae. G3
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(Bethesda). 7(7):2235-2247 (Impact factor: 2.861. Role: Conducted the metabolic profile
measurements. Made the figure and wrote the section describing the experiments.)
2. Xing Z, Wang S, &Tran EJ. (2017) Characterization of the Mammalian DEAD-box protein DDX5
Reveals Functional Conservation with S. cerevisiae ortholog Dbp2 in Transcriptional Control and
Glucose Metabolism. RNA. 23(7):1125-1138 (Impact factor: 4.605. Role: Conduced all

experiments, wrote the paper, made all figures, and conducted all revision experiments.)
3. Zhang H, Xing Z, Kailasam Mani SK, Bancel B, Durantel D, Zoulim F, Tran EJ, Merle P, &
Andrisani OM (2016) RNA Helicase DDX5/p68 regulates Polycomb Repressor Complex 2
function and stability during Hepatitis B Virus Infection and Hepatocarcinogenesis. Hepatology.
64(4):1033-48 (Impact factor: 13.246. Role: Conducted the biochemical (in vitro) experiments.
Made the figure and wrote the section describing the experiments. Generated critical reagents for
overexpressing DDX5 and DDX5 mutants.)
4. Beck ZT, Xing Z, Tran EJ. (2016) LncRNAs: Bridging Environmental Sensing and Gene Expression.
RNA Biol. 13(12): 1189-1196 (Impact factor: 3.9. Role: Made the yeast lncRNA table.)

5. Ma WK, Paudel BP, Xing Z, Sabath IG, Rueda D, &Tran EJ (2016) Recruitment, Duplex
Unwinding and Protein-Mediated Inhibition of the DEAD-box RNA Helicase Dbp2 at Actively
Transcribed Chromatin. Journal of Molecular Biology. 428(6):1091-1106 (Impact factor:
4.632. Role: Conducted the fluorescence anisotropy experiments. Made the figure and wrote the
section describing the experiments.)
6. Lai YH, Choudhary K, Xing Z, Aviran S, & Tran EJ (2018) Genome-wide Discovery of
DEAD-box RNA Helicase Targets Reveals RNA Structural Remodeling in Transcription
Termination. Submitted
7. Wu G, Xing Z, Tran EJ, Yang D (2018) DDX5 is a G-quadruplex helicase and can
transactivate MYC expression. Submitted
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